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Abstract 
The aromatic amino acid biosynthesis pathway, together with its downstream branches, 
represents one of the most commercially valuable biosynthetic pathways, producing a diverse 
range of complex molecules with many useful bioactive properties. Aromatic compounds are 
crucial components for major commercial segments, from polymers to foods, nutraceuticals, and 
pharmaceuticals, and the demand for such products has been projected to continue to increase at 
national and global levels. Compared to direct plant extraction and chemical synthesis, microbial 
production holds promise not only for much shorter cultivation periods and robustly higher 
yields, but also for enabling further derivatization t  improve compound efficacy by tailoring 
new enzymatic steps. This review summarizes the biosynthetic pathways for a large repertoire of 
commercially valuable products that are derived from the aromatic amino acid biosynthesis 
pathway, and it highlights both generic strategies and specific solutions to overcome certain 
unique problems to enhance the productivities of microbial hosts.  
 
Keywords: aromatic amino acid biosynthesis, shikimate pathway, de novo biosynthesis, 
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Highlights 
• The aromatic amino acid biosynthesis pathway yields commercially valuable products. 
• The broad scope of products from aromatic amino acid biosynthesis is described. 
• Biosynthetic pathways and interconnections among the sub-branches are presented. 
• High-level organization of enzymes of the upstream module is illustrated. 
• The exemplary sophisticated regulations in the upstream pathway at various levels are 
highlighted. 
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1. Introduction 
Over the past two decades, technologies arising from synthetic biology and systems biology 
have revolutionized metabolic engineering to establish bio-based production in engineered 
microorganisms. The aromatic amino acid biosynthesis pathway, together with its downstream 
branches, represents one of the most valuable biosynthetic pathways. The products derived from 
this pathway range widely, from various high-volume low-value commodity chemicals to the 
realm of specialty chemicals and complex natural products (Suastegui and Shao, 2016; 
Thompson et al., 2015; Zhang et al., 2018).  
The pathways leading up to the synthesis of L-tryptophan (L-Trp), L-phenylalanine (L-Phe), 
and L-tyrosine (L-Tyr) nodes are ubiquitous in all microorganisms, constituting the backbone 
reactions for the synthesis of a diverse class of compounds. This portion of the pathway can be 
subdivided into the shikimate pathway, the L-Tyr branch, the L-Phe branch, and the L-Trp branch. 
The model hosts Escherichia coli and Saccharomyces cerevisiae have been manipulated to 
produce this group of compounds in most studies, but other species such as Scheffersomyces 
stipitis, Pseudomonas putida, nd Corynebacterium glutamicum have also been engineered as 
production hosts, and in many cases, they outperform E. coli and S. cerevisiae thanks to their 
special biochemical and metabolic features.  
The downstream pathways beyond the biosynthesis of the three aromatic amino acids open a 
treasure trove of high-value molecules with extremely diverse structures, the majority of which 
are produced by plants. These natural products encompass a billion dollar market (Pandal, 2014; 
Rawat et al., 2013; Rinner and Hudlicky, 2012; Winter and Tang, 2012), but their extraction 
from plant tissues requires immense quantities of biomass and cumbersome separation processes. 
Open-field plant growth and the associated costs are also susceptible to environmental factors, 
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which are associated with variability in product yield and composition. In addition, the complex 
and delicate chemistry involved in forming these aromatics makes their de novo chemical 
synthesis very challenging and economically unviable at commercial scales. The implementation 
of microbial factories carrying the combination of tailored endogenous metabolism and 
heterologous biosynthetic pathways represents an encouraging solution to these problems. It 
potentially ensures sustainable and greener processes with higher yields, and also enables further 
derivatization for new drug development. Unlike thebiosynthesis of the high-volume low-value 
chemicals, which has been attempted in various microb al hosts, strain engineering to produce 
these plant-derived natural products has been mainly performed in E. coli and S. cerevisiae. 
Between these two hosts, S. cerevisiae also has the advantage of expressing membrane-
associated eukaryotic enzymes (e.g., cytochrome P450s), which are required for the synthesis of 
some complex natural products derived from plants (Chang and Keasling, 2006; Jung et al., 
2011). 
This review will focus on illustrating the broad scope of products that are derived from the 
aromatic amino acid biosynthesis, their biosynthetic pathways, and the interconnections among 
individual sub-branches. The article begins with the reaction skeleton of aromatic amino acid 
biosynthesis, the different enzyme organizations in prokaryotes and eukaryotes, and the 
sophisticated regulatory mechanisms at various levels. The products belonging to the relevant 
sub-branch reactions are color-coded and grouped together for effective discussion. The 
relatively generic strategies to enhance the upstream flux and the specific solutions to the 
individual problems appearing in the biosynthesis of downstream products are addressed 
separately. We provide future perspectives and recommendations of novel strategies to increase 
the productivities at the end.  
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2. The backbone reactions of aromatic biosynthesis 
2.1 The shikimate pathway 
The shikimate pathway initiates with the condensation of the intermediates of glycolysis and 
the pentose phosphate pathway (PPP), phosphoenolpyruvate (PEP) and erythrose 4-phosphate 
(E4P), respectively (Figure 1a). In S. cerevisiae, the condensation reaction is catalyzed by the 3-
deoxy-D-arabinoheptulosonate 7-phosphate (DAHP) synthase isozymes Aro3 and Aro4, which 
are subjected to feedback inhibition caused by L-Phe and L-Tyr, respectively. In E. coli, three 
isozymes—AroF, AroG, and AroH—play a role in the condensation reaction and are regulated 
by L-Tyr, L-Phe, and L-Trp, respectively, via the transcriptional regulatory protein TyrR (Pittard 
and Yang, 2008). Strikingly, the enzymes in charge of the subsequent series of reactions from 
DAHP to 5-enolpyruvylshikimate-3-phosphate (EPSP) in different organisms have different 
genetic organizations. In lower eukaryotes, the subsequent five distinct catalytic domains are 
fused to form a pentafunctional enzyme that is encoded by a single open reading frame, ARO1, to 
complete the reactions whereas bacteria and plants direct the five reactions by separately 
encoded enzymes. Finally, the central branch point metabolite chorismic acid is produced from 
EPSP by chorismate synthase, Aro2, and it enters one of the two aromatic amino acid branches. 
The determination of these early reactions was mainly based on isolating the intermediates that 
accumulated in the respective gene disruption strains nd analyzing the responses of the 
auxotrophs to the supplementation of the proposed mtabolic intermediates. The detailed 
biochemical features of the enzymes involved in the upstream module have been summarized in 
two review articles (Herrmann, 1995; Pittard and Yang, 2008). 
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2.2 The L-Tyr branch and L-Phe branch  
L-Tyr and L-Phe differ only at the 4-hydroxyl functional group, and their biosynthetic steps 
share the first one, the rearrangement of the enolpyruvyl side chain of chorismate to form 
prephenate (Figure 1b and 1c). In yeast and some bacteria (e.g., Bacillus subtilis), the 
monofunctional chorismate mutase Aro7 is responsible for this conversion, following which, the 
pathway diverges into L-Phe biosynthesis through prephenate dehydratase Pha2 and into L-Tyr 
biosynthesis through another prephenate dehydrogenase Tyr1, yielding the intermediates 
phenylpyruvate and 4-hydroxylphenylpyruvate, respectiv ly. In contrast, E. coli uses two 
bifunctional enzymes to complete the rearrangement of chorismate to prephenate and the 
subsequent step. The gene pheA encodes chorismate mutase-prephenate dehydratase, which is 
feedback inhibited by L-Phe, whereas tyrA encodes chorismate mutase-prephenate 
dehydrogenase, which is feedback inhibited by L-Tyr. Interestingly, the N-terminal parts of these 
two bifunctional enzymes that have chorismate mutase activity do not share significant 
homology with each other or the monofunctional chorismate mutase found in yeasts (Braus, 
1991). The last step in L-Phe and L-Tyr biosynthesis is a reversible transamination reaction, 
catalyzed by aromatic amino acid aminotransferases; th  isozymes are encoded by aro8 and aro9 
in fungi and mainly by tyrB in bacteria. Furthermore, some bacteria, such as cy nobacteria and 
Pseudomonas pp., perform the dehydrogenation reaction prior to the aminotransfer step by 
using arogenate as an intermediate, which is a preferred route in plants (Bonner and Jensen, 
1987).   
 
2.3 The L-Trp branch 
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The L-Trp branch is organized in a more complicated manner than the L-Tyr and L-Phe 
branches (Figure 1b and 1c). A series of multifunctional enzymes are utilized, but the enzyme 
association varies from species to species. In S. cerevisiae, six catalytic domains belonging to 
five enzymes (encoded by TRP1–5) are involved, with TRP3 containing two independent 
catalytic domains. The first step involves the transfer of the amino group from glutamine to 
chorismate, yielding anthranilate, pyruvate, and glutamate as products. The reaction is catalyzed 
by a complex consisting of anthranilate synthase Trp2 (feedback inhibited by L-Trp) and the N-
terminal glutamine amidotransferase domain of Trp3 ( eferred to as Trp3C). The C-terminus of 
Trp3 (referred to as Trp3B) is an indole-3-glycerol-phosphate (InGP) synthase catalyzing the 
fourth step in the L-Trp branch. In contrast, in E. coli, the glutamine amidotransferase domain is 
fused with the anthranilate phosphoribosyl transferas  domain (catalyzing the second step), both 
of which are encoded by trpD. Note that in some literature, glutamine amidotransferase and 
anthranilate phosphoribosyl transferase are ambiguously specified separately as TrpG and TrpD 
because in some bacteria (e.g., Serratia marcescens and Sulfolobus solfataricus (Knochel et al., 
1999; Spraggon et al., 2001)), the two functions are encoded by two separate genes. In E. coli, 
trpG only represents the N-terminal regions of the bifunctional gene trpD, which forms a 
heterotetramer with anthranilate synthase (encoded by trpE) to complete the first step of 
anthranilate synthesis. Following this reaction, the anthranilate phosphoribosyl transferase 
domain located at the C-terminal of TrpD proceeds to introduce a phosphoribosyl moiety from 5-
phosphoribsyl pyrophosphate (PRPP) to the amino group of anthranilate, yielding 
phosphoribosyl anthranilate (PRA). In fungi, this step is carried out by the monofunctional 
enzyme Trp4. 
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The third step in the L-Trp branch entails an internal redox reaction to open the ring, forming 
ketone carboxyphenylamino-1-deoxyribulose 5-phosphate (CDRP), which is catalyzed by the 
monofunctional PRA isomerase Trp1 in S. cerevisiae, Kluyveromyces lactis, and Candida 
maltosa (Braus et al., 1985; Stark and Milner, 1989). Interestingly, in many other fungi (e.g., 
Neurospora crassa, Aspergillus nidulans, and Aspergillus niger (Kos et al., 1985; Mullaney et al., 
1985; Schechtman and Yanofsky, 1983)), the enzyme in charge of this step is fused with the 
bifunctional enzyme Trp3 to form a trifunctional enzyme with the PRA isomerase domain 
arranged at the C-terminal. Fusion of a PRA isomerase domain with an N-terminal InGP 
synthase domain was observed in E. coli, together as a bifunctional enzyme TrpC, whereas the 
InGP synthase domain specified as Trp3B is located  the C-terminal of the glutamine 
amidotransferase specified as Trp3 in S. cerevisiae. 
The final reaction in the L-Trp branch is catalyzed by a bifunctional L-Trp synthase that 
contains two separate active sites in S. cerevisiae, encoded by TRP5 (Miles, 1979; Yanofsky, 
2005). One active site cleaves InGP into indole and glyceraldehyde-3-phosphate, and the other 
one condenses the indole and serine to L-Trp. In many other organisms, including E. coli, this 
function is specified by two separate genes, trpA and trpB, encoding the alpha and beta subunits 
of the tetrameric L-Trp synthase, respectively. Crystal structures revealed a hydrophobic tunnel 
connecting the two active sites and preventing the escape of indole during the movement from 
one subunit to the other (Hyde et al., 1988).  
 
3. Regulation involved in the backbone reactions 
Due to the essential role of amino acid biosynthesis in central metabolism, cells have evolved 
various mechanisms to maintain amino acid homeostasis. Akashi H. et al. calculated the energy 
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cost of synthesizing various amino acids in E. coli based on the consumption of ATP/GTP and 
NADH/NADPH/FADH2 molecules. It was concluded that 74.3, 52.0, and 50.0 high-energy 
phosphate bonds contained in ATP/GTP molecules are required to synthesize one molecule of L-
Trp, L-Phe, and L-Tyr, respectively (here the consumption of reducing agents is converted to that 
of ATP based on a ratio of 2 ATP per 1 NADH) (Akashi and Gojobori, 2002). It is not surprising 
that intrinsically complicated regulations are exerted as different control tiers, impeding the high-
level production of any derivatives produced from this pathway especially considering that the 
corresponding number of energy cost for synthesizing one of the other amino acids is merely 
11.7 to 38.3. Prokaryotes and lower eukaryotes share some common features in regulating 
enzyme activities but utilize distinct mechanisms to regulate the pathway genes at the 
transcriptional and translational levels. Two reviews have comprehensively summarized the 
regulations involved in aromatic amino acid biosynthesis in S. cerevisiae and E. coli, as well as 
the biochemical characteristics of the relevant enzymes (Braus, 1991; Pittard and Yang, 2008). 
The section below only highlights the most representative regulatory events that were detailed in 
these previous reviews. Recapitulating these examplary regulations will assist readers to 
understand the intrinsically complicated regulations behind aromatic amino acid biosynthesis as 
well as design solutions to overcome the hurdles constraining the production of many valuable 
compounds from this pathway. 
 
3.1 Regulation of enzyme activity 
Allosteric checkpoints exist at the entrance of the s ikimate pathway, as well as the 
branching points between the L-Tyr/L-Phe and L-Trp branches. In yeast, the DHAP synthase 
isozymes Aro3 and Aro4 are sensitive to the feedback inhibition posed by L-Phe and L-Tyr, 
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respectively. The most common strategy to open the sluice to the shikimate pathway is to 
overexpress the mutant Aro4K229L and/or Aro3K222L to completely block the binding of L-Tyr and 
L-Phe. Feedback-insensitive mutants Aro4Q166K and Aro4G226S have also been reported in some 
studies (Koopman et al., 2012; Trenchard and Smolke, 2015). The overexpressed mutant 
typically leads to efficient condensation between PEP and E4P, and there is no need to remove 
the wild-type versions of the genes. In E. coli, it is believed that 20%, 80%, and a marginal 
percentage of the total activity of DHAP synthase is provided by L-Tyr-sensitive AroF, L-Phe-
sensitive AroG, and L-Trp-sensitive AroH, respectively (Bongaerts et al., 2001; Tribe et al., 
1976). The feedback inhibition-insensitive mutants AroGfbr and AroFfbr are therefore usually 
overexpressed to deregulate the feedback inhibition. 
Chorismate mutase Aro7 initiates the L-Tyr/L-Phe branch by converting chorismate to 
prephenate in S. cerevisiae and is subjected to feedback inhibition by the endproduct L-Tyr. 
Similarly, L-Trp acts as a repression effector to the anthranilate synthase–glutamine 
amidotransferase complex (encoded by TRP2-TRP3C, Figure 1b), which is in charge of the first 
committed step of the L-Trp branch at the same time as the activator of Ar7, which is a dual 
control strategy utilized by S. cerevisiae to balance the fluxes flowing into the two branches. The 
overexpression of Aro7G141S (Aro7T266I or Aro7T227L) has been conveniently used to allow the 
flux to enter the L-Tyr/L-Phe branch (Rodriguez et al., 2017a; Rodriguez et al., 2015). In E. coli, 
the equivalent feedback-insensitive mutants TyrAfbr, PheAfbr, and TrpEfbr-TrpDN (or called 
TrpEfbr-TrpG, Figure 1c) have been widely overexpressed to produce L-Trp-derived products.  
 
3.2 Transcriptional regulation 
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Intrinsically complicated regulations have also been recognized at the transcriptional level 
(Hinnebusch, 1988; Lee and Hahn, 2013), some of which ave not been fully elucidated. The 
regulatory mechanisms employed by eukaryotes significa tly differ from those used by 
prokaryotes. Eukaryotes use global regulators to modulate amino acid biosynthesis as an entire 
pool in a non-specific manner, whereas prokaryotes generally rely on pathway-specific 
transcriptional regulators in response to the fluctuations of the three aromatic amino acids. 
 
3.2.1 Transcriptional regulation in the lower eukaryotes 
In contrast to bacteria, yeast and fungi maintain relatively large intracellular amino acid pools, 
and the corresponding biosynthetic genes are expressed at significant levels, which is hence 
named “basal control”. Under amino acid starvation, the expression of more than 30 genes 
involved in various amino acid biosynthetic pathways is enhanced, and the genes involved are 
not specifically from the pathway corresponding to the amino acid that is deficient. Such a cross-
pathway regulation is conducted by global transcription regulators via the so-called “general 
control mechanism” (Hinnebusch, 1988). The general control mediated by the transcription 
regulator Gcn4 in S. cerevisiae is the best characterized system of the amino acid biosynthesis 
network. The Gcn4 recognition site has a consensus sequence of 5′-ATGA(C/G)TCAT-3′ (Braus, 
1991), which has been found in the upstream activation sequences of the promoters of many 
amino acid biosynthesis genes. These promoters are typically regulated by both Gcn4-mediated 
general control and amino acid-independent basal control (Arndt et al., 1987; Struhl, 1986). 
Specific to aromatic amino acid biosynthesis, the regulatory events at the entrance of the 
shikimate pathway and the L-Trp branch are briefly discussed below.  
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In addition to the feedback inhibition, due to the important entry position of DHAP synthase 
in the entire pathway, ARO3 and ARO4 are also regulated at the transcriptional level. One Gcn4-
binding site was found in the promoter of ARO3. A single mutation at this site or disruption of 
the GCN4 gene results in a decreased basal level of ARO3 expression (Braus, 1991; Paravicini et 
al., 1989). For ARO3, Gcn4 only maintains its basal-level transcription because no increase in 
ARO3 expression is observed under amino acid starvation, which is different from the regulatory 
role of Gcn4 on ARO4 (Braus, 1991). The basal expression level of ARO4 is not affected by 
disrupting the Gcn4-recognition site in the upstream activation sequence, but amino acid 
starvation will no longer increase its transcription (Kunzler et al., 1992). 
Gcn4-mediated transcription control is also often used in the L-Trp branch. The Gcn4- 
binding sites appear in the promoters of four out of the five genes (TRP2–5) in this branch, with 
TRP1 as the only exception. Unlike the operon structure rpEDCBA employed by bacteria, the 
genes involved in amino acid biosynthesis are widely spread over on the yeast genome, 
indicating that a higher level of control must exist to coordinate the expression of the genes from 
a single pathway. For example, the heterodimeric enzyme complex consisting of anthranilate 
synthase (Trp2) and glutamine amidotransferase (Trp3C) catalyzes the first step in the L-Trp 
branch. Considering that equimolar amounts of the two monomeric polypeptide chains are 
needed, the expression of Trp2 and Trp3 must be coordinated (Braus, 1991). Each of the two 
promoters contains a Gcn4-binding site (Zalkin et al., 1984). A fascinating dual control was 
identified for Trp4. Three Gcn4-binding sites were found in its promoter region, one of which 
could also recruit another set of transcriptional regulators— Pho2/Bas2—involved in regulating 
Pi metabolism (Braus et al., 1989). Anthranilate phosphoribosyltransferase Trp4 requires PRPP 
as a substrate. Even under amino acid starvation, if Pi is limiting, TRP4 expression is still 
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restricted by the occupancy of Pho2/Bas2 on the site that could otherwise bind to Gcn4 to fully 
activate TRP4 expression, thereby preventing the unnecessary overproduction of the enzyme. 
 
3.2.2 Transcriptional regulation in prokaryotes 
In contrast to the employment of global regulators in eukaryotes, the response to the 
intracellular levels of the three aromatic amino acids in prokaryotes is much more localized. The 
transcription of only the genes in the specific amino acid biosynthetic pathway is enhanced when 
the relevant amino acid is in deficiency. This mechanism, named “metabolic control”, is 
mediated through one or both of the pathway-specific regulatory proteins, TyrR and TrpR, with 
intracellular levels that are delicately balanced to fulfill particular regulatory roles (Pittard and 
Yang, 2008).  
TyrR is a large protein, composed of 513 amino acids arranged as an N-terminal domain, a 
central domain, and a C-terminal domain. The unique feature of TyrR is that the three domains 
are relatively independent, have different oligomerization preferences, and all have regulatory 
roles. The N- and C-terminal domains tend to form di ers, whereas the central domain prefers to 
form a hexamer. Depending on the presence of effector molecules and the positions of the TyrR-
binding sites relative to the key regions (e.g., −35, −10, and the transcription initiation site) in a 
promoter, TyrR will take one oligomerization state over the other and can act either as a 
repressor or an activator, and in some cases, playsa crucial dual role in modulating the 
expression of a single gene. 
The tyrR regulon has at least nine genes that are separately transcribed, and the palindromic 
sequence TGTAAAN6TTTACA, together with two flanking nucleotides at each end, comprises 
the tyrR box. Table 1 provides a snapshot of many detailed mechanistic studies summarized in 
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an earlier review (Pittard and Yang, 2008). At least two tyrR boxes were found in the 
transcription units for eight out of the nine genes, with the exception of aroG, which contains 
only one box. The binding of TyrR to one of these boxes requires the presence of ATP and L-Tyr, 
and the box is named a weak box; the other box, the strong box, is bound to TyrR in an effector-
independent manner. In many cases, one of the tyrR boxes is close to or overlaps with the RNA 
polymerase-binding site, mediating the regulatory rle of TyrR to the transcription of the gene. 
In special cases, DNA looping is required between distant binding sites, and the interaction 
might be mediated through TyrR oligomerization. 
TrpR is a much smaller regulatory protein than TyrR, consisting of only 108 amino acids. At 
least five transcription units are involved in the rpR regulon, namely, the trpEDCBA operon, 
aroH, trpR, Mtr, and aroL. TrpR remains a dimer, and its binding to the operator requires prior 
binding with two L-Trp molecules, which will change the conformation of the HTH domains to 
facilitate the recognition. Similar to the mechanism described for TyrR, L-Trp-mediated 
repression is conducted by blocking the binding of RNA polymerase (−35 and −10 positions) or 
its progression (+1 position). TrpR also coordinates with TyrR to regulate the transcription of 
Mtr and aroL (Table 1) (Jeeves et al., 1999; Pittard and Davidson, 1991).  
Lastly, because no nuclear membrane separates transcription and translation events in 
prokaryotes, another unique control is employed to modulate transcription in response to the 
level of specific charged aminoacyl-tRNAs. This mechanism, transcriptional attenuation, is 
found in the regulation of the trpEDCBA operon and pheA (Pittard and Yang, 2008). Briefly, a 
leader sequence encoding a short 14-amino acid peptide exists upstream of the trp operon. Two 
alternative RNA secondary structures can be assumed by the trp operon, and one of them causes 
the early termination of transcription. The leader s quence contains two adjacent L-Trp codons, 
 
 
16
and the sliding of the ribosome will be stalled at this position if the charged tryptophanyl-tRNA 
is scarce. The resulting structure then allows RNA polymerase to continuously travel into the 
coding regions of the various genes in the trp operon. When tryptophanyl-tRNA is abundant, 
ribosomes will not stall, an early termination RNA structure is then formed, preventing the 
unnecessary transcription of the trp operon genes to continuously raise the intracellular L-Trp 
level (Landick et al., 1987). A similar transcriptional attenuation mechanism is used to regulate 
the expression of pheA in response to the concentration of phenylalanyl-tRNA (Landick and Jr., 
1992). Considering that TrpE and PheA catalyze the first reaction in the L-Trp and L-Phe 
branches, respectively, having multiple mechanisms to respond to the fluctuation of the 
corresponding pathway product is critical to maintain amino acid homeostasis. 
 
3.3. Translational regulations 
In eukaryotes, the expression of the global amino acid biosynthesis regulator Gcn4 is 
modulated by amino acids at the translational level. This transcriptional regulator consists of 281 
amino acids, but its mRNA is more than 1,500 nucleotid s long. Interestingly, upstream of the 
start codon AUG, four additional extremely short open reading frames are found, each of which 
is only composed of two or three sense codons followed by a stop codon (Hinnebusch, 1988; 
Thireos et al., 1984). Deleting or introducing mutations in this extra leader sequence results in a 
significant increase in GCN4 expression. It is believed that the appearance of these extra 
translation initiation signals substantially inhibits the ability of the ribosome to re-initiate the 
translation at the actual GCN4 ORF (Mueller and Hinnebusch, 1986), which is a regulatory 
mechanism rarely used in S. cerevisiae but is quite popular in mammals. Under amino acid-
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deficient conditions, the interference of these upstream AUG start codons is suppressed, and the 
translation of GCN4 mRNA becomes most efficient for regulating amino acid biosynthesis. 
 
4. Upstream products derived from the shikimate pathway 
With a limited number of conversion steps, many commodity chemicals can be synthesized 
from the intermediates in the shikimate pathway (Figure 2 and Table 2). Recently, Averesch et 
al. and Huccetogullari et al. discussed metabolic engineering endeavors to produce a variety of 
compounds derived from this upstream module (Averesch and Kromer, 2018; Huccetogullari et 
al., 2019). To avoid redundancy, in the following sections, we will highlight the standard 
strategies for producing this group of compounds and expand upon the product derivatization 
strategies that have not been included in the previous reviews. The products are color-coded in 
Figure 2 and organized by key nodes in the pathway. Most studies have been conducted in E. 
coli and S. cerevisiae, but a few other hosts have also demonstrated surpri ingly high 
productivity. Regardless of the species, for de novo biosynthesis, the overexpression of the 
feedback-inhibited DAHP synthase mutant (Aro3fbr or Aro4fbr in S. cerevisiae and AroFfbr or 
AroGfbr in E. coli) and transketolase (Tkl1 in S. cerevisiae and TktA in E. coli) are the most 
common strategies used to enhance the flux entering the SA pathway and E4P availability, 
respectively. These strategies will not be repeatedly mentioned in the specific examples. Novel 
strategies and non-glucose feedstock that enhanced the production will be particularly 
highlighted. 
        
4.1 The dehydroshikimate node  
4.1.1 Shikimic acid and quinic acid 
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Shikimic acid (SA) is the precursor of oseltamivir phosphate, commercially known as 
Tamiflu®, an anti-influenza medicine (Federspiel et al., 1999). The commercial processes of SA 
synthesis include its extraction from the fruit of Illicium verum or microbial fermentation. The 
latter offers a more abundant supply in a timely manner, which is critical during a severe 
influenza outbreak, when about 30 billion doses of Tamiflu®, equivalent to 3.9 million kg of SA, 
might be needed (Sunder Rangachari, 2013). Since SA is a metabolic intermediate, its 
intracellular accumulation relies on the disruption of the downstream conversion. In E. coli, the 
disruption can be achieved by deleting the self-standing SA kinase I AroK and SA kinase II 
AroL. In the S. cerevisiae mutant, Aro1D920A needs to be overexpressed in the aro1∆ strain 
because Aro1 is a large pentafunctional enzyme, with distinct domains (Aro1C, E, D, B, and A) 
catalyzing the five steps from DAHP to EPSP.  
In E. coli, glucose is transported into cells via the PEP:carbohydrate phosphotransferase (PTS) 
system, in which a phosphoryl group is transferred f om PEP, converting glucose to glucose 6-
phosphate (G6P). To avoid this PEP expenditure, two s rategies are often tested. One is to 
overexpress PEP synthase encoded by ppsAto recycle pyruvate back to PEP, and the other is to 
heterologously express the Zymomonas mobilis glucose transporter and glucokinase, encoded by 
glf and glk, respectively, in a host deficient in the PTS system, which does not require PEP for 
glucose transportation but consumes one ATP. Althoug  both approaches have been widely 
applied, the second one influences SA production more significantly (Chandran et al., 2003). In 
an engineered E. coli overexpressing 3-DHQ synthase encoded by aroB to enhance the 
conversion from DHAP to 3-DHQ, in combination with the aforementioned genetic 
manipulations, 87 g/L SA was produced by 10 L fed batch fermentation supplemented with 15 
g/L yeast extract, with a yield of 0.32 g SA/g glucose and a productivity of 1.64 g/L/h. To avoid 
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the additional cost associated with aromatic amino acid supplementation for culturing the aroK-
deletion strain, Lee et al. proposed to utilize a growth phase-dependent promoter to drive the 
expression of aroK (Lee et al., 2017). With this strategy, cells could still synthesize aromatic 
amino acids while accumulating SA. Furthermore, the enzymes catalyzing the conversion from
3-DHQ to DHS and then to SA were replaced by a bifunctional DHQ-SDH protein from the tree 
Populus trichocarpa to facilitate metabolic channeling. The combined strategy led to an 
accumulation of SA at 5.33 g/L. 
Much higher production of SA has been achieved in C. glutamicum, a gram-positive soil 
bacterium that is used for producing L-glutamate and L-lysine at industrial scales (Kogure et al., 
2016). In addition to the standard overexpression and deletion strategies, two interesting 
strategies were devised to increase the accumulation of SA. When the PTS system was 
interrupted and replaced by overexpressing the endogenous myo-inositol transporter (IolT1) and 
glucokinases (Glk1, Glk2, and Ppgk), glycerol and 1,3-dihydroxyacetone were unexpectedly 
built up at significant amounts. It was reasoned that e overflow of glycolytic intermediates 
caused this accumulation, and the issue was relieved by overexpressing apA encoding 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) an blocking the formation of 1,3-
dihydroxyacetone and glycerol. Besides, an aerobic conversion using growth-arrested high-
density cells was developed, in which cells were grown in the rich medium for 18-20 h, then 
centrifuged, and added to the minimal medium with a ratio of 10% of wet cell weight per culture 
volume. Compared to the routine fed-batch fermentation, using growth-arrested cells reduced the 
carbon loss to cell growth and the byproduct formation, leading to the highest SA titer and yield 
attained by microbial biosynthesis reported so far (141 g/L and 0.49 g of SA per g of glucose). 
 
 
20
Boosting the level of PEP has not been widely attemp d in S. cerevisiae, which might be 
because the flux through E4P was identified as at least one order of magnitude less than that of 
the one through PEP (Suastegui et al., 2016a). Two unique genetic manipulations conducted in S. 
cerevisiae included the overexpression of ribose-5-phosphate ketol-isomerase encoded by RKI1 
and deletion of RIC1 (Suastegui et al., 2017). The study suggested that Ric1 was a novel 
transcriptional repressor, and the corresponding biding sites were found in multiple promoters 
of the genes in the aromatic amino acid pathway; its deletion brought up the SA titer by 27%. 
RKI1 overexpression was predicted in silico by OptForce, which suggested that the carbon flux 
in the PPP could be directed towards E4P without going back to glycolysis. This hypothesis was 
confirmed by an experiment in which the SA titer was increased from 0.8 g/L to 1.0 g/L (based 
on 2% glucose) and then 2.0 g/L (based on 4% glucose) t  2.4 g/L (based on 4% sucrose). 
The metabolic flux analysis demonstrating that E4P is the rate-limiting substrate in S. 
cerevisiae (Suastegui et al., 2016a) motivated researchers to explore other non-model yeasts that 
have a high native xylose-utilization capacity. Xylose is efficiently assimilated through the PPP 
in CUG-clade yeasts, suggesting that these yeasts might have higher E4P availability compared 
to S. cerevisiae. With the classical manipulations such as overexprssing Tkt1, Aro4K220L, and 
Aro1D900A, the exemplary species S. stipitis produced SA at a titer of 3.11 g/L, which was 7-fold 
higher than that by S. cerevisiae under the same conditions (Gao et al., 2017). Thisrepresents the 
highest level of shikimate production in yeasts. Although this titer is still much lower than that of 
bacterial producers, these studies pave the way for engineering eukaryotic hosts that produce 
downstream products with nutraceutical and pharmaceutical value. The biosynthesis of some of 
these downstream compounds requires the participation of cytochrome P450 enzymes, which 
poses significant challenges for the bacterial production hosts. 
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Shikimate dehydrogenase encoded by aroE can also use 3-DHQ as the substrate. In the E. 
coli strain lacking aroD encoding 3DHQ dehydratase, quinic acid was accumulated at 49 g/L in 
fed-batch fermentation, with a yield of 0.21 g/g glucose (Ran et al., 2001). The same authors had 
also tested the heterologous quinic acid dehydrogenase (Qad) from Klebsiella pneumonia, 
because this microorganism can naturally utilize quinic acid as its sole source of carbon. The 
heterologous expression of Qad in E. coli produced 4.8 g/L quinic acid in shake flasks (Draths et 
al., 1992). Quinic acid can be chemically converted to hydroquinone at high yields via oxidative 
decarboxylation and subsequent dehydration. Hydroquin ne is used as an agent to develop 
photographs and an intermediate to synthesize some antioxidants and polymerization inhibitors, 
but in the past its synthesis heavily relied on the usage of carcinogenic benzene as the substrate. 
A recent study on the de novo biosynthesis of arbutin showed that hydroquinone could also be 
obtained by the hydrolysis of 4-hydroxylbenzoate (see ection 4.2.2) (Shen et al., 2017). 
 
4.1.2 cis,cis-Muconic acid 
Muconic acid (MA) is an unsaturated dicarboxylic acid precursor of terephthalic and adipic 
acid, which are monomers of the plastics polyethylene terephthalate (PET) and nylon 66 (Lu et 
al., 2016; Niu et al., 2002). The traditional benzene-based chemical synthetic routes for adipic 
acid and terephthalic acid are detrimental to the environment, warranting the need to establish a 
sustainable green process. The microbial production route can be established via three steps, 
extending from DHS, as follows. DHS dehydratase (AroZ) and protocatechuate decarboxylase 
(AroY) both originate from K. pneumonia. DHS is converted to protocatechuate (PCA), and then
into catechol, which undergoes an oxidative ring cleavage reaction catalyzed by catA-encoded 
catechol 1,2-dioxygenase from Acinetobacter calcoaceticus, Pseudomonas putida, nd C. 
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glutamicum. The expression of these three heterologous enzymes in combination with the 
aforementioned overexpression of three endogenous genes, tktA, aroFfbr, and aroB, and the 
deletion of the downstream gene aroE in charge of converting DHS to SA, led to a high titer of 
36.8 g/L in fed-batch fermentation (Niu et al., 200). 
The basic genetic manipulations necessary to create a S. cerevisiae MA producer are similar 
to those used to enable SA accumulation, with the mutation site in Aro1 switching from the SA 
kinase subunit to the SA dehydrogenase subunit enabl d by Aro1D1409A. The strain expressed 
AroZ, AroY, and Hqd2 from the ascomycete fungus Podospora anserina, the bacterium K. 
pneumonia, and the yeast Candida albicans, respectively (Curran et al., 2012), together with the 
native enzymes Tkl1, Rki1, Aro4K229L, and Aro1D920A in the ric1∆ aro1∆ deletion strain. This 
combination led to the production of 2.0 g/L PCA and 0.33 g/L MA based on 4% glucose shake-
flask fermentation (Suastegui et al., 2016b; Suastegui t al., 2017). These findings led to the 
discussion of whether the deletion of ZWF1, encoding glucose-6-phosphate dehydrogenase 
would be beneficial for MA production. Researchers found that this deletion could force the 
carbon flux to enter through the non-oxidative branch of the PPP, thereby increasing E4P 
levels(Curran et al., 2012; Gold et al., 2015). It was found that while the ZWF1 deletion indeed 
increased the DHS concentration before the incorporation of the three heterologous genes 
accounting for MA biosynthesis, it also decreased the overall production of PCA and MA by 31% 
in the final strain (Suastegui et al., 2017). Considering that the Zwf1-catalyzed reaction is the 
primary source of NADPH, the deletion of ZWF1, in combination with a higher metabolic 
burden imposed by expressing the three-gene heterologous MA pathway on a multi-copy 
plasmid, reduced the fitness. This is because major rear angements occur in the cell to find new 
NADPH sources. Similarly, the interruption of NADPH cofactor regeneration also reduced SA 
 
 
23
production because the step converting DHS to SA requi s NADPH. The authors clarified that 
the deletion of ZWF1 should not be used as a strategy to produce any compounds downstream of 
the DHS node unless NADPH can be efficiently replenished. For the products directly derived 
from DHS, such as MA, whether this step is beneficial depends on the tradeoff between the 
increase in E4P level and the negative impact on cell growth. Leavitt et al. created a hybrid 
promoter induced by aromatic amino acids and placed  KanNeo gene conferring a low level of 
resistance to geneticin (Leavitt et al., 2017). Ethyl methane sulfonate mutagenesis and adaptive 
laboratory evolution were implemented to create mutant strains with an increased flux into the 
aromatic amino acid biosynthesis. The flux was re-di cted to create a strain producing MA at a 
titer of 2.1 g/L in fed-batch fermentation.  
In all these engineered yeast strains, the PCA decarboxylase AroY seems to be the bottleneck 
step, causing significant accumulation of PCA and thus, low MA titers. Some studies have 
suggested that this is due to the O2 sensitivity of this enzyme (Suastegui et al., 2016b; Weber et 
al., 2012), while others believe that its functionality requires the prenylated form of flavin 
mononucleotide as the cofactor, which is insufficient or even missing in some strains, such as the 
CEN.PK family of S. cerevisiae (Weber et al., 2017). Supplying the strain with an overexpressed 
flavin mononucleotide prenyltransferase (Pad1) addresses this bottleneck. Furthermore, with the 
strategies involving the overexpression of E. coli AroB and AroD to enhance the conversion up 
to DHS, and in-pulse triggering of the conversion of DHS to the flow downstream by 
destabilizing endogenous Aro1, the final strain produced 1.2 g/L MA without an additional 
supply of the aromatic amino acids and 5.1 g/L MA when amino acids were supplemented (Pyne 
et al., 2018). 
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The benefit of co-expressing AroY-associated proteins to overcome the accumulation of 
PCA was also observed in other hosts such as P. putida (Johnson et al., 2016) and C. glutamicum 
(Lee et al., 2018). Because both species have the native function of utilizing aromatics (e.g., p-
coumarate, ferulate, and benzoate) via β-ketoadipate pathway, the genes encoding PCA 
dioxygenase (PcaHG), and the enzymes required for further metabolism of MA to 
muconolactone (CatB and CatC, together with their transcriptional regulator CatR) have to be 
deleted. AroY together with its associated protein EcdB from Enterobacter cloacae and 
dehydroshikimate dehydratase AsbF from Bacillus cereus were heterologously expressed in P. 
putida along with the overexpressed native CatA (Johnson et al., 2016). The resulting strain was 
able to directly synthesize MA from the lignin monomer p-coumarate with a titer of more than 
15 g/L, and from glucose with a titer of 4.9 g/L in a fed-batch process. This additional co-
expression of EcdB enabled the host to reach production at least 3-fold higher than the one that 
could not offer the prenylated flavin cofactor. For C. glutamicum, the fermentation was scaled up 
to 7-L and 50-L fed-batch processes, resulting in 38 g/L and 54 g/L of MA based on glucose 
(Lee et al., 2018). 
A useful co-culture strategy was developed to split MA biosynthesis between two E. coli 
strains (Zhang et al., 2015b). The genes encoding the PTS glucose transport system (encoded by 
ptsH, ptsI, and crr) and shikimate dehydrogenase (encoded by aroE and ydiB) were deleted from 
the first strain, enabling it to utilize xylose and accumulate DHS. The xylose isomerase (encoded 
by xylA) in the second strain was then disrupted, but the DHS transporter gene (encoded by shiA), 
together with the three-step MA pathway (encoded by aroZ, aroY, and catA), was overexpressed. 
The resulting co-culture produced 4.7 g/L MA in thefed-batch bioreactor, with a yield of 0.35 
g/g from a mixture of glucose and xylose. Splitting a long biosynthetic pathway into different 
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strains not only relieves the burden caused by extensiv  overexpression and deletion to a 
monoculture but also allows easy fine-tuning of the ratio between the modules accommodated by 
the distinct partners for the optimal outcome. 
 
4.1.3 2-Pyrone-4,6-dicarboxylic acid and vanillin  
2-Pyrone-4,6-dicarboxylic acid (PDC) is a dicarboxylic acid that can also be derived from 
PCA. Owing to its structural similarity with terephthalic acid, the monomeric building block of 
PET, PDC has been tested for polymerization with other diols or hydroxyacids to form polymers 
with interesting features. Luo et al. described a biosynthetic pathway in which dehydroshikimate 
dehydratase (encoded by asbF from Bacillus thuringiensis), PCA 4,5-dioxygenase (encoded by 
pmdAB from Comamonas testosteroni), and CHMS dehydrogenase (encoded by pmdC from C. 
testosteroni) were cloned in an E. coli strain carrying the aroE deletion for DHS accumulation 
(Luo et al., 2018). The endogenous genes ppsA and shiA (encoding the DHS importer) were 
overexpressed by the strong promoter pTrc to increase the availability of PEP and trap DHS 
intracellularly. The sthA-encoded pyridine nucleotide transhydrogenase in E. coli was also 
targeted to enhance the level of NADP+ via two strategies: exchanging the promoter of sthA with 
pTrc or introducing three silent point mutations to the beginning of the coding region of sthA to 
deregulate the endogenous translational control. The combination of all these strategies allowed 
the production of 16.72 g/L PDC based on glucose fed-batch fermentation, with a yield and 
productivity of 0.201 g/g and 0.172 g/L/h, respectively. 
In S. cerevisiae and the fission yeast Schizosaccharomyces pombe, DHS has been further 
extended with four-step conversions to synthesize vanillin β-D-glucoside (VG). Vanillin is one of 
the most important flavoring agents in the world (N., 2014). It is a natural product present in the 
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seedpods of Vanilla planifolia, but its current production mostly relies on a biochemical 
conversion involving lignin deconstruction or synthesis based on petrochemicals (Priefert et al., 
2001). The de novo biosynthesis of vanillin involves the heterologous expression of Podospora 
pauciseta 3-dehydroshikimate dehydratase (3DSD), Nocardia aromatic carboxylic acid reductase 
(ACAR), Homo sapiens O-methyltransferase (OMT), and an additional phosphopantetheinyl 
transferase (PPTase) cloned from C. glutamicum. PPTase is only required by S. cerevisiae and 
not by S. pombe, because the latter possesses endogenous phosphopantetheinylation activity to 
help with the reduction step. The initial titers were fairly low in the two yeasts (45 mg/L and 65 
mg/L), and a decent amount of product was reduced to vanillyl alcohol in S. cerevisiae unless the 
alcohol dehydrogenase ADH6 was disrupted (Hansen et al., 2009). The low production was 
partially caused by the toxicity of vanillin and expression of an Arabidopsis thaliana family 1 
uridine diphosphate (UDP) glycosyltransferase (UGT), which converted vanillin into the 
nontoxic VG with a production increase to 100 mg/L. It was also found that the knockout of 
PDC1, encoding pyruvate decarboxylase, could channel more flux to flow towards the shikimate 
pathway instead of the ethanol end using a continuous chemostat with a very low dilution rate, 
and the final S. cerevisiae strain produced 500 mg/L VG with a yield of 32 mg/g lucose 
(Brochado et al., 2010). 
 
4.2 The chorismate node  
Moving downstream beyond DHS and SA, chorismate becom s the next hub, from which 
various benzoic acids can be synthesized. Many health-related products, such as folate (vitamin 
B9), CoQ9, and aspirin, need benzoic acid as the precursor of their synthesis (Noda et al., 2016; 
Yao et al., 2018). 
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4.2.1 Salicylate, 4-aminobenzoate, 3-aminobenzoate, 2-aminobenzoate, 3-hydroxybenzoate, 
4-hydroxybenzoate, and muconic acid 
The chorismate lyase family of enzymes cleaves the C-C bond of chorismate and its close 
derivatives, releasing pyruvate and benzoic acid attached to either a hydroxyl or an amino group. 
Obtaining pyruvate as a product in these reactions motivated Noda et al. to design an innovative 
“pulling” strategy to boost the flux to synthesize various benzoic acids (Noda et al., 2016). They 
replaced the aforementioned endogenous PTS glucose transport system with galactose permease 
(GalP) and glucokinase (Glk) from E. coli, thereby disrupting the conversion from PEP to 
pyruvate during glucose transportation. In addition, the conversion of PEP to pyruvate during 
glycolysis was also eliminated by knocking out pyruvate kinase encoded by p kF and pykA. This 
increased the available PEP entering the shikimate p thway, and the cells were forced to 
replenish pyruvate via the chorismate lyase-catalyzed reaction. This strategy was first 
demonstrated in the biosynthesis of salicylate, which isomerizes chorismate to isochorismate 
(IsoCA) (IsoCA synthase encoded by menF from E. coli) before C-C bond cleavage (IsoCA-
pyruvate lyase encoded by pchB from Pseudomonas aeruginosa). Without using the standard 
strategies to increase PEP and E4P levels (e.g.,the overexpression of tktA and ppsA), the 
production of salicylate in E. coli already reached 11.5 g/L in the batch culture after 48 h. The 
strategy was subsequently generalized to produce seven different chorismate derivatives, 
including MA, 4-hydroxybenzoate (4-HBA; also known asp-HBA), 3-hydroxybenzoate (3-
HBA), 2-aminobenzoate (2-ABA), 4-aminobenzoate (4ABA; also known as p-ABA), tyrosine, 
and phenol, at 1–3 g/L in test tube-scale culture.  
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Salicylate is a precursor in the synthesis of aspirin and the anti-HIV agent lamivudine and it 
can be combined with endogenously produced UDP-α-D-glucose, catalyzed by salicylate 
glucosyltransferase (UGT74F1) from A. thaliana, to synthesize the plant-derived salicylate 2-O-
β-D-glucoside (SG), which has anti-inflammatory activity, as well as other glycosylated variants; 
once the heterologous deoxysugar pathways are introduced (Qi et al., 2018). In this study, the 
irp9-encoded bifunctional salicylate synthase from Yersinia enterocolitica was expressed to 
complete the two-step conversion from chorismate to salicylate.  
Note that the enzymes that catalyze the synthesis of aminobenzoates are slightly different 
from those involved in the synthesis of hydroxybenzoates, because an amino group needs to be 
transferred from glutamine prior to the lyase-catalyzed reaction. The de novo biosynthesis of 
4ABA was established in S. cerevisiae by overexpressing aminodeoxychorismate synthase 
(Abz1) and aminodeoxychorismate lyase (Abz2) from yeast (with a titer of 215 mg/L) using 
glycerol and ethanol as the feedstock in fed-batch fermentation (Averesch et al., 2016), and in E. 
coli (with a titer of 4.8 g/L) by overexpressing the bacterial analogous enzymes encoded by 
pabABC (Koma et al., 2014). 
One-step extension from chorismate catalyzed by E. coli chorismate lyase (encoded by ubiC) 
leads to the synthesis of 4-HBA, which is currently used to prepare paraben preservatives, 
cosmetics, and pharmaceutical products. Using similar strategies as discussed previously in SA 
and MA production, including the overexpression of transketolase, the feedback-insensitive 
DAHP synthase mutant, and individual enzymes to enhance the conversion from DAHP to 
chorismate, 4-HBA production of 12 g/L was established in E. coli by fed-batch fermentation, 
with a yield of 0.19 g/g glucose, and a productivity of 0.17 g/L/h (Barker and Frost, 2001). In S. 
cerevisiae and P. putida, the downstream Tyr/Phe branch and the Trp branch were both disrupted, 
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and because P. putida has the endogenous PCA degradation pathway, additional knockout of 
pobA (encoding 4-HBA hydroxylase) was performed. Using fed-batch fermentation, titers of 2.9 
g/L and 1.73 g/L were achieved in the two hosts, but the yield and productivity in P. putida were 
5.8-fold and 1.7-fold higher than those obtained in S. cerevisiae (Averesch et al., 2017; Yu et al., 
2016), respectively. This P. putida strain also included a deletion of a glucose catabolism 
repressor encoded by hexR, the expression of which increases the supply of E4P and NADPH. 
The aforementioned E. coli co-culture used to produce MA has also been extended to produce 4-
HBA at 2.3 g/L and 3-aminobenzoic acid (3-ABA; also known as m-ABA) at a low titer of 48 
mg/L, presumably due to the low activity of 3-ABA synthase (PctV) from Streptomyces pactum 
(Zhang et al., 2015b).  
Section 2.3 summarizes the higher order of enzyme association occurring in the trp operon. 
In E. coli, TrpE and TrpD form a heterotetramer to mediate the synthesis of anthranilate and 
PRPP. The N-terminal of TrpD (designated as TrpG in some literature) with TrpE enables amino 
transfer from glutamine to complete anthranilate synthesis. Balderas-Hernández et al. identified a 
TrpD mutant with an early stop codon in the C-terminal anthranilate phosphoribosyl transferase 
domain (Balderas-Hernandez et al., 2009). This mutation led to the accumulation of anthranilic 
acid (2-ABA) in E. coli at 14 g/L in fed-batch fermentation.  
MA can be synthesized via several pathways, which share the last conversion step of 
catechol to MA but differ in the reactions prior to catechol. For example, MA can be derived 
from at least four downstream branches from the chorismate node, including the pHBA route 
(ubiC and pobA) (Sengupta et al., 2015), the 2,3-dihydroxybenzoic ac d (2,3-DHBA) route 
(entCBA and bdc) (Sun et al., 2014; Wang and Zheng, 2015), the salicyl te route (menF, pchB, 
and nahG) (Lin et al., 2014a), and the anthranilate route (trpE, trpG, and antABC) (Sun et al., 
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2013). The production levels of MA in these engineered E. coli strains ranged from 0.17 to 1.45 
g/L in shake-flask fermentation using either glucose r glucose plus glycerol as the carbon 
source. Fujiwara et al. compared the E. coli strains producing MA through the DHS, pHBA, and 
salicylate routes and found that optimum performance was obtained by fusing chorismate 
synthase (AroC) and isochorismate synthase (MenF) to facilitate metabolite channeling 
(Fujiwara et al., 2018). The strain produced MA at 4.45 g/L, with a yield of 0.207 g/g glucose 
and a productivity of 2.77 g/L/day in a jar fermentr. 
 
4.2.2 Arbutin, phenazine-1-carboxamide, gastrodin, gallic acid, and pyrogallic acid 
Arbutin is a plant-derived glycosylated hydroquinone and has been widely used in cosmetic, 
healthcare, and medical industries because of its ab lity to block melanin synthesis for skin 
lightening, as well as its other anti-microbial, anti-i flammatory, and anti-oxidant activities 
(Shen et al., 2017; Yao et al., 2018). Extended from 4-HBA, the de novo biosynthesis of arbutin 
can be achieved by the expression of 4-HBA 1-hydroxylase (Mnx1) from Candida parapsilosis 
and glucosyltransferase (AS) from Rauvolfia serpentina t 4.19 g/L in E. coli strains engineered 
to accumulate 4-HBA (Shen et al., 2017). A similar idea has been extended to Pseudomonas 
chlororaphis (Wang et al., 2018c). The final strain carrying the genome-integrated genes 
encoding Mnx1, AS, XanB2 (chorismate lyase from Xanthomonas oryzae pv. oryzae), and PhzC 
(the P. chlororaphis version of DAHP synthase), and with deletions of pykA (pyruvate kinase 
converting PEP to pyruvate), phzE (converting chorismate for phenazine biosynthesis), and three 
negative regulatory genes (lon, rpeA, and rsmE) produced arbutin at 6.79 g/L and 0.094 g/L/h 
with mixed fed-batch fermentation of glucose and 4-HBA. Previously, the disruption of another 
set of pathway-specific transcriptional repressors encoded by lon, parS, and psrA enabled P. 
 
 
31
chlororaphis to enhance its production of phenazine-1-carboxamide (PCN) at 4.1 g/L, with a 
yield of 0.23 g/g glycerol (Yao et al., 2018). PCN is naturally produced by Pseudomonas trains 
and displays broad-spectrum antibiotic properties. 
Gastrodin is another plant-derived phenolic glycoside naturally synthesized by the herb 
Gastrodia elata, which has been used in East Asian medicine to treat diseases of the central 
nervous system and cardiovascular symptoms. Bai et al. successfully created a microbial 
biosynthetic route composed of carboxylic acid reductase (CAR) from Nocardia iowensis, 
phosphopantetheinyl transferase (Sfp) from B. subtilis to convert apoCAR to its holo form, and 
endogenous alcohol dehydrogenase (ADH) and glycosyltransferase (UGT73B6) from Rhodiola 
sachalinensis (Bai et al., 2016). The strain was first optimized to synthesize 4-hydroxybenzyl 
alcohol via the 4-HBA branch, and then, a more potent glycosyltransferase mutant was identified 
through directed evolution. The final strain produced gastrodin at a titer of 545 mg/L at 48 h in 
shake-flask glucose fermentation. 
The previously mentioned pobA encoding 4-HBA hydroxylase in Pseudomonas pp. has a 
very high activity toward 4-HBA but low activity toward the product PCA. Gallic acid is a 3,4,5-
trihydroxybenzoic acid, widely found in fruits, nuts, and tea, and it has strong anti-oxidant 
properties. To continue the hydroxylation of PCA to synthesize gallic acid, a structure-based 
rational design strategy was applied to P. aeruginosa PobA. The resulting mutant PobA 
containing mutations (Y385F and T294A) enabled the engineered E. coli strain to produce 1.27 
g/L gallic acid in shake flasks (Chen et al., 2017). Gallic acid can be chemically converted to 
pyrogallol (other names: pyrogallic acid or 1,2,3-trihydroxybenzene) through thermal 
decarboxylation under high pressure and temperatures. Due to the highly active nature of each 
hydroxyl group on the benzene ring, pyrogallol has been used as the precursor to synthesize 
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many bioactive compounds such as bendiocarb (insecticide), trimethoprim (antibiotic), and 
gallamine triethiodide (muscle relaxant) (Wang et al., 2018b). To create an artificial biosynthetic 
pathway, the entCBA operon (encoding IsoCA synthase, isochorismatase, and 2,3-dihydro-2,3-
dihydroxybenzoic acid dehydrogenase) was overexpressed to convert chorismate to 2,3-
dihydroxybenzoic acid (2,3-DHBA). Then, five candidate oxygenases and hydroxylases were 
screened for the ability to transform the C1-carboxyl group of 2,3-DHBA to a hydroxyl group. 
Salicylate 1-monooxygase, encoded by nahG from P. putida, displayed a high in vitro 
conversion efficiency. Its heterologous expression, t gether with other optimization strategies, 
including the enhancement of the flux in the SA pathway, gene expression balancing, and 
alleviation of product autoxidation, led to the production of pyrogallic acid at ~1 g/L in E. coli in 
shake-flask culture (Wang et al., 2018b).  
 
5. Products derived from the L-Trp branch 
5.1 5-Hydroxytryptophan, serotonin, and melatonin 
5-Hydroxytryptophan (5-HTP) is a natural non-canonical amino acid (Figure 3 and Table 3). 
It has been used for over 30 years as a precursor of the neurotransmitter serotonin to treat 
serotonin disorders that cause depression and a variety of other medical conditions such as 
chronic headaches, insomnia, and binge eating disorder and obesity (Lin et al., 2014b; Mora-
Villalobos and Zeng, 2017; Mora-Villalobos and Zeng, 2018; Sun et al., 2015). Owing to its 
structural similarity to L-Trp, orally administered 5-HTP can easily pass through the blood–brain 
barrier and then be converted into serotonin in the central nervous system. The commercial 
production of 5-HTP currently relies on its extraction from the seeds of the African plant 
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Griffonia simplicifolia, whose season- and region-dependent supply strongly influences cost-
effective production.  
In both animals and plants, the biosynthesis of serotonin takes place in two steps but differs 
in the order. In animals, L-Trp is hydroxylated to 5-HTP by tryptophan 5-hydroxylase, and 
tryptophan decarboxylase (TDC) then converts 5-HTP into serotonin, whereas in plants, the 
decarboxylation occurs first, producing tryptamine as the intermediate, followed by the 
hydroxylation step catalyzed by tryptamine 5-hydroxylase. In the literature, both tryptophan 5-
hydroxylase and tryptamine 5-hydroxylase are labeled as T5H, but the latter is a cytochrome 
P450 enzyme that is expressed in the endoplasmic reticulum membrane of plants (Fujiwara et al., 
2018).  
Tryptophan 5-hydroxylase in humans and animals uses5,6,7,8-tetrahydrobiopterin (BH4) 
and Fe2+ as cofactors and O2 as a co-substrate. During Trp hydroxylation, BH4 is oxidized to 
pterin-4α-carbinolamine (BH3OH) and is regenerated through pterin-4α-carbinolamine 
dehydratase (PCD) and dihydropteridine reductase (DHPR) (Hara and Kino, 2013). In humans, 
BH4 is converted from GTP via three steps, involving GTP cyclohydrolase I (GCHI), 6-
pyruvate-tetrahydropterin synthase (PTPS), and sepiapterin reductase (SPR) (Yamamoto et al., 
2003) (Figure 3b). E. coli does not naturally synthesize BH4, but it can use 
tetrahydromonapterin (MH4) as an alternative cofactr for tryptophan 5-hydroxylase (Figure 3c). 
However, the system required for MH4 regeneration is ot fully available in E. coli and has to be 
heterologously incorporated.  
Tryptophan 5-hydroxylase belongs to the family of pterin-dependent aromatic amino acid 
hydroxylases (AAAHs), which also includes phenylalanine-4-hydroxylases (P4Hs). The AAAHs 
from animals usually consist of the N-terminal regulatory domain, the central catalytic domain, 
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and the C-terminal domain involved in BH4 utilization and tetramer formation (Fitzpatrick, 
2003). Prokaryotic P4Hs have only one catalytic domain corresponding to the central domain in 
animal AAAHs but show little activity to act on L-Trp. Because MH4 replaces BH4 as the major 
source of pterin in E. coli, P4Hs use MH4 instead of BH4 as their native coenzyme. Lin et al. 
implemented a protein-engineering strategy to create a mutant P4HW179F from Xanthomonas 
campestris (encoded by phhA), which reduced the substrate preference for L-Phe over L-Trp 
from 33.5 to 1.5 (Lin et al., 2014b). The final strain expressed P4HW179F and the MH4 
regeneration pathway, including PCD (encoded by phhB) from P. aeruginosa and 
dihydromonapterin reductase (DHMR; encoded by folM) from E. coli (Figure 3c), in addition to 
the trpES40FDCBA operon. The host was a previously well-developed L-Phe overproducer 
carrying pheA and tyrA deletions that prevented the synthesis of L-Phe and L-Tyr (Huang et al., 
2013; Lin et al., 2014a), and in this study, its tnaA gene, encoding tryptophanase (TnaA) 
(catalyzing the degradation of tryptophan and 5-HTP to the corresponding indole), was knocked 
out. The engineered strain was fermented at 30 °C to prevent oxidative degradation and produced 
5-HTP at 153 mg/L at the expense of 9.7 g/L glucose in shake flasks and at 1.1–1.2 g/L with the 
supplementation of 2 g/L -Trp (Lin et al., 2014b).  
Similar protein engineering based on in silico structure models was applied to another 
bacterial AAAH from Cupriavidus taiwanensis. The mutant AAAHW192F, with enhanced 
substrate preference towards L-Trp, enabled an E. coli strain harboring the human BH4 (Figure 
3d) regeneration pathway and tryptophanase disruption to produce 5-HTP at 0.55 g/L in 24 h 
with the supplementation of 1 g/L Trp. Here, the BH4 regeneration pathway, including PCD and 
DHPR, was used to regenerate the endogenous MH4 (Mora-Villalobos and Zeng, 2017). The 
same research group later developed a two-stage fermentation process to synthesize serotonin 
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through a decarboxylation reaction of 5-HTP catalyzed by the TDC from Catharanthus roseus. 
As mentioned earlier, in plants, TDC-catalyzed decarboxylation occurs prior to the 
hydroxylation step. The promiscuity of TDC caused it to recognize L-Trp as a substrate and 
decarboxylate it to tryptamine. To address this issue, the team split the production in two strains: 
the first strain synthesized 5-HTP at a titer of 962 mg/L, and the cell-free medium was fed to the 
second strain expressing TDC, leading to the production of 154.3 mg/L serotonin through fed-
batch fermentation. The first strain was created based on a previous L-Trp overproducer, S028. 
Note that a different mutant, CtAAAHF197L, E219C, was designed based on the in silico structure 
model and was verified to have a much larger kcat/Km than that of the initial variant 
CtAAAHW192F towards L-Trp (Mora-Villalobos and Zeng, 2018). One study expressed both TDC 
and tryptamine-5-hydroxylase cloned from rice (Oryza sativa). Its expression in E. coli was 
enabled with the 37 amino acids at the N-terminal of tryptamine-5-hydroxylase replaced with the 
glutathione S-transferase tag to enable soluble expression. The resulting E. coli strain produced 
serotonin at 24 mg/L and 20 °C with the supplementation of L-Trp at 0.2 g/L in test tubes. 
Surprisingly, unlike the expression of other L-Trp hydrolases, neither cofactor biosynthesis nor 
regeneration pathways were needed for tryptamine-5-hydroxylase expression (Park et al., 2011). 
Instead of using the native MH4 as the cofactor, Wang et al. recently reconstituted the BH4 
synthesis and regeneration pathways in an E. coli strain expressing a truncated version of human 
TPH2 (N∆145, C∆24), which had a significantly better soluble expression than that of the wild 
type (Wang et al., 2018a). The GCHI used in the BH4 synthesis was encoded by mtrA from B. 
subtilis, which improved BH4 biosynthesis, and the four other genes were human-sourced 
(Figure 3b). The entire biosynthetic pathway was sectioned into L-Trp, hydroxylation, and BH4 
modules. By modulating the plasmid copy number and promoter strength, the relative expression 
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levels among different modules were fine-tuned. Theproduction of 5-HTP was optimized to 1.3 
g/L in shake flasks and 5.1 g/L in a fed-batch fermnter using glycerol as the carbon source, 
representing the highest reported levels for the microb al de novo production of 5-HTP. 
Zhang et al. compared the performance of L-Trp hydrolase from prokaryotic and eukaryotic 
sources, as well as the MH4 and BH4 systems, when using S. cerevisiae as a host (Zhang et al., 
2016). The prokaryotic system involves an evolved P4H variant from X. campestris, folM 
(encoding DHMR) from E. coli, and phhB (encoding PCD) from P. aeruginosa for MH4 
regeneration (Figure 3c), as discussed previously; the eukaryotic system involves tryptophan 5-
hydroxylase from Oryctolagus cuniculus or tryptophan 5-hydroxylase from Schistosoma 
mansoni, together with a BH4 biosynthesis pathway, including PTPS and SPR from Rattus 
norvegicus, DHPR and GCH from E. coli, and PCBD from P. aeruginosa (Figure 3b). The 
results showed that the BH4 pathway enabled a 17-fold higher production of 5-HTP than its 
MH4 counterpart. It was also found that the overexpssion of the native dihydrofolate reductase 
DFR1 to catalyze tetrahydrofolate synthesis could enhance the performance of the prokaryotic 
pathway by influencing MH4 generation. 
 To overcome the challenge of expressing L-Trp hydrolases in bacteria, Sun et al. devised a 
novel 5-HTP biosynthesis route via anthranilate, which omitted the requirement of the cofactors 
BH4 and MH4 (Sun et al., 2015). The rationale was th t he enzymes encoded by trpDCBA 
could possibly accept 5-hydroxyanthranilate (5-HAA) as a substrate, considering that it only 
differs from the native substrate anthranilate by the 5-hydroxyl group. However, there is no 
reported anthranilate hydroxylase. Thus, they select d two salicylate 5-hydroxylases (S5Hs) 
cloned from Ralstonia sp. and P. aeruginosa characterized to hydroxylate salicylate into 
gentisate. As anthranilate is actually 2-ABA, whereas salicylate is 2-HBA, it was hypothesized 
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that S5H would also accept anthranilate as a substrate; subsequently, the researchers found a 
promising putative S5H gene cluster (designated as salABCD) from Ralstonia eutropha. These 
enzyme complexes require NAD(P)H instead of BH4 as the cofactor. Although the activities of 
TrpDCBA and SalABCD towards the nonnative substrates w re proven separately in this study, 
the combined pathway did not accumulate 5-HTP at the beginning. It was suggested that the 
heterotetrameric complex formed by the native TrpE and TrpD may hinder the access of 
SalABCD to the substrate anthranilate, or that TrpDCBA preferred anthranilate over 5-HAA. A 
two-step strategy was then implemented to address thi  issue. One strain harboring TrpEfbrG and 
SalABCD produced 5-HAA, and after 24 h, the other strain harboring TrpDCBA converted 5-
HAA in the collected supernatant of the first culture to 5-HTP, with the final titer reaching 98 
mg/L at 12 h. 
Melatonin, a natural hormone regulating the circadian rhythm, is produced by the pineal 
gland in the brain through acetylation and methylation steps. It has been sold as an over-the-
counter dietary supplement, and studies have suggested it  role in treating cancer and other 
neurological diseases (Hardeland, 2008; Leonardo-Mendonca et al., 2015; Xu et al., 2015). 
Unlike serotonin, melatonin can be transported across the brain–blood barrier and be absorbed by 
the central nervous system. At present, melatonin is primarily produced through chemical 
synthesis, which requires toxic substrates or catalysts. 
Heterologous expression of N-acetyltransferase (AANAT) and S-adenosyl- L-methionine 
(SAM)-dependent N-acetylserotonin O-methyltransferase (ASMT) converts serotonin to 
melatonin. Germann et al. constituted a production pathway composed of S. mansoni TPH, H. 
sapiens DDC (5-HTP decarboxylase), Bos taurus AANAT, and H. sapiens ASMT in S. 
cerevisiae (Germann et al., 2016). The BH4 synthesis pathway ws enabled by the expression of 
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PTS/SPR from R. norvegicus and basal-level expression of GTP cyclohydrolase I (GCH1 and 
FOL2); the BH4 regeneration pathway combined DHPR from R. norvegicus and PCBD from P. 
aeruginosa. All the genes were integrated into the genome excpt ASMT, which was 
beneficially placed on a high-copy plasmid. Supplementing 500 mg/L methionine, the precursor 
of SAM, did not increase production, indicating that the native SAM level was sufficient, but 
overexpression of the endogenous acetaldehyde dehydrogenase ALD6 increased production by 
10%, presumably by improving the supply of acetyl-CoA. Melatonin production of 14.5 mg/L 
was obtained by using the synthetic feed-in-time (FIT) medium or mineral medium 
supplemented with glucose. The FIT medium mimics small-scale fed-batch fermentation because 
glucose was gradually released by the exogenously added glucoamylase from a solubilized 
glucose polymer. 
 
5.2 Violacein and deoxyviolacein 
 
Violacein and deoxyviolacein are naturally produced purple indolocarbazoles that are of 
great interest because of their antimicrobial, antileishmanial, antiviral, and antitumor properties. 
Several gram-negative bacteria produce them (mainly v o acein), including Alteromonas 
luteoviolacea, Chromobacterium violaceum, Pseudoalteromonas luteoviolacea, and 
Janthinobacterium lividum (Rodrigues et al., 2014; Rodrigues et al., 2013; Sun et al., 2016a). 
Similar to many other secondary metabolites, their production in microorganisms is possibly 
triggered by self-defense against environmental danger. Violacein has also been used as a 
colorant for textile dyeing. 
The accumulation of these pigments in some bacteria is enabled by the vioABCDE operon. L-
Trp oxidase VioA first converts L-Trp to indole-3-pyruvic acid imine, and two of these 
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molecules are combined to form protodeoxyviolaceinic acid, catalyzed by iminophenyl-pyruvate 
dimer synthase (VioB) and violacein biosynthesis enzyme (VioE). Protodeoxyviolaceinic acid 
can be processed either directly by violacein synthase (VioC) or sequentially by tryptophan 
hydroxylase (VioD) and then by VioC, yielding deoxyviolacein or violacein as the final product. 
Rodrigues et al. placed the vioABCE cluster from C. violaceum under the control of an inducible 
araC promoter in E. coli (Rodrigues et al., 2013). To increase the availabilty of L-Trp, the 
feedback-insensitive mutants TrpEN168D, C237R, M293T, and A478T and SerAT372D (3-phosphoglycerate 
dehydrogenase) were created, and the latter increased the endogenous level of L-serine (L-Ser), 
which served as the co-substrate of indole in the TrpB-catalyzed condensation, the last step of 
the L-Trp biosynthesis pathway. Other overexpression targe s included endogenous TktA (to 
increase the E4P level), AroFBL (to enhance the flux in the upstream shikimate pathway), and 
TrpDCBA (to increase the flux in the Trp biosynthesis branch). In addition, the genes trpR, trpL, 
tnaA, and sdaA were interrupted. TrpR and TrpL are involved in downregulating the genes in the 
L-Trp branch, whereas TnaA (tryptophanase) and SdaA (L-Ser deaminase) are involved in L-Trp 
and L-Ser degradation, respectively. In this study, 10 g/L arabinose was used as both the carbon 
source and the inducer. The combination of all these strategies led to an accumulation of 
deoxyviolacein at 324 mg/L in shake flasks. The addition of VioD from J. lividum led to the 
complete conversion of deoxyviolacein to violacein, reaching 710 mg/L in a 300 h fed-batch 
process based on arabinose. An immediate follow-up st dy indicated that the disruption of 
arabinose catabolism and switching to glycerol as acarbon source could further increase the 
production of deoxyviolacein to 1.6 g/L in fed-batch culture (Rodrigues et al., 2014). 
The five genes in the vioABCDE operon actually use internal ribosome-binding sites, and the 
stop codon of the previous gene overlaps with the start codon of the next. Due to the high 
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performance of C. glutamicum as a host to produce aromatic amino acids, Sun et al.
overexpressed the vioABCDE operon in an established industrial L-Trp hyperproducer, ATCC 
21850, and inserted a C. glutamicum ribosome-binding site in front of each vio gene (Sun et al., 
2016a). The resulting strain produced violacein at a titer of 5436 mg/L, with a productivity of 47 
mg/L/h, representing the highest levels of production from both native and heterologous hosts. 
Some studies also focused on optimizing the fermentation processes of the native producers, e.g., 
C. violaceum (1.1 g/L), Duganella sp. (1.62 g/L), and J. lividum (3.5 g/L), and the heterologous 
hosts, e.g., Citrobacter freundii (4.13 g/L) (Duran et al., 2007; Lu et al., 2009; Wang et al., 2009; 
Yang et al., 2011). 
 
5.3 Indole, hydroxyindole, indigo, and indirubin 
Indole alkaloids (also called indigoids) such as indirubin and indigo are plant-derived 
secondary metabolites, many of which possess important pharmaceutical properties and have 
been employed as medicines and dyes since ancient times (Han et al., 2013). Indirubin, also 
known as couraupitine B, a red isomer of indigo, is the active ingredient in Danggui Longhui 
Wan, a traditional Chinese medicine for the treatment of chronic granulocytic leukemia (Berry et 
al., 2002). It also effectively treats diseases such as Alzheimer’s disease (Hoessel et al., 1999). 
Indirubin and indigo compounds are currently extracted from plant materials, but due to their 
small quantities, downstream processing is very challenging and laborious.  
Indole is oxidized by the heterologous naphthalene dioxygenase (NDO) from Comamonas p. 
to form 3-hydroxyindole (interconvertible with 3-oxindole), 2-hydroxyindole (interconvertible 
with 2-oxindole), or isatin. The spontaneous dimerization of 3-hydroxyindole forms indigo in E. 
coli. When 0.5 g/L of 2-oxindole was added to L-Trp-containing media, it was dimerized with 3-
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hydroxyindole, leading to the maximal production of indirubin at 58 mg/L. Further increases in 
2-oxindol had no effect on the titer, but the proportion of indirubin in indigoids could be 
optimized to 48% when 1.5 g/L 2-oxindole was supplemented (Zhang et al., 2014). A compelling 
study found that cysteine supplementation at 0.36 g/L could increase the proportion of indirubin, 
presumably by influencing the regioselectivity of the flavin-containing monooxygenase (FMO) 
from Methylophaga aminisulfidivorans, thereby enhancing the synthesis of 2-hydroxyindole over 
3-hydroxyindole as the major product in L-Trp-containing media. The resulting E. coli strain was 
capable of producing 223.6 mg/L indirubin and 6.8 mg/L indigo, as opposed to 5 mg/L indirubin 
and 920 mg/L indigo when no cysteine was supplemented (Han et al., 2011; Han et al., 2013). 
One study suggested that the L-Trp symporter encoded by tnaB (located 90 bp downstream of 
tnaA) was specifically responsible for transporting the exogenous L-Trp, which is converted to 
indole by TnaA (Li and Young, 2013). 
To avoid supplementation of expensive precursors, the de novo biosynthesis of indigo and 
indirubin was established in E. coli; FMO from M. aminisulfidivorans was introduced into an E. 
coli strain overexpressing its native TnaA (catalyzing the β-elimination of L-Trp to indole), AroL 
(increasing the flux in the shikimate pathway), TktA (increasing E4P availability), and the two 
feedback-insensitive mutants AroGD146N and TrpES40F. Simultaneously, the pathway-specific 
negative regulator TrpR and the pyruvate kinases PykF and PykA (increasing PEP availability) 
were all interrupted. Fed-batch fermentation led to the production of indirubin (0.056 g/L) and 
indigo (0.64 g/L) using glucose as the carbon source (Du et al., 2018). In an earlier study, Berry 
et al. expressed P. putida NDO and the native TrpEfbrDCB/26A in E. coli with a mutation 
introduced in the trpB gene to inactivate the conversion of indole and L-Ser to L-Trp (Berry et al., 
2002). Of note, in vitro analysis suggested that AroG was inhibited by indoxyl r its downstream 
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intermediates. To address this issue, the AroGfbr mutant was cloned in two co-transformed 
plasmids to increase the abundance of AroGfbr and dilute the negative inhibitory impact. It was 
also found that preincubation of the enzyme with PEP provided partial protection against 
inactivation. The overexpression of TktA and disruption of pykA and pykF were correspondingly 
conducted to increase PEP availability. Combining all these strategies enabled a high production 
of 18 g/L in fed-batch fermentation with L-Trp fed at an increasing rate from 0.2 to 0.5 g/min 14 
h after the start of glucose feed. 
 
6. Products derived from the L-Phe branch 
6.1 Phenylpyruvate node 
6.1.1 Phenyllactic acid  
E. coli has endogenous phenylpyruvate reductase (PPR) activity, which converts 
phenylpyruvate to phenyllactic acid (Figure 4 and Table 4); this is equivalent to incorporating 
an aromatic side chain to lactic acid, the precursor of the widely used polymer polylactic acid. 
The addition of a bulky functionality could improve the physical property of polylactic acid. To 
augment the production of phenyllactic acid in E. coli, Fujita et al. expressed a heterologous PPR 
encoded by pprA from Wickerhamia fluorescens in the E. coli strain that was mutated to prevent 
the synthesis of L-Tyr and L-Trp. Fed-batch fermentation was carried out with glucose 
supplemented with L-Tyr and L-Trp at concentrations of 0.15–0.2 g/L for 144 h, resulting in 
phenyllactic acid production at a titer of 29.2 g/L and a yield of 0.16 g/g glucose (Fujita et al., 
2013). 
 
6.1.2 2-Phenylethanol  
 
 
43
Another endogenously synthesized compound from the phenylpyruvate node is obtained 
through the Ehrlich pathway to produce 2-phenylethanol. Due to its floral scent, 2-phenylethanol 
is one of the three most popular benzenoid flavors (the others being vanillin and cinnamyl 
alcohol) and widely applied in food and cosmetics. The Ehrlich pathway is initiated with a 
transamination reaction to convert amino acids to the corresponding α-keto acids, followed by a 
decarboxylation step to fusel aldehydes. Depending on the availability of reductases or oxidases, 
fusel aldehydes are converted to fusel acids or alchols as the end products. In S. cerevisiae, the 
endogenous phenylpyruvate decarboxylase that is usually overexpressed for this conversion is 
Aro10, and the intermediate phenylacetaldehyde can be acted on by the alcohol dehydrogenase 
Adh2 to complete the Ehrlich pathway and generate fus l alcohols. Kim et al. chose to express 
Aro10 and Adh2 from S. cerevisiae in the fast-growing thermotolerant yeast Kluyveromyces 
marxianus (Kim et al., 2014b). Evolutionary engineering was then attempted to grow this strain 
during serial subcultures in media containing p-fluorophenylalanine, an L-Phe analog acting as a 
competitive inhibitor of protein synthesis. Previously, it was used to isolate an L-Phe-
overproducing mutant S. cerevisiae strain that was relieved from feedback regulation. The 
evolved K. marxianus strain produced 1.3 g/L 2-phenylethanol without additional L-Phe 
supplementation. Surprisingly, overexpressing transketolase (TktA) and PEP synthetase (PPS) to 
increase the availability of the two precursors of the shikimate pathway did not enhance 
production (Kim et al., 2014b). The de novo biosynthesis of 2-phenylethanol has also been 
established in an E. coli strain expressing the heterologous 2-keto acid decarboxylase (Kdc4427) 
and alcohol dehydrogenase (Adh4428) enzymes from Enterobacter sp. The strain also carried 
those commonly used genetic manipulations to enhance the flux to the upstream phenylpyruvate 
pathway and precursor supply, but the titer (320 mg/L) and productivity (13.3 mg/L/h) were 
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lower than those achieved by the eukaryotic hosts. A oxicity assay suggested severe inhibition 
of cell growth when the concentration of 2-phenylethanol reached 2 g/L (Liu et al., 2018a). 
Considering the toxicity of the product at economically viable concentrations, whole-cell 
bioconversion and in situ product removal were often applied in combination  achieve high 
production of 2-phenylethanol. Kim et al. converted 10 g/L L-Phe (used as the sole nitrogen 
source) to 2-phenylethanol in S. cerevisiae at 6.1 g/L (Kim et al., 2014a). Polypropylene glycol 
1200 was added to the medium as an extractant for 2-phenylethanol. In addition to Aro9 and 
Aro10, the transcriptional activator Aro80 was also overexpressed because it could be activated 
by aromatic amino acids and aromatic alcohols through positive feedback regulation. The study 
also confirmed the role of Ald3, with its removal disrupting the competing step from 
phenylacetaldehyde to phenylacetate. Another study also indicated that the deletion of Aro8 
encoding aromatic amino acid transaminase in S. cerevisiae nhanced the accumulation of 2-
phenylethanol, suggesting that Aro8 and Aro9 are two transaminases catalyzing opposite 
reactions (Romagnoli et al., 2015). Combining biotransformation with organic extraction has 
been applied to S. cerevisiae and K. marxianus using oleic acid and polypropylene glycol 1200, 
respectively, as the extractants to improve the production to 12.6 g/L and 10.2 g/L; both systems 
relied on the endogenous Ehrlich pathway (Etschmann and Schrader, 2006; Stark et al., 2002). 
 
6.1.3 S-mandelate and R-mandelate  
Chiral mandelic acid and 4-hydroxymandelic acid are important fine-specialty chemicals in 
the synthesis of various pharmaceuticals (Chang et al., 2007; Reifenrath and Boles, 2018; Ward 
et al., 2007). 4-Hydroxymandelic acid can also be converted to ethyl vanillin, which is an 
important flavoring agent in food, beverages, and cosmetics (Reifenrath and Boles, 2018). 4-
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Hydroxymandelate synthase (HmaS) from A ycolatopsis orientalis converts 4-
hydroxyphenylpyruvate to 4-hydroxymandelate but also recognizes phenylpyruvate as a less-
preferred substrate. Reifenrath et al. created two S. cerevisiae strains sharing a basic design 
foundation: increasing the flux in the shikimate pathway, preventing downstream 
decarboxylation and transamination (deleting aro8, aro9, aro10, and pdc5), and removing the L-
Trp branch (deleting trp2) (Reifenrath and Boles, 2018). Depending on whether P A2 or Tyr1 
was deleted, the L-Phe or L-Tyr branch was disrupted and 1 g/L hydroxylmandelate or 0.236 g/L 
mandelate was produced, respectively.  
Mandelate produced from the HmaS-catalyzed reaction is actually in the S-form. Two 
additional steps convert the S-form to the R-form: 4-hydroxymandelate oxidase (Hmo) from 
Streptomyces coelicolor can convert S-mandelate to phenylglyoxylate, and D-mandelate 
dehydrogenase (DMD) from Rhodotorula graminis when heterologously expressed catalyzes the 
unique stereo-reduction of phenylglyoxylate to R-mandelate in E. coli. Similar to engineering S. 
cerevisiae as a host, to trap phenylpyruvate for mandelate synthesis, the first steps entering the L-
Trp branch and L-Tyr branch were disrupted by deleting trpE and tyrA genes, and the 
downstream enzymes (encoded by tyrB and aspC) catalyzing the conversion of phenylpyruvate 
to L-Phe were also removed. The resulting strains were able to produce S-mandelate at 1.02 g/L 
when HmaS was expressed together with AroFfbr and PheAfbr in shake flasks, and if Hmo and 
DMD were included, R-mandelate was produced at 0.88 g/L (Sun et al., 2011). 
 
6.1.4 L-Phenylglycine and D-phenylglycine 
Through a promising transaminase, HpgT, phenylglyoxylate can be converted to L-
phenylglycine, which is an important side-chain building block for synthesizing the antibiotics 
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penicillin, virginiamycin S, and pristinamycin I, and the antitumor drug taxol (Croteau et al., 
2006; Liu et al., 2014a; Mast et al., 2011). The aminotransfer step uses an unusual amino donor, 
L-Phe, and releases phenylpyruvate, which is the beginnin  substrate of this L-phenylglycine 
branch. Sets of enzymes (HmaS, Hmo, and HpgT) originating from A. orientalis and S. 
coelicolor were purified from E. coli and characterized in vitro. The set from S. coelicolor 
demonstrated higher specific activities and was then expressed in a previous L-Phe-
overproducing E. coli strain (Liu et al., 2014b). This strain has its glucose transportation PTS 
system attenuated by disrupting the crr gene to avoid glucose overflow, which reduces acetic 
acid accumulation and thus enhances the yield of L-Phe. It also carried a thermostable mutant, 
AroGD146N, which was beneficial to the fermentation setup, considering that thermosensitive 
promoters were used to drive gene expression. Besides, tyrA mutant was also created to eliminate 
the formation of 4-hydroxyphenylpyruvate; tyrB and aspC were both disrupted to save 
phenylpyruvate just for L-phenylglycine synthesis. The production was reported as 51.6 mg/g dry 
cell weight (Liu et al., 2014a). Thus, HpgT from S. coelicolor is an L-phenylglycine 
aminotransferase, and the product is in the L-form. There are also HpgATs in nature that 
specifically catalyze the amino transfer to produce D-phenylglycine. Similar to L-phenylglycine, 
D-phenylglycine is often used for preparing semi-synthetic pharmaceuticals such as 
cephalosporin and penicillin. D-Phenylglycine aminotransferase was obtained by screening the P. 
putida genome DNA library in E. coli. As the amino transfer reaction was reversible, D-
hydroxyphenylglycine was used as the substrate, and the screening was based on the formation 
of 4-hydroxyphenylglyoxylate, which has a specific absorbance at 340 nm. The gene carried by 
the positive clone was found to strongly correlate with the previously confirmed D-phenylglycine 
aminotransferase HpgAT from Pseudomonas stutzeri. In vitro characterization supported the 
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stereoinverting capability of this HpgAT: only L-glutamate was accepted as the donor, and when 
D-glutamate was used, no D-phenylglycine could be produced. By assembling this gene with 
HmaS from A. orientalis and Hmo from S. coelicolor into the E. coli strain that was engineered 
to accumulate phenylpyruvate (by overexpressing AroFfbr and PheAfbr and deleting pheA, tyrA, 
tyrR, tyrB, and aspC), 146 mg/g dry cell weight D-phenylglycine was obtained in fed-batch 
fermentation (Muller et al., 2006). 
 
6.2 The cinnamate node 
6.2.1 Trans-cinnamic acid, cinnamaldehyde, cinnamyl alcohol, hydrocinnamyl alcohol, and 
benzoic acid  
Trans-cinnamic acid is a phenylpropanoid that is widely used in food and cosmetics as a 
flavoring or fragrance agent, and it also possesses antibacterial and anticancer properties (De et 
al., 2011; Sova, 2012). It also serves as the precursor for synthesizing many other value-added 
compounds, such as flavonoids, styrene, p-hydroxycinnamic acids, cinnamaldehyde, and caffeic 
acid. A previously engineered L-Phe-overproducing E. coli strain was used to heterologously 
express phenylalanine ammonia lyase (PAL) from Streptomyces maritimus, which produced 
trans-cinnamic acid at 6.9 g/L when casamino acid was supplied as a feeding solution (Bang et 
al., 2018).  
The three major cinnamon or sweet-spice aromas that have been widely used in food, 
cosmetic, and pharmaceutical industries are cinnamaldehyde, cinnamyl alcohol, and 
hydrocinnamyl alcohol. Cinnamaldehyde is also a popular natural nematicide (Kong et al., 2007; 
Ooi et al., 2006). Its current production mainly relies on tissue extraction from Cinnamomum 
species or chemical synthesis associated with difficult downstream processing. To enable 
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microbial production, Gottardi et al. heterologously expressed three genes encoding (1) 
phenylalanine ammonia lyase 2 (PAL2) from A. thaliana, converting L-Phe to trans-cinnamic 
acid; (2) ACAR from Nocardia sp., reducing trans-cinnamic acid to cinnamaldehyde; and (3) 
phosphopantetheinyl transferase (EntD) from E. coli to activate acar, because an endogenous 
phosphopantetheinylation activity is missing in S. cerevisiae (Gottardi et al., 2017). 
Cinnamaldehyde was not the final product, and it was reduced by the endogenous ADHs to 
cinnamyl alcohol, and then, unknown enzymes in S. cerevisiae continued reducing cinnamyl 
alcohol to hydrocinnamyl alcohol as the major product (113.1 mg/L). Toxicity assays indicated 
that trans-cinnamic acid and cinnamaldehyde exerted high toxicity at 100 mg/L, whereas 
cinnamyl alcohol and hydrocinnamyl alcohol exhibited mild cell growth inhibition at 200 mg/L. 
Another biosynthetic route for cinnamaldehyde is through cinnamoyl-CoA. After the 
deamination of L-Phe into trans-cinnamic acid by PAL, an acid-thiol ligation of trans-cinnamic 
acid to cinnamoyl-CoA can be carried out by 4-coumarate:CoA ligase (4CL), and cinnamoyl-
CoA reductase (CCR) will then reduce cinnamoyl-CoA t  cinnamaldehyde. Bang et al. chose 
PAL from S. maritimus, 4CL from S. coelicolor, and CCR from A. thaliana and expressed them 
in an E. coli strain that was intensively engineered for L-Phe production (Bang et al., 2016). 
Besides the common strategies to improve L-Phe production, PheAE159A, E232A, dm, which only had 
the first 300 amino acids of the wild-type PheA was used, which excluded the L-Phe regulatory 
domain. The two mutations (E159A, E232A) revived the substrate-binding affinity of the 
truncated PheA. The resulting strain produced cinnamaldehyde at 75 mg/L. The culture 
supernatant was found to kill 82% of Bursaphelenchus xylophilus nematodes after 4 h treatment. 
Multiple independent studies suggest that the PAL-catalyzed reaction is the rate-limiting step 
in trans-cinnamate production; therefore Masuo et al. designed an alternative route via D-
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phenyllactate that did not involve the PAL reaction (Masuo et al., 2016). Some bacteria, such as 
Clostridium spp., possess phenyllactate dehydratase (Fld), which dehydrates D-phenyllactate to 
trans-cinnamate. Fld is uniquely composed of four proteins encoded by fldABCI. FldA is a 
cinnamoyl-CoA:phenyllactate CoA-transferase, transferring the CoA from cinnamoyl-CoA to D-
phenyllacate and releasing D-phenyllactyl-CoA and trans-cinnamate as the products. FldBC is a 
dehydratase forming a heterotrimeric enzyme complex with FldA. FldI has the required ATPase 
activity for activating FldBC-catalyzed dehydration to recycle phenyllacetyl-CoA back to 
cinnamoyl-CoA; it also has a [4Fe-4S] cluster, and its sensitivity to oxygen disables the host 
from producing the expected product under regular aerobic conditions. To overcome this hurdle, 
the fermentation was split into (1) the aerobic process to accumulate D-phenyllacate and (2) a 
subsequent anaerobic process to convert the supernatant from the first-stage culture to trans-
cinnamate at 1.7 g/L, which was higher than the titers achieved by using the PAL-dependent 
route in a batch process. 
 
6.2.2 Styrene and hydroxystyrene 
One of the sources for cloning the pal gene is S. maritimus, a gram-positive, mycelium-
forming soil bacterium. S. maritimus possesses a plant-like β-oxidation amino acid modification 
that converts cinnamoyl-CoA into benzoyl-CoA. The wild-type strain accumulates benzoate 
(125–460 mg/L) after cell growth reaches the maximal level with various carbon sources 
(glucose, cellobiose, starch, and cellulose), althoug  the detailed underlying mechanism remains 
unclear. As benzoyl-CoA is the key intermediate in the biosynthetic pathway of the natural 
product enterocin in S. maritimus, encPHIMJN were suggested as genes coding for the enzymes 
responsible for synthesizing benzoic acid. Benzoic ac d is the precursor of terephthalic acid, 
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caprolactam, and phenol, which are the monomeric building blocks of PET, nylon 6, and 
polycarbonate, respectively (Noda et al., 2012). 
Another very important compound that can be derived from the trans-cinnamate node is 
styrene. It is a versatile commodity chemical mainly used to produce various industrially 
important polymers. Its current production is derivd from petroleum through the energy-
intensive chemocatalytic dehydrogenation of ethylbenzene (McKenna and Nielsen, 2011; 
McKenna et al., 2014). Styrene is also synthesized naturally by Styracaceae trees, but the 
corresponding enzymes responsible for styrene biosynthesis have not been deconvoluted thus far. 
McKenna et al. screened PAL and trans-cinnamate decarboxylase (PADC) from bacterial, yeast, 
and plant sources, and established the first microbial styrene production from sustainable 
feedstocks (McKenna and Nielsen, 2011). PAL from two cyanobacteria, Anabaena variabilis 
and Nostoc punctiforme, and the plant A. thaliana, and PADC from the bacteria Lactobacillus 
plantarum and B. subtilis and the yeast S. cerevisiae were individually expressed, and the cell 
lysates were evaluated against the corresponding substrate. Although all these candidate PALs 
displayed the expected activity towards L-Phe, none of the proposed PADCs succeeded in 
converting trans-cinnamate to styrene. Instead, the enzymes from L. plantarum and B. subtilis 
displayed decarboxylase activity on p-coumaric acid, leading to the production of p-
hydroxystyrene. Interestingly, the previously characterized ferulic acid decarboxylase (FDC1) 
from S. cerevisiae was shown to be capable of converting both trans-cinnamate or p-coumaric 
acid. Its expression with various PALs in an E. coli L-Phe-overproducing commercial strain, 
ATCC 31884, led to the maximal styrene production (260 mg/L) when PAL from A. thaliana 
was assembled with FDC1. Toxicity assays indicated that cell growth stopped when the styrene 
concentration reached ~300 mg/L. The same research group also attempted to engineer S. 
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cerevisiae as a host. They started with evolving L-Phe-overproducing strains by gradually 
increasing the amount of m-fluoro-DL-phenylalanine, the Phe analog that was previously sed to 
evolve strains with enhanced flux through the L-Phe biosynthetic pathway, showing net 
extracellular accumulation of 2-phenylethanol and 2-phenylacetate. The resulting positive 
mutants were shown to have 1.8–9.3-fold upregulation of ARO genes, but the coding or the 
upstream noncoding regions of these genes remained intact. FDC1 expression was naturally 
induced by trans-cinnamate and the basal level expression was found to be sufficient to channel 
all the trans-cinnamate to styrene. Heterologous expression of PAL from A. thaliana with an 
Aro4 feedback-insensitive mutant gene with additional deletion of ARO10 in the best evolved 
strain led to styrene production of 29 mg/L (McKenna et al., 2014).  
 
7. Products derived from the L-Tyr branch 
7.1 Phenylpropanoic acids: p-coumaric acid, caffeic acid, and ferulic acid 
p-Coumaric acid (hydroxycinnamate), caffeic acid (3,4-dihydroxycinnamic acid), and ferulic 
acid are phenylpropanoic acids derived from the L-Tyr branch (Figure 5 and Table 5). These 
phenylpropanoic acids have attracted increasing attention as valuable monomers of liquid crystal 
polymers for electronics, as well as for their various pharmaceutical properties (Kaneko et al., 
2006; Kang et al., 2012). p-Coumaric acid also serves as the pivotal precursor for the 
biosynthesis of a wide variety of flavonoids and stilbenoids in plants. There are two routes to 
establish p-coumaric acid biosynthesis, both starting from the deamination of an aromatic amino 
acid. One is carried out by tyrosine ammonia-lyase (TAL) to convert L-Tyr to p-coumaric acid 
directly, whereas the other involves the deaminatio of L-Phe to trans-cinnamate, catalyzed by 
PAL, followed by the hydroxylation of trans-cinnamate to yield p-coumaric acid, which is 
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catalyzed by the plant cytochrome P450 cinnamate 4-hydroxylase (C4H) and cytochrome P450 
reductase. Various bacteria and eukaryotic microorganisms such as Sporidiobolus pararoseus, 
Rhodotorula graminis, Saccharomycopsis fibuligera, nd Rhodotorula glutinis possess a PAL 
and/or TAL enzyme, which usually displays a preference for L-Phe over L-Tyr (Vannelli et al., 
2007). The first over-gram-scale d  novo production of p-coumaric acid was established in S. 
cerevisiae by Rodriguez et al (Rodriguez et al., 2015). Considering that the pathway 
intermediates in the L-Trp branch only differ from the corresponding ones in the L-Phe branch by 
the 4-hydroxy group, enzymes such as phenylpyruvate decarboxylase (Aro10), pyruvate 
decarboxylase (Pdc5), and transaminases (Aro8 and Aro9) can recognize both phenylpyruvate 
and 4-hydroxyphenylpyruvate as the substrates. When the TAL from Flavobacterium johnsoniae 
was heterologously expressed, the strain produced p-coumaric acid at 1.93 g/L using the 
aforementioned synthetic FIT medium. The same reseach group subsequently compared the 
performance of two yeast strain backgrounds, S288c and CEN.PK, with the identical set of 
genetic manipulations, in both batch and chemostat fermentation settings. The strain S288c is 
widely used in genetics and physiology studies, whereas the strain CEN.PK is often used for 
industrial biotechnology advancement (Rodriguez et al., 2017a). With the same genetic 
modifications, the production of p-coumaric acid by CEN.PK reached 2.4 g/L and 0.507 g/L for 
batch and chemostat fermentation, respectively, which were higher than those achieved by S288c. 
Through transcriptome analysis, the CEN.PK strain showed 652 genes to be significantly 
up/downregulated versus 1,927 genes being significatly ffected by p-coumaric acid production 
in S288c. Metabolomics analysis also revealed that the changes in intracellular metabolite 
concentrations in CEN.PK were much lower than those in S288c, suggesting that CEN.PK is a 
more robust platform strain for producing aromatic compounds. 
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A hydroxylation step at the 3-position of the benzyl ring converts p-coumaric acid to caffeic 
acid, which is usually catalyzed by cytochrome P450 monooxygenases in plants. An additional 
OMT further converts caffeic acid to ferulic acid. The 4-coumarate 3-hydroxylase (C3H or Sam5) 
from Saccharothrix espanaensis and OMT from A. thaliana (COM) were co-expressed with 
TAL from S. espanaensis n an L-Tyr-overproducing E. coli strain, resulting in the production of 
p-coumaric acid at 974 mg/L, caffeic acid at 150 mg/L, and ferulic acid at 196 mg/L in shake-
flask culture (Kang et al., 2012). S espanaensis  an actinomycete species producing two 
heptadecaglycoside antibiotics, saccharomicins A and B, in which caffeic acid links a large 
oligosaccharide portion to the amino sulfonic acid taurine via an amide bond (Berner et al., 
2006). Zhang et al. reconstituted two parallel biosynthesis routes in another L-Tyr-overproducing 
E. coli strain, rpoA14(DE3). One route consisted of TAL from R. glutinis and Sam5 from S. 
espanaensis, and the other route also included 4CL obtained from Petroselinum crispum to 
convert p-coumaric acid to coumaroyl-CoA and E. coli native CoA thioesterases (TE) to convert 
caffeoyl-CoA to caffeic acid in the last step. The conversion from coumaroyl-CoA to caffeoyl-
CoA was catalyzed by Sam5. Batch fermentation showed that the first route rendered a better 
performance, with the production reaching 106 mg/L after 4 days (Zhang and Stephanopoulos, 
2013). 
The non-cytochrome P450 hydroxylase HpaBC in both E. coli and Pseudomonas aeruginosa 
can hydroxylate p-coumaric acid to caffeic acid. When p-coumaric acid was fed as a precursor, 
the E. coli strain overexpressing the native HpaBC converted p-coumaric acid more efficiently 
than the bacterial cytochrome P450 enzyme CYP199A2F185L mutant from Rhodopseudomonas 
palustris did, although this mutant has been improved to display a higher conversion efficiency 
than that of the wild-type CYP199A2. De novo biosynthesis was established by expressing TAL 
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from R. glutinis and the native HpaBC in a commercial L-Phe-overproducing E. coli strain, 
ATCC31884, in which additional knockouts of pheA and tyrA were performed to convert the 
strain from an L-Phe overproducer to an L-Tyr overproducer (TyrA was replaced by the 
overexpressed TyrAfbr). The combination of these manipulations yielded 767 mg/L caffeic acid 
after 72 h(Huang et al., 2013). A crude cell assay showed that TAL from Rhodobacter 
capsulatus expressed in E. coli has a slightly better activity toward L-Tyr than the widely used 
TAL from R. glutinis does (Lin and Yan, 2012).  
Furuya et al. conducted a whole-cell conversion by expressing HpaBC from P. aeruginosa in 
E. coli, and 56.6 mM (10.2 g/L) caffeic acid was obtained in 24 h by repeatedly adding 20 mM 
p-coumaric acid four times during the reaction (Furuya and Kino, 2014). A similar whole-cell 
conversion was also performed with a mutant bacterial cytochrome P450, CYP199A2F185L, from 
R. palustris expressed in E. coli, which exhibited 5.5 times higher hydroxylation activity for p-
coumaric acid than that of the wild-type enzyme. The production of caffeic acid reached 15 mM 
(2.8 g/L) from 20 mM p-coumaric acid in 24 h, and in this case, the expression of 
CYP199A2F185L was accompanied by the redox partners consisting of putidaredoxin reductase 
(PdR) from P. putida and palustrisredoxin (Pux) from R. palustris (Furuya et al., 2012). For the 
conversion from p-coumaric acid to caffeic acid in E. coli, CYP199A2F185L was a better choice 
than C3H from S. espanaensis. Rodrigues et al. assembled each of these two enzymes with the 
codon-optimized TAL from R. glutinis and found that CYP199A2F185L displayed a higher 
catalytic activity than that of C3H, which enabled caffeic acid production of 1.56 mM (280 mg/L) 
from 3 mM L-Tyr as the supplemented precursor (Rodrigues et al., 2015). For all these whole-
cell conversions, glucose or glycerol is normally supplemented as an energy source to regenerate 
the necessary cofactors. 
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7.2 Other compounds derived from the p-coumaric acid node: p-hydroxystyrene and 
phenylpropionic acids 
Similar to styrene discussed in section 6.2.2, p-hydroxystyrene (4-vinylphenol) is widely 
used as a monomer for producing various polymers applied in coating, elastomers, and resins in 
photolithography and semiconductor manufacturing (Verhoef et al., 2009; W. et al., 1999). Its 
biosynthesis also perfectly mirrors the styrene pathw y and relies on the non-oxidative 
decarboxylation of p-coumaric acid catalyzed by p-coumaric acid decarboxylase (PDC). 
Considering that p-hydroxystyrene as a solvent is very toxic to the production host, solvent-
tolerant hosts such as P. putida strains were selected to express PDC from Lactobacillus 
plantarum and PAL/TAL from Rhodosporidium toruloides. The strains were previously 
designed for phenol and p-coumarate production, and the fcsgene encoding feruloyl-coenzyme 
A synthetase was additionally disrupted to prevent p-coumaric acid degradation. Relying on two-
stage fed-batch fermentation in combination with in situ product extraction using 1-decanol, 21 
mM (2.5 g/L) p-hydroxystyrene was obtained overall, while a high concentration of 147 mM 
product (17.6 g/L) was accumulated in the organic phase (Verhoef et al., 2009). The same pairs 
of heterologous genes synthesized p-hydroxystyrene at 0.4 g/L in an E. coli L-Phe overproducer 
in fed-batch fermentation, and the production toxicity led to a rapid decline in cellular respiration 
during fermentation (Qi et al., 2007). 
Besides p-hydroxystyrene, 3-(4-hydroxyphenyl) propionic acid and 3-phenylpropionic acid 
are important commodity aromatic acids used as synthetic precursors in chemical, food, 
agriculture, and pharmaceutical industries. They ar cu rently manufactured through chemical 
synthesis, which involves solvents and catalysts toxic to the environment. Since there are no 
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precedent pathways existing in nature for their synthesis, their de novo biosynthesis relied on 
finding appropriate enoate reductases (ERs) that can hydrogenate the C=C bond of cinnamic acid 
or hydroxycinnamic acid (i.e., p-coumaric acid). Eleven potential ERs from nine microorganisms 
were screened, and only the ER from Clostridium acetobutylicum displayed the expected activity 
under both anaerobic and aerobic conditions. By expressing this ER and TAL from R. glutinis in 
the aforementioned commercial L-Phe-overproducing E. coli strain ATCC31884 with the 
additional classical modifications to enhance L-Phe or L-Tyr production, the resulting strains 
could synthesize 366.77 mg/L 3-phenylpropionic acid an  225.10 mg/L 3-(4-hydroxyphenyl) 
propionic acid (Sun et al., 2016b). 
 
7.3 Phenylethanoids: tyrosol, hydroxytyrosol, 3,4-dihydroxyphenylacetate, and salidroside 
Phenylethanoids are naturally present in olive trees and green tea and exhibit powerful 
antioxidant activity and disease-preventing potential (Chung et al., 2017; Li et al., 2018a). Their 
de novo biosynthesis starts from the same decarboxylation step of 4-hydroxyphenylpyruvate to 
4-hydroxyphenylacetaldehyde. The corresponding enzyme catalyzing this reaction is missing in 
E. coli but can rely on the heterologously expressed Aro10 from S. cerevisiae. To channel the 
carbon flux provided by the upper module shikimate pathway to tyrosol biosynthesis, PheA 
catalyzing the first and second steps in the L-Phe branch and phenylacetaldehyde dehydrogenase 
(FeaB) were knocked out, and the latter one is responsible for further converting 4-
hydroxyphenylacetaldehyde to the corresponding 4-hydroxyphenylacetate. The native ADHs in 
E. coli were sufficient to convert 4-hydroxyphenylacetaldehyde to tyrosol. The resulting strain 
produced tyrosol at 573 mg/L from glucose. When 1.8 g/L L-Tyr was used as the substrate, the 
whole-cell conversion produced 1.2 g/L of tyrosol, wherein the aromatic amino acid 
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aminotransferase Aro8 from S. cerevisiae was expressed to enhance the conversion of L-Tyr to 4-
hydroxyphenylpyruvate (Xue et al., 2017). In a later study, Li et al. incorporated both ARO10 
and ADH6 from S. cerevisiae to E. coli to improve tyrosol production and extended the pathw y 
for hydroxytyrosol production by overexpressing theE. coli native hydroxylase HpaBC (Li et al., 
2018a). To improve the production, ascorbic acid was added to prevent hydroxytyrosol oxidation, 
and 1-dodecanol was added as an in situ extractant to overcome product toxicity. NH4Cl was 
removed from the culture to force the transamination fr m L-Tyr to 4-hydroxyphenylpyruvate 
and release NH4
+. The combined manipulations in an L-Tyr-overproducing E. coli strain with 
feaB knockout resulted in 647 mg/L tyrosol produced from glucose and 1,243 mg/L when L-Tyr 
(1 g/L) was fed at 0, 12, and 24 h after inoculation. In the same E. coli L-Tyr-overproducing 
strain to produce hydroxytyrosol, when E. coli feaB instead of S. cerevisiae ADH6 was 
overexpressed, the acetaldehyde moiety was oxidized to the acetic acid moiety, and 3,4-
dihydroxyphenylacetate became the final product because the native hydroxylase HpaBC could 
convert 4-hydroxyphenylacetate. Finally, the pyruvate kinase genes pykA and pykF were 
removed to conserve PEP, and the final strain produce  3,4-dihydroxyphenylacetate at 1,856 
mg/L in the mixed glucose/glycerol media (Li et al., 2019).  
Salidroside, a glucoside of tyrosol, is one of the major active ingredients of the medicinal 
herb rhodiola, which possesses various health-boosting activities, including bone loss reduction 
(Chung et al., 2017); neuro-, cardio-, and hepatoprotection; and the prevention of stress-induced 
impairments and disorders (Liu et al., 2018b). Chung et al. screened 12 uridine diphosphate-
dependent glycosyltransferases (UGTs) from A. thaliana and found that only UGT85A1 could 
glycosylate tyrosol to form salidroside (Chung et al., 2017). In an E. coli strain expressing 
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UGT85A1 and a plant aromatic aldehyde synthase (AAS) from P. crispum and lacking tyrR, 
pheA, and feaB, salidroside was produced at 288 mg/L in shake-flask culture.  
Recently, high-level production of salidroside was achieved in a syntrophic E. coli 
consortium. The two strains were obligatory cooperators through the cross-feeding of L-Tyr and 
L-Phe. The L-Phe-deficient strain also lost the ability to take up glucose (via ptsG and manZ 
deletions), and instead, it used xylose as the sole carbon source. It expressed 2-keto acid 
decarboxylase (KDC) from Pichia pastoris GS115 and used the endogenous ADH to complete 
the synthesis of tyrosol. The L-Tyr-deficient strain used glucose exclusively (via xylA deletion) 
and was able to convert glucose to UDP-glucose via phosphoglucomutase (Pgm) and UDP-
glucose pyrophosphorylase (GalU). This strain expressed the above-mentioned 
glycosyltransferase UGT85A1 and also carried the del tion of ushA encoding UDP-sugar 
hydrolase to avoid the decomposition of UDP-glucose. The co-culture was optimized with 
different sugar concentrations and inoculation ratios of the two strains, with the highest 
production of salidroside reaching 6.03 g/L in fed-batch fermentation (Liu et al., 2018b). 
 
7.4 Other compounds derived from 4-hydroxylphenylpyruvate or the L-Tyr node: salvianic 
acid A and L-DOPA 
Salvianic acid A (3-(3′,4′-dihydroxyphenyl)-2-hydroxypropanoic acid), also called 
“danshensu”, is the major bioactive ingredient of the Chinese herb Salvia miltiorrhiza (danshen). 
It is well known for its promising antioxidant activi y and therapeutic potential in the treatment 
of vascular diseases (Yao et al., 2013; Zhou et al., 2017). Its derivatives, such as salvianolic acids 
B and A, and rosmarinic acid, have useful properties for applications in pharmaceutical and food 
industries. The content of salvianic acid A in crude S. miltiorrhiza was found to be only 0.045% 
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(Lam et al., 2007), which prevents large-scale applications. The de novo microbial biosynthesis 
of salvianic acid A can be achieved through the reduction of the ketone group and 3-
hydroxylation of the phenyl ring in 4-hydroxyphenylp ruvate regardless of the order of the 
reactions. 4-Hydroxyphenylpyruvate reductases have been isolated from various plants, but they 
often showed broad substrate specificity. Yao et al. chose a mutant D-lactate dehydrogenase (D-
LDHY52A) from Lactobacillus pentosus, which had been previously created to exhibit catalytic 
activity towards phenylpyruvate, and assembled it with the native hydroxylase HpaBC, which 
hydroxylates the phenyl ring in several L-Tyr pathway intermediates (Yao et al., 2013). The 
pathway was assembled in parallel using either plasmids or the genomic integration in an L-Tyr-
overproducing E. coli strain. The plasmid version enabled salvianic acidA production of 7.1 g/L 
in fed-batch fermentation, which was slightly higher than the genomically integrated version (5.6 
g/L), but the latter did not require the supplementation of any antibiotics or inducers (Yao et al., 
2013; Zhou et al., 2017).  
L-3,4-Dihydroxyphenylalanine (L-DOPA) is a phenolic compound obtained from Mucuna 
pruriens seeds. It has been used in the treatment of Parkinson’s disease, caused by the deficiency 
of the neurotransmitter dopamine. Many microbial species possess tyrosinase, which can 
synthesize L-DOPA in one step, directly from L-Tyr. Feeding A. oryzae, Yarrowia lipolytica, 
Bacillus sp. JPJ, Brevundimonas sp. SGJ, Pseudomonas melanogenum, Vibrio tyrosinaticus, or 
Acremonium rutilum with L-Tyr (0.5–8.6 g/L) induced the expression of the endogenous 
tyrosinase, resulting in high-level conversion (0.497–7.7 g/L) to form L-DOPA (Ali and Ikram-
ul-Haq, 2006; Ali et al., 2005; Ali et al., 2007; Ikram-ul-Haq et al., 2002; Krishnaveni et al., 
2009; Yoshida et al., 1973; Yoshida et al., 1974). Thede novo biosynthesis from glucose has 
also been established in E. coli, relying on the endogenous p-hydroxyphenylacetate 3-
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hydroxylase HpaBC, which has a broad substrate specificity and thus can add a hydroxyl group 
to L-Tyr to form L-DOPA (Wei et al., 2016). Besides the deletion of TyrR (the L-Tyr pathway 
repressor), the carbon storage regulator A (CsrA), which regulates the expression levels of three 
enzymes directly participating in PEP metabolism, was disrupted too. The PTS-mediated glucose 
transport (ptsH∆, ptsI∆, and crr∆) was replaced by the GalP/GlK-mediated system to further 
increase PEP availability. Besides, glucose-6-phospate dehydrogenase encoded by zwf was 
knocked out to enhance the carbon flow in the PPP, whereas pyruvate was recycled to PEP via 
the overexpression of ppsA. Prephenate dehydratase and its leader peptide genes (pheLA) were 
also disrupted to eliminate the loss of prephenate to he competing L-Phe biosynthesis branch. 
Moreover, an innovative protein engineering strategy was applied to fuse TyrAfbr, TyrB, and 
HpaBC via a (G4S)3 linker to facilitate substrate channeling. With this foundation strain, L-
DOPA production reached 307 mg/L. To further enhance the production, multiplex automated 
genome engineering (MAGE) was implemented, which targeted the ribosome-binding sites of 23 
genes involved in L-Tyr biosynthesis and replaced them with random sequences. After 30 
MAGE cycles, a mutant strain with 34% higher production was obtained. With the correction of 
the spontaneous mutation occurring in the 5′-UTR sequence of HpaC in the HpaBC operon, the 
final strain was able to produce 8.67 g/L L-DOPA based on fed-batch fermentation.  
The above titer was much higher than when relying o endogenous tyrosinase for the 
conversion of L-Tyr, but it was still lower than that by another bioconversion route, which relies 
on a different enzyme, tyrosine phenol-lyase (TPL), to assemble L-DOPA or catechol, pyruvate, 
and ammonia salt. This enzyme has been found in Erwinia herbicola, a thermophilic 
Symbiobacterium species, and C. freundii, and the conversion has been demonstrated in E. 
herbicola and the heterologous hosts P. aeruginosa and E. coli, with the highest level of L-
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DOPA reaching 29.8 g/L when pyrocatchol and sodium pyruvate were each supplemented at 50 
mM and ammonia at 0.65 mM (Lee et al., 1996). When toluene dioxygenase (TDO) and cis-
toluene dihydrodiol dehydrogenase (TCGDH) from P. putida were incorporated, benzene could 
replace catechol as the starting substrate, and E. coli and P. aeruginosa produced 592 mg/L and 
2.7 g/L of L-DOPA, respectively (Park et al., 1998). 
 
8. Benzylisoquinoline alkaloids 
 
Benzylisoquinoline alkaloids (BIAs) are a diverse class of plant alkaloids derived from L-Tyr 
(Figure 6 and Table 6). They exhibit a broad range of pharmacological activities, including the 
antimicrobial and anticancer agents sanguinarine (Tr nchard and Smolke, 2015) and berberine 
(Galanie and Smolke, 2015); the cough suppressant noscapine, which also displays anticancer 
activity (Li et al., 2018b); the analgesics morphine and codeine (Galanie et al., 2015); and 
magnoflorine, which prevents atherosclerotic disease and protects human lymphoblastoid cells 
(Minami et al., 2008). Their synthesis requires complex enzymatic and regulatory activities, 
rendering synthetic chemistry approaches ineffectiv due to the structural complexity. On the 
other hand, native plant hosts exhibit distinct alkaloid profiles, but the BIA products and 
intermediates are accumulated at low levels. Their structural similarity also complicates the 
downstream purification processes.  
The reconstruction of plant-sourced BIA biosynthesis in microbial hosts has been extremely 
challenging. Many of the enzymes involved are plant endoplasmic reticulum membrane-bound 
proteins that are often not amenable to heterologous expression. When 20–30 genes sourced 
from plants, mammals, bacteria, and fungi are combined nto one host, it is difficult to balance 
their expression levels, both among themselves and relative to the upstream enzymes in L-Tyr 
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biosynthesis, for efficient de novo biosynthesis. It is impossible to accurately predict the rate-
limiting steps, but any impairment in the pathway will cause an intermediate buildup and thus, 
significantly decrease the final product yield.  
The condensation of dopamine (obtained through the decarboxylation of L-DOPA) and 4-
hydroxyphenylacetaldehyde (obtained through the decarboxylation of 4-hydroxyphenylpyruvate) 
serves as the first committed step in BIA biosynthesis in native plant hosts such as Thalictrum 
flavum and Papaver somniferum. This step is catalyzed by norcoclaurine synthase (NCS) to 
produce (S)-norcoclaurine. The subsequent chain of methylation reactions catalyzed by 
norcoclaurine 6-O-methyltransferase (6OMT), coclaurine-N-methyltransferase (CNMT), and 3′-
hydroxy-N-methylcoclaurine 4′-O-methyltransferase (4′OMT), and a hydroxylation reaction 
catalyzed by cytochrome P450 (CYP80B1 or NMCH) lead to the synthesis of (S)-reticuline, the 
first key branch point intermediate, from which a wide variety of BIA metabolites can be derived. 
Before these plant-sourced enzymes were functionally expressed in microbial hosts, studies 
focused on using the commercially available substrate norlaudanosoline to yield (R,S)-reticuline. 
This alternative substrate differs from the natural substrate (S)-norcoclaurine at the 3′-hydroxyl 
group, and therefore, the CYP80B1-catalyzed hydroxylation can be skipped in the synthetic 
pathway. Smolke’s group expressed 6OMT, CNMT, and 4′OMT enzyme variants from T. flavum 
and P. somniferum in all possible combinations in S. cerevisiae cells fed with 1 mM 
norlaudanosoline, after which the combinations with h gh conversion were selected (Hawkins 
and Smolke, 2008). Using an enzyme titration strategy hat increased the expression level of each 
of the three methyltransferases using a galactose-induc ble plasmid, the expression of 6OMT was 
found to be rate limiting. By additional expression of the berberine bridge enzyme (BBE) from P. 
somniferum, the N-methyl moiety of (S)-reticuline completed the oxidative cyclization and was 
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converted to (S)-scoulerine, which represents a second important branch point metabolite 
entering either the sanguinarine branch or the berberine branch. 
For the berberine branch, in a subsequent study (Galanie and Smolke, 2015), scoulerine 9-O-
methyltransferase (S9OMT) and cytochrome P450 canadine synthase (CAS) from T. flavum, P. 
somniferum, Coptis japonica, and Argemone mexicana, together with cytochrome P450 
reductase (CPR) from A. thaliana, were expressed, leading to the production of 1.8 mg/L (S)-
canadine and 6.5 µg/L berberine (spontaneous oxidization product from (S)-canadine) in S. 
cerevisiae in shake-flasks and 621 µg/L (S)-canadine and 27 µg/L berberine in a 0.2 L batch 
bioreactor. In both cases, 1–2 mM norlaudanosoline was supplied. 
Reconstitution of the sanguinarine biosynthesis branch mainly encompasses overcoming the 
challenges associated with expressing multiple plant cytochrome P450s, including 
cheilanthifolinesynthase (CFS), stylopine synthase (STS), cis-N-methylstylopine14-hydroxylase 
(MSH), and protopine 6-hydroxylase (P6H). In another study conducted by Smolke’s group 
(Trenchard and Smolke, 2015), all available enzyme variants from five species (A. mexicana, 
Eschscholzia californica, P. somniferum, S. cerevisiae, and A. thaliana) were tested. The results 
proved that it is not necessary to pair a cytochrome P450 with the CPR from the same species. 
Besides, high-level expression of endoplasmic reticulum membrane-bound cytochrome P450s is 
stressful to yeast, and thus, a balanced expression at a  appropriate growth stage is important for 
high-level production. Other parameters that impacted ytochrome P450 expression and 
sanguinarine production included growing temperature and carbon source. With these strategies 
combined, the yeast strain fed with norlaudanosoline y elded 80 µg/L sanguinarine, together with 
various intermediates ranging from 76 to 548 µg/L. 
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Although feeding the commercial substrate norlaudanosoline simplifies part of the pathway 
design, the natural substrates for 6OMT and CNMT are not norlaudanosoline and 6-O-
methylnorlaudanosoline, respectively. Transport of BIA substrates is also somewhat inefficient, 
warranting the consolidation of the entire d  novo biosynthesis from a cheap feedstock. In plants 
and animals, L-DOPA is mainly synthesized from L-Tyr by a BH4-dependent tyrosine 
hydroxylase (TyrH), whereas E. coli and yeast do not have the native ability to synthesize BH4. 
To equip E. coli with the ability to synthesize (S)-reticuline from glucose or glycerol, a special 
copper-containing tyrosinase (TYR) from Streptomyces castaneoglobisporus was expressed in 
an L-Tyr-overproducing E. coli strain, leading to the production of 293 mg/L L-DOPA in the 
absence of reconsitutited BH4 biosynthesis (Nakagaw et al., 2011). L-DOPA decarboxylase 
(DODC) from P. putida, monoamine oxidase (MAO) from Micrococcus luteus, and NCS from C. 
japonica were incorporated into this strain. Unlike the conde sation in S. cerevisiae, the 
substrates of NCS are dopamine and 3,4-dihydroxyphenylacetaldehyde (instead of 4-
hydroxyphenylacetaldehyde), which is the hydroxylation product converted from dopamine 
catalyzed by MAO. Therefore, the product of this three-step reaction is (S)-norlaudanosoline, 
differing from (S)-norcoclaurine at the 3-hydroxyl group. Their expression together with 6OMT, 
CNMT, and 4′OMT, all from C. japonica, enabled E. coli to produce (S)-reticuline at 2.26 mg/L 
based on glucose and 6.24 mg/L when glycerol was used a  the carbon source. It was found that 
L-DOPA was unintentionally converted to its quinone derivative (via the o-diphenolase activity 
of TYR), which was easily polymerized to form dark melanin pigment in the culture. To address 
this issue, TYR from S. castaneoglobisporus was replaced by TYR from Ralstonia 
solanacearum because the latter enzyme was reported to possess low o-diphenolase activity. 
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This replacement led to a 7-fold increase in the de novo biosynthesis of (S)-reticuline based on 
glycerol (46 mg/L).  
Considering that yeast does not naturally synthesize BH4, in order to functionally express 
tyrosine hydroxylase originated from mammals, BH4 biosynthesis and regeneration pathway has 
to be reconstituted. The strategies have been discussed in section 5.1—activating tryptophan 5-
hydroxylase, the enzyme converting L-Trp to 5-HTP and requiring the participation of BH4 
(Figure 3). Briefly, GTP cyclohydrolase I (GCHI), 6-pyruvoyl-tetrahydropterin synthase (PTPS), 
and sepiapterin reductase (SepR) convert GTP to BH4; pterin-4alpha-carbinolamine dehydratase 
(PCD) and quinonoid dihydropteridine reductase (QDHPR) are required to recycle BH3OH back 
to BH4. Except GCHI, all the enzymes need to be hetrologously expressed. Another challenge 
is that TyrH is subjected to both substrate and prouct inhibitions. A few mutations were 
reported to relieve such inhibitions (Briggs et al., 2011; Nakashima et al., 2002; Quinsey et al., 
1998), among which the triple mutations (W166Y, R37E, R38E) created on TyrH from R. 
norvegicus led to the highest level of conversion (Trenchard et al., 2015). When coupled with 
DODC from P. putida, NCS from C. japonica, the three methyltransferases from P. somniferum, 
and the cytochrome P450 CYP80B1 (also known as NMCH) from E. californica with its 
reductase partner from P. somniferum, the mutant TyrHW166Y, R37E, R38E enabled the S. cerevisiae 
strain to produce 19.2 µg/L (S)-reticuline from glucose. 
An alternative is to identify a BH4-independent tyrosine hydroxylase that could be functional 
in S. cerevisiae. DeLoache et al. implemented protein engineering strategies to cytochrome P450 
tyrosine hydroxylase from sugar beet (Beta vulgaris) (DeLoache et al., 2015). To facilitate the 
screening, an enzyme-coupled biosensing platform was developed to convert the intermediate L-
DOPA into a fluorescent pigment betaxanthin. Using this biosensor, a double mutant (TyrH*, 
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also known as CYP76AD1W13L, F309L) was obtained by PCR mutagenesis, which improved th  L-
DOPA titer and avoided the side reaction from L-DOPA to L-dopaquinone. When coupled with 
other downstream enzymes described in the previous example when BH4-dependent TyrH was 
studied (Trenchard et al., 2015), this mutant BH4-independent TyrH* enabled the d  novo 
biosynthesis of 80.6 µg/L (S)-reticuline from glucose in S. cerevisiae. 
Although E. coli has been engineered to produce (S)-reticuline at a much higher level than 
that produced by S. cerevisiae, the production of diverse alkaloids beyond (S)-reticuline is still 
difficult in E. coli because several membrane-bound cytochrome P450s cannot be functionally 
expressed. To address this issue, an E. coli–S. cerevisiae co-culture was set up (Minami et al., 
2008). S. cerevisiae cells expressing either BBE or the diphenyl ring bridging enzyme 
(CYP80G2) and CNMT from C. japonica were cultured for 20 h and then combined with E. coli 
cells containing (S)-reticuline biosynthetic genes, which had been cultured in the presence of 5 
mM dopamine for 12 h. The co-culture was incubated for another 48–72 h. Magnoflorine and 
scoulerine were synthesized at 7.2 mg/L and 8.3 mg/L, respectively.  
With the success in connecting (S)-reticuline biosynthesis to the utilization of a cheap carbon 
source in microbial hosts, pioneering studies have been conducted to demonstrate the 
reconstitution of complex natural product biosynthesis processes such as the complete 
biosynthesis of the pain-killing opioids thebaine (6.4 µg/L) and hydrocodone (0.3 µg/L) (Galanie 
et al., 2015) and the anticancer and cough-suppressing agent noscapine (2.2 mg/L) (Li et al., 
2018b). Twenty to thirty enzymes from plants, bacteria, yeast, and mammals, including multiple 
additional challenging plant enzymes, were expressed in S. cerevisiae. Tremendous endeavors 
have been made in identifying the missing catalytic steps, thereby enabling (1) the functional 
expression of the challenging enzymes through mutagenesis and chimeric protein construction, 
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(2) the identification of the rate-limiting steps, (3) the tuning of the expression levels, and (4) 
adjustments in fermentation conditions. The current production levels in microbial systems have 
not satisfied the conditions for mass production yet. Considering the high price of this group of 
compounds, production at ~5 g/L would enable an economically competitive process compared 
to the plant-sourced production. Nevertheless, all these studies have pushed the frontier of 
tackling the challenges associated with extremely long multi-source pathways for the production 
of rare high-value molecules and have opened up potential pathways for synthesizing novel BIAs. 
 
9. Flavonoids and stilbenoids 
Flavonoids and stilbenoids comprise two other large families of secondary metabolites that 
are derived from aromatic amino acid biosynthesis in plants and display a wide variety of health-
promoting properties (antioxidant, antiviral, antibacterial, and anticancer properties) (Figure 7 
and Table 7). Similar to BIA biosynthesis, plant-sourced synthesis is constrained by the long 
cultivation cycle and complex recovery process. Thelimited genetic tools available to 
manipulate plant genomes also make plant-sourced production very challenging for mechanistic 
studies and the creation of novel derivatives with potentially improved functions. In comparison, 
although the productivities currently achieved by engineered microbial hosts have not met 
commercial expectations, the scope for improvement ca  be foreseen owing to the ease of 
manipulating microbial hosts. As shown by the examples discussed in the sections below, 
microbial platforms offer the unique advantage to achieve combinatorial assembly of enzymes 
from a wide variety of sources, which enlarge the mix-and-match space for seeking optimal 
outcomes. Among thousands of structures belonging to this group, we mainly selected the ones 
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with established e novo biosynthetic pathways in microbial hosts with the aim of illustrating 
their connections to the upstream aromatic amino acid biosynthesis. 
p-Coumaric acid (derived from L-Tyr) and cinnamate (derived from L-Phe) are the starting 
precursors for synthesizing flavonoids containing lear C6–C3–C6 skeletons (e.g., naringenin 
and (2S)-pinocembrin), stilbenoids having C6–C2–C6 skeletons (e.g., resveratrol and pinosylvin), 
and a wide variety of derivatives (through methylation, alkylation, oxidation, C- and O-
glycosylation, and hydroxylation). Cinnamate can be hydroxylated to p-coumaric acid through 
cinnamate 4-hydroxylase (C4H), a cytochrome P450 whose functional expression requires the 
assistance of cytochrome P450 reductase (CPR1). 4CL adds a CoA moiety to form p-coumaroyl-
CoA. Depending on the availability of the next-step enzyme, p-coumaroyl-CoA can be 
condensed with three molecules of malonyl-CoA to form either resveratrol (catalyzed by a type 
III polyketide synthase STS) or naringenin (catalyzed by chalcone synthase CHS and chalcone 
isomerase CHI).  
 
9.1 Representative flavonoids: naringenin and (2S)-pinocembrin 
Santos et al. described the assembly of enzymes from tw  microbial sources and multiple 
plant species (Santos et al., 2011), including TAL (from R. glutinis or Rhodobacter sphaeroides), 
4CL (from S. coelicolor or P. crispum), CHS (from A. thaliana or Pericallis hybrida), and CHI 
(from Medicago sativa or Pueraria lobata) in an L-Tyr-overproducing E. coli strain. Through 
extensive exploration of enzyme sources and fine-tuing of relative gene expression levels, the 
best combination produced naringenin at 29 mg/L from glucose without additional 
supplementation of any precursor from the aromatic amino acid biosynthetic pathway. Since 
malonyl-CoA is the other substrate for naringenin biosynthesis, when 20 mg/L cerulenin (an 
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inhibitor of fatty acid biosynthesis) was supplemented, the strain was capable of producing up to 
84 mg/L naringenin, indicating the necessity of optimizing the availability of malonyl-CoA. A 
similar combination of PAL (instead of TAL) from R. glutinis, 4CL, CHS, and CHI was 
incorporated into a Phe-overproducing strain, in which matC (encoding Rhizobium trifolii 
malonate carrier protein) and matB (encoding R. trifolii malonate synthetase) were expressed to 
convert the supplemented malonate to malonyl-CoA (Wu et al., 2013). The counterpart product 
of naringenin, (2S)-pinocembrin, was produced at 40.02 mg/L.  
 With the same strain backgrounds, two independent E. coli strains were designed to 
expressing different portions of the biosynthetic pathway, one of which secreted both L-Tyr and 
p-coumaric acid to the co-cultured partner to synthesize naringenin (Ganesan et al., 2017). 
Owing to the flexibility to adjust the relative biosynthetic strength between the co-cultured 
specialists with reduced metabolic stress, the overall p oduction of naringenin was improved to 
41.5 mg/L without cerulenin addition. Meanwhile, significant amounts of L-Tyr and p-coumaric 
acid accumulated even when the initial ratio between th  upstream strain and the downstream 
strain was made 1:5. However, the downstream strain presented significant growth disadvantage 
and its proportion was reduced to 16.7% over a cultivation course of 60 h. The discrepancy 
between the “pre-set” and final ratios was caused by the dynamic growth and the complex 
interaction between the two strains (Zhang et al., 2015a; Zhang et al., 2015b) but nonetheless 
indicated the necessity of flexibly increasing the portion of the rate-limiting steps with the rest of 
the pathway to improve the overall production. 
The de novo biosynthesis of naringenin was also established in S. cerevisiae, in which the 
carbon fluxes from both L-Tyr and L-Phe were combined (Koopman et al., 2012). The enzymes 
were mainly cloned from A. thaliana, which has four isozymes for PAL and 4CL, and three 
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isozymes for CHS and CHI, as well as a number of genes mediating the further modifications of 
naringenin. To prevent the formation of 2-phenylethanol and tyrosol via the Ehrlich pathway, 
three out of the four 2-oxo acid decarboxylases, including Aro10, Pdc5, and Pdc6, were deleted, 
leaving only pyruvate decarboxylase (Pdc1) to enable ppropriate strain growth on glucose. 
Increasing the copies of CHS3 integration was found to reduce the accumulation of p-coumaric 
acid and increase the production of naringenin to 109 mg/L in an aerated, pH-controlled batch 
reactor. 
Regarding the limiting precursor malonyl-CoA, Wu et al. implemented the clustered 
regularly interspaced short palindromic repeats interference (CRISPRi) system to fine-tune 
central metabolism to improve the carbon channel towards malonyl-CoA without significantly 
altering biomass accumulation (Wu et al., 2015). Out of 30 target genes, mainly from the 
glycolysis, PPP, TCA cycle, and fatty acid biosynthesis pathways, 12 were found to increase 
malonyl-CoA availability after their expression levels were disrupted. Combinatorial genetic 
perturbation was conducted, and the highest production of naringenin (421.6 mg/L) was obtained 
in the E. coli strain with the knockdown of fabF (encoding 3-oxoacyl-acyl carrier protein 
synthase II), fumC (encoding fumarate hydratase), sucC (encoding succinyl-CoA synthetase), 
and adhE (encoding acetaldehyde dehydrogenase). Some of these knockdowns are not intuitive, 
suggesting that high-level carbon redistribution occurs if the expression of a primary metabolic 
pathway gene is altered. 
 
9.2 Representative stilbenoids: resveratrol and pinosylvin 
Resveratrol is naturally present in higher plants, such as blueberries and grapes, and is known 
for its antioxidant properties, which have drawn much attention from nutraceutical and cosmetic 
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industries. Its microbial biosynthetic pathway was established from the assembly of TAL from 
Herpetosiphon aurantiacus, 4CL from A. thaliana, and resveratrol synthase (also called stilbene 
synthase) VST1 or STS from Vitis vinifera (Li et al., 2015). A unique mutant of acetyl-CoA 
carboxylase (ACC1S659A, S1157A) was incorporated. The enzyme converts cytosolic acetyl-CoA to 
the rate-limiting malonyl-CoA, and the double mutantations prevent its phosphorylation and 
subsequent degradation. Based on the hypothesis that the production of resveratrol is limited by 
the downstream enzyme expression, 8–11 copies of TAL, 4CL, and VST1 were integrated into 
the Ty4 retrotransposon sites in the genome of S. cerevisiae, resulting in the production of 
235.57 mg/L resveratrol in batch fermentation. The production was further optimized by the 
addition of a fed-batch fermentation following the batch fermentation when glucose was depleted. 
Providing glucose or ethanol as the carbon source in the fed-batch fermentation stage improved 
the total production of resveratrol to 415.65 mg/L and 531.41 mg/L, respectively. When VST1 
was expressed in E. coli, the enzyme can also act on cinnamoyl-CoA, leading to the synthesis of 
pinosylvin (or trans-3,5-dihydroxystilbene) as the counterpart of resveratrol derived from L-Tyr 
(Wu et al., 2017). The strain simultaneously expressed PAL from Trichosporon cutaneum and 
4CL from P. crispum. CRISPRi revealed that repression the expression of six genes—fabF, fabB, 
eno, adhE, fumC, and sucC—enabled the highest production of pinosylvin (281 mg/L). Here, 
FabB catalyzes the same reaction as FabF (fatty acid biosynthesis), and Eno catalyzes the 
interconversion of 2-phosphoglycerate to PEP. Their rep ession presumably increases PEP 
availability. 
 
9.3 Representative derivatives of the naringenin pathway: ponciretin, sakuranetin, 
kaempferol, liquiritigenin, resokaempferol, quercetin, and fisetin 
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Naringenin is a building block for synthesizing a wide variety of flavones, isoflavones, and 
flavonols. Other valuable modifications such as O-methylation and glycosylation also occur 
during flavonoid biosynthesis in plants and confer improved biological activities. For example, 
the synthesis of two O-methylflavonoids, sakuranetin (7-O methylnaringenin), and ponciretin 
(4′-O-methylnaringenin), displaying antifungal and antibacterial activities, are mediated by 
naringenin O-methyltransferase (NOMT) from O. sativa and soybean O-methyltransferase 
(SOMT2) from Glycine max (Kim et al., 2013). Assembling each of these enzymes with TAL 
(from S. espanaensis), CHS (from Populus euramericana), and 4CL (from O. sativa) in an L-
Tyr-overproducing E. coli strain led to the production of 42.5 mg/L ponciretin and 40.1 mg/L 
sakuranetin. Note that this strain did not carry the heterologously expressed CHI, indicating that 
the isomerization reaction might have occurred spontaneously. Besides, icdA encoding isocitrate 
dehydrogenase was deleted to increase the supply of CoA as the precursor for malonyl-CoA 
synthesis. 
A p-coumaroyl-CoA-accumulating yeast strain carrying Aro4K229L, Aro7G141S, F. johnsoniae 
TAL, P. crispum 4CL, P. hybrid CHS, and M. sativa CHI, in the background with Aro10 and 
Pdc5 deletion, was constructed as the base strain (Rodriguez et al., 2017b). Extension with 
Astragalus mongholicus flavanone 3-hydroxylase (F3H) and A. thaliana flavonol synthase (FLS) 
led to the synthesis of kaempferol (26.57 mg/L) in sy thetic fed-batch FIT media. When 
chalcone reductase (CHR) (from A. mongholicus) was added into the overexpression queue, 
isoliquiritigenin appeared as an intermediate, and resokaempferol was accumulated at 0.51 mg/L. 
In this strain, p-coumaric acid, kaempferol, naringenin, and liquiritigenin were also observed at 
much higher levels, indicating the incomplete reduction of p-coumaroyl-CoA mediated by CHR. 
Finally, cytochrome P450 (FMO) from P. hybrida was fused in-frame with cytochrome P450 
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reductase (CPR) from C. roseus and co-expressed in the resokaempferol-producing strain to 
synthesize fisetin (2.29 mg/L) and in the kaempferol-p ducing strain to synthesize quercetin 
(20.38 mg/L). 
 
9.4 Representative curcuminoids: curcumin 
Curcuminoids are another family of plant polyphenols that prevent oxidative damage in 
normal cells during the treatment of allergy, asthma, cancer, and Alzheimer’s disease. Wang et al. 
described the assembly of enzymes from different sources as being akin to building Legos to 
generate several phenylpropanoid acids (cinnamic acid, p-coumaric acid, caffeic acid, and ferulic 
acid), stilbenoids (resveratrol, piceatannol and pinosylvin), and curcuminoids (curcumin, 
bisdemethoxycurcumin and dicinnamoylmethane) (Wang et al., 2015). Besides the pathways that 
have been discussed in the previous sections, piceatannol can be obtained from resveratrol 
through the specific C-3′-hydroxylation catalyzed by C3H from S. espanaensis. Co-expression of 
TAL from S. espanaensis, 4CL from A. thaliana, STS from Arachis hypogaea, and C3H from S. 
espanaensis in E. coli led to the production of 21.5 mg/L piceatannol. Bisdemethoxycurcumin is 
the condensed product of two molecules of p-coumaroyl-CoAs, whereas the symmetric reaction 
occurring at cinnamayl-CoA produces dicinnamoylmethane, both of which can be catalyzed by 
curcuminoid synthase (CUS) from O. sativa. It was found that 4CL from A. thaliana can also 
recognize ferulic acid and thus ligate it with CoA to yield feruloyl-CoA. The final assembly of 
the genes encoding TAL, C3H, COMT (from M. sativa), 4CL, and CUS established a complete 
biosynthetic pathway in the E. coli strain fed with 3 mM L-Tyr, producing curcumin at 0.6 mg/L.  
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9.5 Dihydrochalcones: phloretin, phlorizin, nothofagin, trilobatin, and naringenin 
dihydrochalcone 
CHS has been found to be shared between flavonoid ad ihydrochalcone biosynthesis in 
various fruits. Phloretin, the first committed dihydrochalcone, is formed by the CHS-catalyzed 
decarboxylative condensation of p-dihydrocoumaroyl-CoA with three units of malonyl-CoA and 
a subsequent cyclization. The pathway is initiated by the formation of p-dihydrocoumaroyl-CoA 
from p-coumaroyl-CoA, which is mediated by a double bond reductase (DBR). This reaction can 
be realized by the native enzyme TSC13 in S. cerevisiae. In plants, the biosynthesis of phloretin 
can be extended by many different UDP-dependent-glycosyltransferases (UGTs) that act on 
either the phloretin ring directly or the hydroxyl groups to form the antidiabetic molecule 
phlorizin, the antioxidant molecule nothofagin, and the sweet compound naringenin 
dihydrochalcone. The assembly of PAL2 (from A. thaliana), AmC4H (from Ammi majus), CPR1 
(from S. cerevisiae), 4CL2 (from A. thaliana), CHS (from Hypericum androsaemum), and 
TSC13 (from S. cerevisiae) led to an initial production of phloretin at 42.7 mg/L in S. cerevisiae 
(Eichenberger et al., 2017). The incorporation of additional glycotransferase, including 
UGT88F2 (from Pyrus communis), CGT (from O. sativa), or UGT73B2 (from A. thaliana), led 
to the production of three glycosylated dihydrochalones: phlorizin (65 mg/L), nothofagin (59 
mg/L), and trilobatin (32.8 mg/L) in 24-well fermentation. Finally, extending the overexpressed 
enzyme set with the UDP-rhamnose transferases 1,2RHAT (from Citrus maxima) and RHM2 
(from A. thaliana), responsible for converting the native UDP--glucose to UDP-L-rhamnose, 
resulted in the biosynthesis of naringenin dihydrochal one at 11.6 mg/L. It is noteworthy that the 
host was not extensively engineered to overproduce any of the precursors, indicating the scope 
for further improvement in the production of these glycosylated products.  
 
 
75
 
10. Conclusions, advanced strategies and future outlooks 
 
 
Despite the importance of aromatic amino acid pathwy derivatives, their current production 
levels based on microbial hosts are still far from meeting the criteria of commercialization. For 
commodity chemicals, even the pre-pilot scale requir s titer, yield, and productivity to reach 10–
100 g/L, 40–80%, and 0.5–2 g/L/h, respectively. Some compounds in this group can be produced 
at relatively high titers but their yields and/or productivities are still lower than the standards. For
this reason, at least for now, high-value specialty romatics might be more likely to make 
commercialization successes (Thompson et al., 2015). 
To enable high-level biosynthesis of aromatic amino acid pathway derivatives, especially, 
plant-derived natural products whose synthesis typically requires 20–30 enzymatic reactions, the 
strategies that have been summarized in the previous sections at a high level include (1) 
partitioning a complex pathway into smaller modules, (2) independently addressing the 
outstanding issues arising from individual modules, and (3) overcoming the obstacles to 
connecting modules. This is because distinctly different challenges are recognized in individual 
parts of a pathway. Any impairment in the pathway will cause an intermediate buildup, thereby 
considerably decreasing the final product yield. The upstream pathway is native to the microbial 
hosts, being directly linked to their primary metabolism; therefore, the host employs 
sophisticated controls to minimize unnecessary energy xpense (Braus, 1991; Hinnebusch, 1988; 
Lee and Hahn, 2013; Luttik et al., 2008). For the downstream foreign add-on steps, heterologous 
expression poses the major limitation (Jiang et al., 2012). Many plant-sourced enzymes are so 
delicate that the alteration of the intracellular expression environment would impair their 
functions. The modular design approach enables resea ch rs to reach an optimal balance by 
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searching a relatively small combinatorial space, and using delicate “design-build-test-learn” 
cycles to improve the production by thousands of times over the starting levels (e.g., 15,000-fold 
improvement in taxol production (Ajikumar et al., 2010)). 
Throughout our research, we identified a few new direct ons that could potentially improve 
the production of aromatic amino acid pathway derivatives. Therefore, the following sections are 
dedicated to discussing the rationales of these strategies. We look forward to seeing the 
verification of their impacts on the biosynthesis of aromatic amino acid derivatives by the 
colleagues working in this area in the near future. 
 
10.1 Reconstruct gluconeogenesis to optimize the availability of PEP  
In contrast to the various successful engineering approaches that have been devised to 
enhance the accumulation of E4P, strategies to increase the availability of PEP have not been 
thoroughly investigated in yeast. The presence of organelles results in the compartmentalization 
of metabolites, which reduces the availability of the desired precursors in the cytoplasm and 
dilutes the possibility of reaching higher product titers. Our metabolic flux analysis showed that 
the rates of PEP conversion to pyruvate are at leasone order of magnitude higher than the E4P 
flux in the pentose phosphate pathway (Suastegui et al., 2016a). This is expected because 
pyruvate has considerably more metabolic fates in the cell; hence it is in higher demand for 
production of essential metabolites in aerobic respi ation, fatty acid production, and production 
of other amino acids. Future direction to improve th availability of PEP needs to consider a 
good metabolic balance for efficient biomass formation. 
A new strategy for pyruvate recirculation could explore the expression of heterologous genes, 
namely ppsA from E. coli, and the pyruvate, orthophosphate dikinase PDK from the plant A. 
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thaliana. One of the advantages of expressing heterologous enes is that posttranslational 
modifications that inactivate proteins in yeast (such as phosphorylation and ubiquitylation) can 
be usually avoided. To ensure high pyruvate availability in the cytosol to serve as the substrate 
for the recirculation enzymes, the main carriers that ransport pyruvate into the mitochondria 
need to be knocked out. This strategy has been previously established in S. cerevisiae to increase 
the cytosolic pools of pyruvate to elevate the production polyketides (Cardenas and Da Silva, 
2016). In this study, two mitochondrial, outer membrane transporters (POR1 and POR2) and two 
mitochondrial pyruvate inner membrane carriers (MPC1 and MPC2) were deleted. Single-gene 
knockouts revealed that POR2 and MPC2 were good canid tes to increase the pool of pyruvate 
in cytoplasm, resulting in at least a 3-fold improvement in triacetic acid lactone (TAL) 
production. The combination of these further increased the titers of TAL from ~300 mg L-1 to 
almost 1.0 g L-1. 
Gluconeogenesis is a metabolic pathway whose activation is triggered by a diauxic shift. 
When glucose is depleted, the glycolytic genes will undergo downregulation, while the 
gluconeogenic ones will be activated with the goal of regenerating primary metabolites. Because 
the gluconeogenic pathway is highly ATP-consuming, very strict regulations at all metabolic 
levels protect the cell from unnecessary energy expenditures in the presence of high 
concentrations of glucose. In S. cerevisiae, gluconeogenesis starts from the conversion of 
cytosolic malate to pyruvate through an NADP+-dependent malic acid enzyme (pyruvic-malic 
enzyme, MAE1) or through the conversion of malate to OAA through the cytosolic malic acid 
dehydrogenase enzyme (MDH2) (Figure 8). OAA is further converted to PEP through the PCK1 
enzyme. Similar to pyruvate, malate can also be transported into the mitochondria through the 
action of the specific carrier (OAC1). This is an in er membrane transporter that imports the 
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cytosolic OAA produced from pyruvate by the enzyme pyruvate carboxylase (PYC) (Palmieri et 
al., 1999). Therefore, the deletion of this transporter gene could be a potential strategy to 
increase the malate pool for the initiation of gluconeogenesis. In addition, considering that 
MDH2 and PCK1 are originated from the gluconeogenic pathway whose transcription is 
repressed in the exponential phase, equipping them directly with strong constitutive promoters 
might be problematic given the potential impact on the native cellular metabolism. It would be 
preferable to span a panel of promoters with different strengths to ensure an appropriate 
expression balance. 
 
10.2 Engineering post-translational modifications  
Post-translational modifications (PTMs) serve as another regulatory command to control the 
stability, localization, and activity of proteins in cells. Two of the most common posttranslational 
modifications in eukaryotic systems are phosphorylation and ubiquitylation. The former is 
usually associated with enzymatic activity, whereas the latter serves as a tag for protein 
degradation. PTMs are commonly orchestrated by a network of genes and the corresponding 
study has been determinant in understating major hierarchical regulatory mechanisms of key 
metabolic pathways. Hence, it is not unexpected that PTMs could play a crucial role in the 
regulation of highly energy-demanding pathways such as gluconeogenesis and the biosynthesis 
of aromatic amino acid.   
Several studies have revealed that, indeed, the gluconeogenic genes undergo major PTMs as 
an additional control level to regulate their cellular activity and abundance. For example, the 
aforementioned cytosolic MDH protein (MDH2p) contais two phosphorylation residues at the 
proline 1 (P1) residue and the threonine 6 (T6) residue. Through biochemical characterizations, it 
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has been demonstrated that substituting P1 to serine (P1S), or removing the first 12 residues of 
the protein can reduce its degradation when cells are hifted from non-fermentable carbon 
sources (acetate) to growth on glucose(Hung et al., 2004; Minard and McAlister-Henn, 1992).  
Through global proteomic studies, four lysine residues (K42, K180, K254, and K259) subjected 
to ubiquitylation have also been identified in MDH2 (Swaney et al., 2013). It would be 
interesting to discern whether a higher activity of this enzyme can be achieved in the presence of 
glucose. Different mutant versions of the gene MDH2 can be constructed and incorporated into 
the new genetic platform to study the recirculation of malate to OAA. 
To finalize the reconstruction of gluconeogenesis, the phosphoenolpyruvate carboxykinase 
gene, PCK1, can also be overexpressed, in order to ensure the conversion of OAA to PEP. Thus 
far there is no evidence of PCK1 undergoing PTMs such as phosphorylation or ubiquitylation. 
However, high sequence similarity with the protein Aro4 was observed in the first 12 amino 
acids, which is known to undergo phosphorylation at the serine residues 2 and 4 (Albuquerque et 
al., 2008). Therefore, new mutant versions of PCK1 with amino acid substitutions to avoid 
phosphorylation can be constructed and overexpressed to complete the production of PEP in the 
presence of glucose. 
 
10.3 Creating a biochemical driving force 
A potential pitfall of overexpressing MDH2 to increase the PEP availability is that the 
enzyme favors the reverse reaction, which is the conversion of OAA to malate (Zelle et al., 
2008). An alternative strategy is to express a version of MDH2 with known irreversible activity, 
such as the malate:quinone oxidoreductase (Mqo) from E. coli (Figure 8). 
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This rational can also be complemented by linking the metabolic engineering strategies with 
a biochemical driving force (Shen et al., 2011) (Shen et al., 2011). Common driving forces are 
linked to energy exchange metabolites such as ATP, NADH, and NADPH. In this light, the 
activity of the enzymes of study can be elevated if its reaction can provide or complement a 
cofactor deficiency created by the deletion of select d genes. To enhance the production of 
aromatic compounds, such a driving force can be created by deleting the ZWF1 gene in the 
oxidative pentose phosphate pathway. This would requi  a new source for replenishment of 
cytosolic NADPH levels that can be attained by exprssing dehydrogenase enzymes that depend 
on the NADP+ cofactor. Expression of heterologous MDH2 enzymes that prefer NADP+ as the 
cofactor could help establish the metabolic driving force. One potential gene for this strategy is 
the NADPH-dependent MDH enzyme involved in pyruvate m tabolism and carbon fixation 
pathways in several organisms such as Zea mays (Metzler et al., 1989), A. thaliana, and 
Methanobacterium thermoautotrophicum (Thompson et al., 1998) (Figure 8). 
 
10.4 Global perturbations 
Besides the targeted rational strategies that have been discussed in the above sections, 
dynamic approaches at a genome-scale need to be develop d to allow engineering the partition of 
the flux between two of the most important pathways, namely, glycolysis and the pentose 
phosphate pathway for the accumulation of aromatic amino acid compounds. The intrinsically 
complicated regulations involved in the native upstream module prohibit the extra energy 
expenditure to create “foreign” molecules. With therapid development of the CRISPR-
associated technologies (e.g., CRISPR activation and CRISPR interference), creating a 
combinatorial library including both upregulation ad downregulation at the genome-scale is 
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now feasible. This platform would enable the modulation of gene expression within its native 
genome context, bypassing the need to utilize heterologous or synthetic promoters. Rather than 
limiting the system to an “on” or “off” state (i.e., overexpression or deletion), it can provide a 
platform in which genes can be studied in a wide range of transcriptional strengths. This property 
enables the creation of “fluidic” genetic landscapes that otherwise would not be possible by 
single-gene deletion or overexpression (e.g., the glycolytic genes). Molecular sensors to detect 
the final product or the intermediates of aromatic mino acid biosynthesis in a high-throughput 
manner need to be developed. Success has been demonstrated in the colorimetric reaction for 
detecting L-DOPA and the fluorescence protein-based naringenin sensor (DeLoache et al., 2015; 
Skjoedt et al., 2016 (accepted)).  
In addition, the current repertoire of microbial hosts needs to be broadened. Some 
nonconventional microbes possess special biochemical and physiological features that are 
beneficial to the production of aromatic amino acid pathway derivatives. Genome-scale 
transcriptome programming integrated with high-throughput screening might be the most 
desirable technology to further deepen the understanding of non-model organisms. 
 
10.5 Enhancing the conversions in the downstream module 
For the downstream module, ensuring successful gene expression in heterologous hosts is a 
complex process, without general rules to follow. It is impossible to accurately predict the rate-
limiting steps when expressing enzymes from a wide variety of sources. A consensus drawn 
from pioneering work in opioid (Galanie et al., 2015; Thodey et al., 2014), artemisinic acid 
(Paddon et al., 2013; Ro et al., 2006; Westfall et al., 2012), and taxol (Ajikumar et al., 2010; 
Jiang et al., 2012) production is that it is important to explore the functional space defined by the 
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natural sequence diversity (Trenchard and Smolke, 2015); in each of these three platforms, a 
suite of enzymes from mammals, plants, bacteria, and fu gi were assembled and tested to 
determine an optimal combination. Moreover, cytochrme P450 requires a partner enzyme, CPR, 
to shuttle electrons (Jung et al., 2011), and in some cases also requires interaction with 
cytochrome b5, which provides additional redox support to achieve full activity (Paddon et al., 
2013; Schenkman and Jansson, 2003; Zhang et al., 2007). Sufficient evidence has indicated that 
it is not necessary to match cytochrome P450 with the CPR from the same species; pairing 
multiple species-sourced enzymes has led to better turnovers (Paddon et al., 2013; Trenchard and 
Smolke, 2015). 
Expressing membrane-bound enzymes can induce endoplasmic reticulum stress response 
because these enzymes have N-terminal signal peptides that are directly inserted into the 
endoplasmic reticulum (Sandig et al., 1999; Trenchard and Smolke, 2015; Zimmer et al., 1997). 
In some cases, altering the expression level of cytchrome P450 relative to CPR can increase the 
product yield because incomplete interactions betwen these two proteins can result in the 
release of reactive oxygen species, which reduce cell viability (Li et al., 2016; Paddon and 
Keasling, 2014; Paddon et al., 2013; Zangar et al., 2004). Besides, the expression of multiple 
cytochrome P450s could cause heme depletion, which can further induce cellular stress. In this 
scenario, a strategy of expressing the rate-limiting e zymes in endogenous heme biosynthesis 
should be considered, which has been shown to succesfully alleviate such a stress (Michener et 
al., 2012). 
Streamlining the performance of a process involving more than 20 steps requires the 
coordination of the corresponding genes. Synthesizing a desired compound often creates 
competition with cell growth, in which case, being able to easily fine-tune the expression of 
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individual genes is essential. This might be achieved by varying promoter strength, integrating 
additional copies of the rate-limiting step, and adjusting the temperature to optimize enzyme 
activity (Ajikumar et al., 2010; Fossati et al., 2014; Galanie and Smolke, 2015; Trenchard and 
Smolke, 2015). Once a high-production strain is established in shaking flasks, the production can 
be continuously improved in a bioreactor. By adjusting parameters such as temperature, pH, 
oxygen level, and sugar-feeding pattern, usually an increased yield of at least an order of 
magnitude can be expected.  
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Table 1.  The TyrR-mediated transcriptional regulations of L-Tyr regulon genes. 
Gene TyrR Box Mechanisms and Special Features 
tyrR 
(tyrosine pathway 
regulator) 
A strong box and a weak box 
with the strong box overlapping 
with the -35 position. 
1. The protein has an N-terminal domain, a central domain, and a C-
terminal domain. 
2. The presence of effector molecules and the positions of the TyrR-
binding sites in a promoter determine the oligomerization states of 
TyrR, and its consequent role of being a repressor or an activator. 
tyrB 
(tyrosine 
aminotransferase) 
 
aroP 
(aromatic amino 
acid transporter) 
 
aroL 
(shikimate kinase) 
 
 
 
 A strong box and a nearby 
weak box found immediately 
downstream of the transcription 
initiation site 
 1. L-Tyr-mediated hexamer binding (strong repression) or L-Phe-
mediated dimer binding (weaker repression) prevents active 
transcription. 
2. For aroP, another promoter upstream but in the opposite direction, 
occupies RNA polymerase and further lowers the availability of RNA 
polymerase to bind to the promoter of aroP. 
3. For aroL, a TrpR binding site appears immediately downstream of 
the TyrR box. L-Trp-mediated repression requires TyrR binding to the 
TyrR box first, suggesting the potential spatial interaction of TrpR and 
TyrR. Besides, another strong box exists in the upstream region of the 
promoter, suggesting the possibility of TyrR-mediated DNA looping 
during oligomerization. 
 
aroF 
(DAHP 
synthease) 
1. A strong box and a nearby 
weak box found upstream 
with the weak box overlapping 
with the -35 sequence. 
2. Another strong box exists in 
the further upstream region of 
the promoter. 
 
1. L-Tyr-mediated repression conducted through TyrR hexamer binding 
to the weak box. 
2. L-Phe-mediated repression was also observed when TyrR level is 
increased. 
 
aroG 
(DAHP 
synthease) 
A single strong box in the -35 
position 
1. Competition between TyrR and RNA polymerase leads to repression 
even in the absence of aromatic amino acids. 
 
tyrP 
(Tyr-specific 
transporter) 
 
A strong box and a nearby weak 
box found upstream 
with the weak box overlapping 
with the -35 sequence. 
1. L-Tyr-mediated repression via TyrR hexamer binding to the weak 
box. 
2. L-Phe (or L-Trp, to a lesser extent)-mediated activation conducted 
through TyrR dimer binding to the strong box and interacting with the α-
subunit of RNA polymerase bound to the -35 position in the presence of 
L-Phe (or L-Trp) and absence of L-Tyr. 
mtr 
(Trp-specific 
transporter) 
1. A strong box and a weak box 
found upstream with the strong 
box close to the -35 position 
2. A TrpR binding site overlaps 
with the -35 position. 
 
1. L-Tyr (or L-Phe)-mediated activation via the interaction between the 
N-terminal domain of TyrR and RNA polymerase. 
2. L-Trp-mediated repression (no longer need to transport L-Trp into the 
cells). 
folA 
(dihydrofolate 
reductase) 
 A strong box and a weak box 
found in the far end upstream 
1. Activation by TyrR in the presence of L-Tyr. 
2. Activation requires all three domains of TyrR to be fully functional. 
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Table 2. The microbial production of the upstream products from the shikimate pathway.   
 
Node Target 
Compound 
Host Titer 
(g/L) 
Yield 
(mg/g) 
Productivity 
(mg/L/h) 
Fermentation 
type 
Unique strategies and genotype Reference 
Dehydroshikimate Shikimic 
acid 
 
E. coli 87 320 1640 Fed batch  
(53 h) 
Zm-glf, Zm-glk, Ec-aroFfbr, Ec-tktA,  
Ec-aroE, Ec-serA, and pts∆ 
Chandran et al., 
2003 
E. coli  5.33 213 222 Shake flask  
(24 h) 
 
Growth phase-dependent promoter for 
aroK; the plant-sourced DHQ-SDH bi-
functional enzyme facilitated DHS 
channeling; Ec-aroB, Ec-aroGfbr,  
Ec-ppsA, and Ec-tktA 
Lee et al., 2017 
C. glutamicum 141 490 2938 Fed batch 
(48 h) 
Cg-tkt, Cg-tal, Ec-aroGS180F, Cg-aroBDE, 
Cg-IolT1, Cg-glks (glk1, glk2, and ppsk), 
Cg-gapA, qsuD∆, qsuB∆, aroK∆, ptsH∆, 
and hdpA∆; Using growth-arrested high 
density cells 
Kogure et al., 
2016 
S. cerevisiae 1.98 (glucose) 
2.5 (sucrose) 
54.4 
(glucose) 
62.5 
(sucrose) 
27.8 
(glucose) 
33.3 
(sucrose) 
Shake flask 
(72 h) 
Sc-ARO1D920A, Sc-ARO4K229L, Sc-
TKL, ScRKI1, ric1∆, and aro1∆ 
Suastegui et al., 
2017 
S. stipitis 3.11 77.8 25.9 Shake flask 
(120 h) 
S. stipitis has native and superior xylose 
utilization capacity; Ss-ARO4K220L, Ss-
TKT1, and Ss-ARO1D900A 
Gao et al., 2017 
Quinic acid E. coli 49 210  1020 Fed batch  
(48 h) 
Ec-aroE and aroD∆ Ran et al., 2001 
E. coli 4.8 333 66.7 Shake flask 
(72 h) 
Kp-qad and aroD∆ Draths et al., 
1992 
Muconic 
acid 
 
E. coli 36.8 174 767 Fed batch  Kp-aroY, Kp-aroZ, Ac-catA, Ec-tktA, Ec-
aroFfbr, Ec-aroB, and aroE∆ 
Niu et al., 2002 
P. putida 4.92  
(glucose) 
15.59  
(p-coumarate) 
61 
(glucose) 
797 (p-
coumarate  
90 (glucose) 
210  
(p-
coumarate) 
Fed batch  
 (54 h, 
glucose) 
(73 h, p-
coumarate) 
Pp-catA, Ecl-aroY, Ecl-ecdB, Bc-asbF, 
catRBC∆ and pcaHG∆; The strain 
fermented on p-coumarate also carries 
Ecl-ecdD, another AroY-associated 
protein. 
Johnson et al., 
2016 
C. glutamicum 54 197 340 Fed batch 
(168 h) 
Kp-aroY, Kp-kpdBD, catB∆, aroE∆, and 
pcaHG∆ 
Lee et al., 2018 
E. coli 
coculture 
4.7 350 
(mixed 
glu/xyl) 
65.3 Fed batch  
(72 h) 
strain 1: ptsH∆, ptsI∆, crr∆, aroE∆, ydiB∆; 
strain 2: Kp-aroY, Kp-aroZ, Ac-catA, Ec-
shiA, and xylA∆ 
Zhang et al., 
2015a 
S. cerevisiae 0.32  
(2.362 
MA+PCA) 
8  
(59 
MA+PCA) 
4.4  
(32.8 
MA+PCA) 
Shake flask  
(72 h) 
Kp-aroZ, Kp-aroY, Ca-HQD2, Sc-
ARO1D1409A, D920A, Sc-ARO4K229L, Sc-
TKL, Sc-RKI1, ric1∆, and aro1∆ 
Suastegui et al., 
2017 
S. cerevisiae 0.141 3.91 1.31 Shake flask 
(108 h) 
Sc-ARO4K229L, Sc-TKL, Pa-aroZ, Ecl-
aroY, Ca-HDQ2, aro3∆, and zwf1∆ 
Curran et al., 
2012 
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Table 2. The microbial production of the upstream products from the shikimate pathway (continued).   
 
Node Target Compound Host Titer 
(g/L) 
Yield 
(mg/g) 
Productivity 
(mg/L/h) 
Fermentati
on type 
Unique strategies and genotype Reference 
Dehydroshikimate Muconic acid 
 
S. cerevisiae 2.1 12.9 9 Fed batch  
(240 h) 
Transcription factor-enabled aromatic 
amino acid biosensor and anti-
metabolite-driven adaptive laboratory 
evolution; Sc-ARO1 and Sc-PAD1 
Leavitt et al., 
2017 
S. cerevisiae 1.2 
or 5.1 (with 
amino acid 
supplement) 
13 
(58) 
7.14 
(30.4) 
Fed batch 
(168 h) 
Coupling MA pathway to degron-tagged 
ARO1; Sc-ARO1-CLN2PEST, Sc-PAD1, 
Ca-HQD2, Sc-ARO4fbr, Ec-aroB, Ec-
aroD, Pa-aroZ, Kp-aroY, aro3∆, and 
arp4∆ 
Pyne et al., 2018 
2-Pyrone-4,6-
dicarboxylic acid 
E. coli 16.72 201 172 Fed batch  
(96 h) 
Enhancing DHS by overexpressing an 
importer, and manipulating 
NADPH/NADP+ by modifying soluble 
pyridine nucleotide transhydrogenase; 
Ec-aroGfbr, Ec-ppsA, Ec-shiA, Bt-asbF, 
Ct-pmdAB, Ct-pmdC, Ec-sthA, and 
aroE∆ 
Luo et al., 2018 
Vanillin S. cerevisiae 0.045 2.25 0.94 Shaking 
flask (48 h) 
Ppa-3DSD, Hs-OMT, Ng-ACAR, Cg-
PPTase, and adh6∆ 
Hansen et al., 
2009 
 S. pombe 0.065 3.25 1.35 Shaking 
flask (48 h) 
Ppa-3DSD, Hs-OMT, Ng-ACAR, and 
At-UGT 
Vanillin β-D-
glucoside  
S. cerevisiae 0.5  32 N/A chemostat  
 
In silico design and target selection; 
Ppa-3DSD, Hs-OMT, Ng-ACAR, Cg-
PPTase, adh6∆, and pdc1∆ 
Brochado et al., 
2010 
Chorismate Salicylate E. coli 11.5 320 240 Batch  
(48 h) 
Replacing endogenous PTS system 
and disrupting conversion of PEP to 
PYR; Ec-menF, Ppa-pchB, Ec-galP, Ec-
glk, Ec-ppsA, Ec-maeB, Ec-ppc, pheA∆, 
tyrA∆, pykA∆, pykF∆, ptsH∆, and ptsI∆ 
Noda et al., 2016 
Salicylate 2-O-β-D-
glucoside 
E. coli ~2 
 
~160 
(glucose + 
glycerol) 
~42 Shaking 
flask (48 h) 
Ec-galU, Ec-pgm, Ye-irp9, At-Ugt74F1, 
pheA∆, and tyrA∆ 
Qi et al., 2018 
4-Aminobenzoate 
 
E. coli 4.8 160 100 Fed-batch  
(48 h) 
Ec-aroFfbr, Ec-pabAB, and Ec-pabC Koma et al., 
2014 
E. coli 2.88 112 60 Test tube  
(48 h) 
Ec-pabAB and Ec-pabC (Referring 
salicylate production for additional 
genetic modifications) 
Noda et al., 2016 
S. cerevisiae 0.215 
 
2 
(glycerol + 
ethanol) 
2 Fed-batch 
(108 h) 
 
Sc-ABZ1, Sc-ABZ2, Sc-ARO4K229L, 
aro7∆, and trp3∆ 
Averesch et al., 
2016 
E. coli 1.83 152 38 Test tube  
(48 h) 
Ec-pabA, Ec-pabB, and Ec-pabC 
(Referring salicylate production for 
additional genetic modifications) 
Noda et al., 2016 
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Table 2. The microbial production of the upstream products from the shikimate pathway (continued).   
 
Node Target Compound Host Titer 
(g/L) 
Yield 
(mg/g) 
Productivity 
(mg/L/h) 
Fermentation 
type 
Unique strategies and genotype Reference 
Chorismate 4-Hydroxybenzoate 
 
E. coli 12 100 167 Fed-batch  
(72 h) 
Ec-ubic, Ec-tktA, Ec-aroFfbr, Ec-aroB, Ec-aroL, 
Ec-aroA, and Ec-aroC 
Barker et al., 
2001 
E. coli 1.82 391 19 Test tube  
(96 h) 
Ec-ubiC (Referring salicylate production for 
additional genetic modifications) 
Noda et al., 2016 
E. coli  
co-culture 
2.3 110 24 Fed batch  
(96 h) 
Strain 1: producing upstream module of DHS; 
Strain 2: Ec-shiA, Ec-aroE, Ec-aroL, Ec-aroA, 
Ec-aroC, and Ec-ubiC 
Zhang et al., 
2015b 
S. cerevisiae 2.9 2.2 29 Fed batch  
(100 h) 
Ec-aroL, Ec-ubiC, Ec-aro4K229L, aro7∆, and trp3∆ Averesch et al., 
2017 
P. putida 1.73 139 54 Fed batch  
(44 h) 
Ec-ubiC, Pp-aroGD146N, pobA∆, pheA∆, trpE∆, 
and hexR∆ 
Yu et al., 2016 
3-Hydroxybenzoate 
 
E. coli 2.18 192 30 Test tube  
(72 h) 
Sh-hyg5 (Referring salicylate production for 
additional genetic modifications) 
Noda et al., 2016 
E. coli  
co-culture 
0.048 2.4 0.33 Test tube  
(144 h) 
Strain 1: containing upstream module of DHS; 
Strain 2: Sp-pctV  
Zhang et al., 
2015b 
Anthranilic acid E. coli 14,000 200 412 Fed batch 
(34 h) 
 
TrpD* has an early stop codon, and the protein 
only maintains the N-terminal glutamine 
amidotransferase activity but losts the 
anthranilate phosphoribosyl transferase at the C-
terminal, leading to anthranilic acid 
accumulation;  
Ec-trpD*, Ec-aroGfbr, and Ec-tktA 
Balderas-
Hernández et al., 
2009 
Muconic acid 
 
E. coli 3.1 136 32.3 Test tube (96 
h) 
Ec-menF, Pae-pchB, Pp-nahG, and Pp-catA 
(Referring salicylate production for additional 
genetic modifications) 
Noda et al., 2016 
E. coli 0.17 21.3 2.36 Shake flask  
(72 h) 
pHBA route: Ec-ubiC, Ec-aroFfbr, Ec-aroE, Ec-
aroL, Pp-pobA, Kp-aroY, Ac-catA, ptsH∆, ptsI∆, 
crr∆, and pykF∆ 
Sengupta et al., 
2015 
E. coli 0.48 38.4 
(glucose+
glycerol) 
10 Shake flask  
(48 h) 
2,3-DHBA route: Ec-aroL, Ec-ppsA, Ec-tktA, Ec-
aroGfbr, Ec-entCBA, Kp-bdc, Pp-cat, and entE∆ 
Sun et al., 2014 
E. coli 0.605 168 8.4 Shake flask  
(72 h) 
2,3-DHBA route: Ec-aroGfbr, Ec-aroL,  
Ec-entCBA Ec-entX, and Pp-catA 
Wang et al., 
2015 
E. coli 1.45 116 
(glucose+
glycerol) 
30.2 Shake flask  
(48 h) 
salicylate route: Ec-aroL, Ec-ppsA, Ec-tktA, Ec-
aroGfbr, Pa-pchB, Ec-entC, Pp-nahGopt, Pp-catA, 
pheA∆, and tyrA∆ 
Lin et al., 2014a 
E. coli 0.39 31.2 
(glucose+
glycerol) 
122 Shake flask  
(32 h) 
anthranilate route: Ec-ppsA, Ec-tktA, Ec-aroGfbr, 
Ec-aroB, Ec-aroE, Ec-aroL, Ec-trpE, Ec-trpG, 
Pa-antABC, Pp-catA, Ec-glnA, and trpD∆ 
Sun et al., 2013 
E. coli 4.45 0.207 61.8 Test Tube  
(72 h) 
Fusion of AroC and MenF to facilitate metabolite 
channeling; Ec-galP, Ec-glk, Pp-nahG, Pp-catA, 
Pa-pchB, Ec-aroC/Ec-menF, ptsH∆, ptsI∆, 
pheA∆, tyrA∆, pykA∆, and pykF∆ 
Fujiwara et al., 
2018 
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Table 2. The microbial production of the upstream products from the shikimate pathway (continued).   
 
Node Target 
Compound 
Host Titer 
(g/L) 
Yield 
(mg/g) 
Productivity 
(mg/L/h) 
Fermentation 
type 
Unique strategies including genotype Reference 
Chorismate Arbutin 
 
E. coli 4.19 140 87.3 Shake flask  
(48 h) 
Cp-MNX1, Rs-AS, Ec-aroL, Ec-ppsA, Ec-tktA, 
Ec-aroGfbr, and Ac-ubiC 
Shen et al., 2017 
P. chlororaphis 6.79 N/A 94.3 
Fed batch  
(72 h) 
Pc-ppsA, Pc-tktA, Pc-phzC, Pc-aroB, Pc-
aroD, Pc-aroE, Xo-xanB2, Cp-MNX1, Rs-AS, 
pykA∆, pykF∆, phzE∆, pobA∆, lon∆, rpeA∆, 
and rsmE∆ 
Wang et al., 
2018c 
Phenazine-
1-
carboxamide 
(PCN) 
P. chlororaphis 4.1 230 
(glycerol) 
137 Shake flask 
 (30 h) 
Disrupting pathway specific negative 
regulatory genes; Pc-phzEDFABGH, lon∆, 
parS∆, and prsA∆ 
Yao et al., 2018 
Gastrodin E. coli 0.545 27.3 11.4 Shake flask  
(48 h) 
Ec-aroGfbr, Ec-ubiC, Ni-car, Bs-sfp, and Rsa-
UGT73B6F389S 
Bai et al., 2016 
Gallic acid E. coli 1.27 102 
(glucose+
glycerol) 
35.3 Shake flask 
 (36 h) 
Pae-pobAY385F, T294A, Ec-aroL, Ec-ppsA, Ec-
tktA, Ec-aroGfbr, and Ec-ubiC  
Chen et al., 2017 
Pyrogallic 
acid 
E. coli 1.036 
(with 2 mM 
ascorbic acid 
supplement) 
46 
(glucose+
glycerol) 
43.2 Shake flask 
(24 h) 
Ec-aroL, Ec-ppsA, Ec-tktA, Ec-aroGfbr, Ec-
entCBA, and Pp-nahG 
Wang et al., 
2018b 
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Table 3. The microbial production of compounds derived from L-Trp.   
 
Target 
Compound 
Host Reported titer,  
yield, and/or productivity 
(carbon source with 
additional supplements) 
The genetic manipulations in the final producer Fermentation type 
(total hours) 
Reference 
 
Metabolic engineering strategies  
5-Hydroxy-
tryptophan 
E. coli 153 mg/L (Glu);  
1.1–1.2 g/L (Glu with 2 g/L 
L-Trp supplement) 
Xc-p4hW179F, MH4 regeneration pathway (Pa-pcd and Ec-dhmr),  
Ec-trpES40FDCBA, pheLA∆, tyrA∆, and tnaA∆ 
Shake flask  
(48 h) 
Lin et al., 2014b 
Fermentation at 30°C to prevent oxidative degradation. 
E. coli 550 mg/L (Glu with 1 g/L  
L-Trp supplement) 
Ct-aaahW192F, MH4 regeneration pathway (Hs-PCD and Hs-DHPR), and 
tnaA∆ 
Shake flask  
(24 h) 
Mora-Villalobos  
et al., 2017 
Fermentation at 30°C to prevent oxidative degradation. 
E. coli 5.1 g/L (glycerol) 
(1.3 g/L in shake flasks) 
Hs-TPH2N∆145, C∆24, BH4 synthesis pathway (Bs-mtrA, Hs-PTPS, Hs-SPR), 
BH4 regeneration pathway (Hs-PCD, Hs-DHPR), and tnaA∆ 
Fed batch (40 h) Wang et al., 2018a 
Modulation of plasmid copy number and promoter strength. 
E. coli 98 mg/L (Glu) Strain 1 (Re-salABCD and Ec-trpEfbrG); Strain 2 (Ec-trpDCBA) Two-stage shake 
flask (stage 1: 24 h; 
stage 2: 12 h) 
Sun et al., 2015 
SalABCD uses NAD(P)H as the cofactor, omitting the usage of the BH4 or 
MH4 system. 
S. cerevisiae 0.255 µg/L/OD (Glu with 2 
g/L L-Trp supplement) 
Xc-p4hW179F, MH4 regeneration pathway (Pa-pcd, Ec-dhmr, and Sc-DFR1) Shake flasks  
(72 h) 
Zhang et al., 2016 
Sm-T5H, BH4 synthesis pathway (Ec-gch, Rn-PTPS, and Rn-SPR), BH4 
regeneration pathway (Ec-dhpr and Pa-pcbd) 
The eukaryotic system enabled 17-fold higher production than the 
prokaryotic system 
Serotonin E. coli 154 mg/L (Glu); 
(962 mg/L 5HTP produced 
by strain 1) 
Strain 1 containing Ct-aaahF197L,E219C, MH4 regeneration pathway (Hs-PCD 
and Hs-DHPR), and trpR∆; Strain 2 containing cr-TDC and tnaA∆. 
Two-stage fed batch 
fermentation 
(60 h stage 1 and  
52 h stage 2) 
Mora-Villalobos  
et al., 2018 
Strain 1 was created from the strain S028, a previous L-Trp overproducer. 
E. coli 24 mg/L (Glu with 0.2 g/L 
L-Trp supplement) 
Os-GST-∆37T5H, and Cr-TDC Test tube (24 h post 
IPTG induction) 
Park et al., 2011 
Melotonin S. cerevisiae 14.5 mg/L 
(FIT medium or mineral 
medium supplemented 
with glucose) 
Sm-TPH, Hs-DDC, Bt-AANAT, Hs-ASMT, Sc-ALD6 
BH4 synthesis pathway (Rn-PTS and Rn-SPR), and BH4 regeneration 
pathway (Rn-DHPR and Pa-pcbd1) 
Fed batch  
(small-scale in 
microplates) 
 
Germann et al., 
2016 
Basal levels: SAM, Sc-GCH1, and Sc-FOL2 
Genome integration of all the genes except Hs-ASMT in high-copy plasmid; 
Special feed-in-time (FIT) medium.  
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Table 3. The microbial production of compounds derived from L-Trp (continued). 
 
Target 
Compound 
Host Reported titer,  
yield, and/or productivity 
(carbon source with 
additional supplements) 
The genetic manipulations in the final producer Fermentation type Reference 
 
Metabolic engineering strategies  
Indigo E. coli 920 mg/L 
(2 g/L L-Trp) 
Ma-fmo Batch  
(24 h)  
Han et al., 2011 
920 mg/L Indigo and 5 mg/L indirubin 
E.  coli 640 mg/L (Glu) Ma-fmo, Ec-tnaA, Ec-tktA, Ec-aroGD146N, Ec-trpES40F, Ec-aroL, trpR∆, 
pykF∆, and pykA∆ 
Fed batch 
(72 hr) 
Du et al., 2018 
De novo biosynthesis 
E. coli 18 g/L (Glu with 0.2-0.5 
g/min L-Trp) 
Pp-ndo, Ec-aroGfbr, and Ec-trpEfbrDCB/26A Fed batch  
(72 h) 
  
Berry et al., 2002 
AroGfbr was provided by two plasmids; Indoxyl or its downstream 
intermediates significantly inhibited AroG; PEP was found to protect AroG 
from inhibition. 
Indirubin E.  coli 58 mg/L (3.28 g/L L-Trp 
and 0.5 g/L 2-oxindole) 
Cs-ndo Batch Zhang et al., 2014 
Supplementation of 2-oxindole played a more favorable influence than 
isatin due to the inhibitory effect of isatin; Increasing 2-oxindole from 0 to 
1.5 g/L improved the proportion of indirubin from 5% to 48%. 
E. coli 223.6 mg/L (2 g/L L-Trp 
and 0.36 g/L Cys) 
Ma-fmo Batch 
(48 h) 
 
Han et al., 2013 
Han et al., 2011 
 
Cysteine influenced the regioselectivity of FMO and enhanced the 
synthesis of 2-hydroxindole (6.8 mg/L indigo) 
E.  coli 56 mg/L (Glu) Ma-fmo, Ec-tnaA, Ec-tktA, Ec-aroGD146N, Ec-trpES40F, Ec-aroL, trpR∆, 
pykF∆, and pykA∆ 
Fed batch 
(72 h) 
Du et al., 2018 
 
De novo biosynthesis 
Violacein  E. coli 710 mg/L (Glu) 
 
Ji-vioD, Cv-vioABCE operon, Ec-trpEfbr, Ec-serAfbr, Ec-tktA, Ec-aroFBL, Ec-
trpDCBA, trpR∆, trpL∆, tnaA∆, and sdaA∆ 
Fed batch  
(300 h) 
Rodrigues et al., 
2013 
The expression of vioABCE was induced by arabinose, which was also 
used as the carbon source; Ji-vioD was genome-integrated. 
C. glutamicum 5.4 g/L (Glu) 
54 mg/g glucose 
47 mg/L/hr 
Cv-vioBAECD Fed batch 
(115 h) 
Sun et al., 2016a 
Inserting rbs in front of each vio gene; exploiting the established industrial 
L-Trp hyper producer strain ATCC 21850 
Deoxy-
violacein 
E. coli 324 mg/L 
(10 g/L arabinose) 
Cv-vioABCE operon, Ec-trpEfbr, Ec-serAfbr, Ec-tktA, Ec-aroFBL, Ec-
trpDCBA, Ec-trpR∆, trpL∆, tnaA∆, and sdaA∆ 
Shake flasks 
(228 h) 
Rodrigues et al., 
2013 
The expression of vioABCE was induced by arabinose, which was also 
used as the carbon source. 
E. coli 1.6 g/L (glycerol) 
20 mg/g glycerol 
8 mg/L/hr 
Cv-vioABCE operon, Ec-trpEfbr, Ec-serAfbr, Ec-tktA, Ec-aroFBL, Ec-
trpDCBA, trpR∆, trpL∆, tnaA∆, sdaA∆, and araBAD∆ 
Fed-batch  
(200 h) 
Rodrigues et al., 
2014 
Arabinose catabolism was disrupted; Arabinose was used only as an 
inducer. 
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Table 4. The microbial production of compounds derived from L-Phe. 
 
Target 
Compound 
Host Reported titer,  
yield, and/or productivity 
(carbon source with 
additional supplements) 
The genetic manipulations in the final producer Fermentation 
type 
(total hours) 
Reference 
 
Metabolic engineering strategies  
D-phenyllactic 
acid 
E. coli 29.2 g/L (Glu with 0.2 g/L  
L-Tyr and 0.15 g/L L-Trp); 
0.16 g/g glucose 
Ec-aroGfbr, Ec-pheAfrb, and Wf-pprA Fed-batch 
(144 h) 
Fujita et al., 2013 
The starting strain have been mutated to prevent the synthesis of L-Tyr and 
L-Trp 
2-Phenylethanol K. marxianus 1.3 g/L (Glu) Sc-ARO10, Sc-ADH2, and Km-AroGfbr Batch 
(72 h) 
Kim et al., 2014b 
K. marxianus is a thermal tolerance yeast with a short doubling time. 
E. coli  320 mg/L 
13.3 mg/L/h 
Es-kdc4427, Es-adh4428, Ec-aroF, Ec-pheA, Ec-tktA, and Ec-ppsA Batch  
(24 h) 
Liu et al., 2018a 
Severe product inhibition was observed. 
S. cerevisiae  6.1 g/L  
(10g/L L-Phe as the sole N 
source) 
Sc-ARO9, Sc-ARO10, Sc-ARO80, and ald3∆ Two-phase 
batch 
(72 h) 
Kim et al., 2014a 
Whole cell conversion using PPG1200 as the in situ extractant;  
Aro80 is a transcriptional activator regulator whose function can be further 
enhanced by aromatic amino acids. 
K. marxianus 10.2 g/L  
(with high conc. of L-Phe) 
Whole cell conversion using PPG1200 as the in situ extractant Fed-batch  
(30 h) 
Etschmann et al., 
2006 
S. cerevisiae 12.6 g/L 
(with high conc. of L-Phe) 
Whole cell conversion using oleic acid as the in situ extractant 
 
Fed-batch  
(153 h) 
Stark et al., 2002 
Mandelate and  
4-hydroxy-
mandelate 
E. coli 1.02 g/L (S-mandelate) 
0.88 g/L (R-mandelate) 
(S-mandelate) Ao-hmaS, Ec-aroFfbr, Ec-pheAfbr, trpE∆, tyrA∆, tyrB∆, and 
aspC∆; (R-mandelate) Sco-hmo and Rg-dmd in addition 
Shake flasks 
(84 h) 
Sun et al., 2011 
The biosynthesis of all three aromatic amino acids was disrupted. 
S. cerevisiae 1 g/L (4-hydroxy-mandelate) 
 
Ao-hmaS, Sc-ARO1, Sc-ARO3fbr, Sc-ARO4fbr, aro10∆, pdc5∆, trp2∆, 
aro8∆, aro9∆, and pha2∆  
Shake flasks 
(120 h) 
Reifenrath and 
Boles, 2018 
0.236 g/L (mandelate) Ao-hmaS, Sc-ARO1, Sc-ARO3fbr, Sc-ARO4fbr, aro10∆, pdc5∆, trp2∆, 
aro8∆, aro9∆, and tyr1∆ 
Phenylglycine E. coli 51.6 mg/g DCW  
(L-phenylglycine) 
Sco-hmaS, Sco-hmo, Sco-hpgT, Ec-tyrAS121L, Ec-aroGD146N, Ec-pheAfbr, Ec-
ydiB, Ec-aroK, crr∆, tyrB∆, and aspC∆  
Shake flasks 
(48 h) 
Liu et al., 2014a 
Using temperature-sensitive promoters to induce the expression at 38°C; 
Sco-HpgT is a L-hydroxyphenylglycine aminotransferase. 
E. coli 146 mg/g DCW 
(D-phenylglycine) 
Ao-hmaS, Sco-hmo, Pp-hpgT, Ec-aroFfbr, Ec-pheAfbr, pheA∆, tyrA∆, tyrR∆, 
tyrB∆, and aspC∆ 
Fed-batch 
(24 h) 
Muller et al., 2006 
PpHpgT is a D-hydroxyphenylglycine aminotransferase. 
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Table 4. The microbial production of compounds derived from L-Phe (continued). 
 
Target 
Compound 
Host Reported titer,  
yield, and/or productivity 
(carbon source with 
additional supplements) 
The genetic manipulations in the final producer Fermentation 
type 
(total hours) 
Reference 
 
Metabolic engineering strategies  
Trans-cinnamate, 
cinnamaldehyde, 
cinnamylalcohol, 
and hydro- 
cinnamylalcohol 
E. coli 6.9 g/L (trans-cinnamate) 
0.028 g/g glu 
0.138 g/L/h 
Sm-pal, crr∆, tyrR∆, trpE∆, tyrA∆, and pykA∆ Fed-batch 
(86 h) 
Bang et al., 2018 
Casamino acid was supplied as a feeding solution. 
S. cerevisiae 0.3 mg/L (cinnamaldehyde) 
27.8 mg/L (cinnamylalcohol) 
113.1 mg/L  
(hydrocinnamylalcohol) 
At-PAL2, Ns-acar, Ec-entD, and Sc-ADHs Shake flasks 
(26 h) 
Gottardi et al., 
2017 
Cinnamate and cinnamaldehyde are more toxic to cell growth than 
cinnamylalcohol and hydro cinnamylalcohol. 
E. coli 75 mg/L (cinnamaldehyde) Sm-pal, Sco-4cl, At-CCR, Ec-aroGD146N, A202T, Ec-ydiB, Ec-aroK, Ec-
pheAE159A, E232A, dm, Ec-galP, Ec-glk, crr∆, tyrR∆, trpE∆, tyrA∆, and pykA∆ 
Shake flasks 
(48 h) 
Bang et al., 2016 
PheAE159A, E232A, dm has the first 300 amino acids of the wild-type PheA, which 
excludes the L-Phe regulatory domain; the two mutations revive the 
substrate binding affinity of the truncated PheA. 
E. coli 1.7 g/L (trans-cinnamate) Ec-aroGfbr, Ec-phefrb, Wf-pprA, and Cs-fldABCI Two-stage 
batch 
(172 h) 
Masuo et al., 2016 
Aerobic phase to accumulate D-phenyllactate and anaerobic phase to 
convert D-phenyllactate to trans-cinnamate by the O2-sensitive FldABCI. 
Benzoic acid S. maritimus 257 mg/L (glucose) 
337 mg/L (cellobiose) 
460 mg/L (starch) 
125 mg/L cellulose 
Native plant-like β-oxidation pathway composed of encPHIMJN; can utilize 
cellobiose due to the endogenous β-glucosidase; 
Secreting the heterologous endo-glucanase tfu0901 cloned downstream of 
the phospholipase D promoter with the signal peptide from  
phospholipase D from Streptoverticillium cinnamoneum 
Shake-flask 
(4-6 days) 
 
Noda et al., 2012 
Styrene E. coli 260 mg/L (styrene) At-PAL2 and Sc-FDC1 in ATCC31884 Shake-flask 
(39 h) 
McKenna et al., 
2011  ATCC 31884 is a commercial L-Phe overproducing strain. 
S. cerevisiae 29 mg/L (styrene) 
1.44 mg/g glucose 
At-PAL2 (Sc-FDC1), Sc-ARO4K229L, and aro10∆ Shake-flask  
(48 h) 
McKenna et al., 
2014 Using the evolved strain after m-fluoro-DL-phenylalanine treatment; 
transcription analysis revealed several Aro genes in the upper module were 
up-regulated; fdc1 was endogenously expressed with the native promoter. 
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Table 5. The microbial production of compounds derived from the L-Tyr branch. 
 
Target 
Compound 
Host Reported titer,  
yield, and/or productivity 
(carbon source with 
additional supplements) 
The genetic manipulations in the final producer Fermentation 
type 
(total hours) 
Reference 
 
Metabolic engineering strategies  
p-Coumaric acid, 
caffeic acid, and 
ferulic acid 
S. cerevisiae 1.93 g/L (p-coumaric acid) 
 
Fj-tal, Sc-ARO4K229L, Sc-ARO7G141S, Ec-aroL, pdc5∆, and aro10∆ Fed batch 
(72 h) 
Rodrigues et al., 
2015 96-deep well plate with FIT media 
S. cerevisiae 2.0 g/L (p-coumaric acid, 
S288c, batch) 
2.4 g/L (p-coumaric acid, 
CEN.PK, batch) 
Sc-ARO4K229L, Sc-ARO7G141S, Ec-aroL, Fj-tal, pdc5∆, and aro10∆ Batch and 
CSTR 
 
Rodriguez et al., 
2017a 
CSTR gave 0.410 g/L (S288c) and 0.507 g/L (CEN.PK) production at the 
steady state; CEN.PK strain showed fewer changes in the transcription profile 
and intracellular metabolites concentrations. 
E. coli 974 mg/L (p-coumaric acid) 
150 mg/L (caffeic acid) 
196 mg/L (ferulic acid) 
Se-tal, Ec-aroGfbr, Ec-tyrAfbr, and tyrR∆ Shake flask 
(36 h) 
Kang et al., 2012 
Se-tal, Se-sam5, Ec-aroGfbr, Ec-tyrAfbr, and tyrR∆ 
Se-tal, Se-sam5, At-COM, Ec-aroGfbr, Ec-tyrAfbr, and tyrR∆ 
E. coli 106 mg/L (caffeic acid) Route 1: Rg-TAL and Se-Sam5 in strain rpoA14(DE3); 
Route 2: Rg-TAL, Se-Sam5, Pc-4CL, and the native Ec-te  
Batch 
(4 days) 
Zhang et al., 
2013 
Strain rpoA14(DE3) was a previously constructed L-Tyr overproducer. 
E. coli 767 mg/L (caffeic acid) Rg-TAL, Ec-hpaBC, Ec-tyrAfbr, Ec-aroGfbr, Ec-ppsA, Ec-tktA, pheA∆, and 
tyrA∆ 
Shake flask 
(72 h) 
Huang et al., 
2013 
The host E. coli ATCC31884 is a commercial L-Phe overproducer. 
E. coli 10.2 g/L (caffeic acid based 
on 4-time supplementation 
of 20 mM p-coumaric acid) 
Pa-hpaBC  Whole cell 
conversion  
(24 h) 
Furuya et al., 
2014 Repeatedly adding 20 mM of p-coumaric acid 4 times during the reaction. 
E. coli 2.8 g/L (caffeic acid based 
on supplementation of 20 
mM p-coumaric acid) 
CYP199A2F185L, Pp-pdR, and Rp-pux Whole cell 
conversion  
(24 h) 
Furuya et al., 
2012 Pp-PdR, and Rp-pux serve as the redox partners for electron transfer. 
E. coli 280 mg/L (caffeic acid 
based on supplementation 
of 3 mM L-Tyr) 
Rg-TAL, Se-C3H or Rp-CYP199A2F185L, Pp-pdR, and Rp-pux Whole cell 
conversion  
(63 h) 
Rodrigues et al., 
2015 
 
CYP199A2F185L displayed a higher catalytic activity than C3H; Pp-PdR, and 
Rp-Pux serve as the redox partners of CYP199A2 for electron transfer. 
Hydroxystyrene P. putida 2.5 g/L 
90 mg/L/h 
Rt-PAL/TAL, Lp-pdc, and fcs∆ Two-stage fed 
batch 
(50 h) 
Verhoef et al., 
2009 Product toxicity was overcome by using 1-decanol as the in situ extractant; 
The host previously optimized for phenol and p-coumaric acid production. 
E. coli 0.4 g/L Rt-PAL/TAL and Lp-pdc in strain NST74 Fed batch 
(56 hr) 
Qi et al., 2007 
NST74 is a previously constructed L-Phe overproducer. 
3-Phenylpropionic 
acid 
3-(4-
hydroxyphenyl) 
propionic acid  
E. coli 366.77mg/L  
(3-phenylpropionic acid) 
225.10mg/L  
(3-(4-hydroxyphenyl) 
propionic acid) 
 Rg-TAL, Ca-er, Ec-tyrAfbr, Ec-aroGfbr, Ec-ppsA, and Ec-tktA,  
in ATCC31884 (3-phenylpropionic acid);  
Rg-TAL, Ca-er, Ec-tyrAfbr, Ec-aroGfbr, Ec-ppsA, Ec-tktA, pheA∆, and tyrA∆ 
in ATCC31884 (3-(4-hydroxyphenyl) propionic acid). 
Shake flask 
(72 h) 
Sun et al., 2016b 
Screened 11 ERs from 9 microorganisms; the host E. coli ATCC31884 is a 
commercial L-Phe overproducer. 
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Table 5. The microbial production of compounds derived from the L-Tyr branch (continued). 
 
Target 
Compound 
Host Reported titer,  
yield, and/or productivity 
(carbon source with 
additional supplements) 
The genetic manipulations in the final producer Fermentation 
type 
(total hours) 
Reference 
 
Metabolic engineering strategies  
Tyrosol  E. coli 573 mg/L 
 
Sc-ARO10, pheA∆, and feaB∆ (de novo biosynthesis); 
Sc-ARO10, Sc-ARO8, pheA∆, and feaB∆ (whole cell conversion). 
Shake flask 
(48 h) 
Whole cell 
conversion  
(20 h) 
Xue et al., 2017 
1203 mg/L tyrosol was produced in the whole cell conversion when 1.8 g/L  
L-Tyr was used as the substrate. 
Hydroxytyrosol E. coli 647 mg/L (from glucose) 
1243 mg/L (1 g/L L-Tyr was 
fed three times) 
Sc-ARO10, Sc-ADH6, Ec-hpaBC, Ec-tyrA, Ec-ppsA, Ec-tktA, Ec-aroGfbr, and 
feaB∆ 
Shake flask 
(48 h) 
Li et al., 2018a 
Ascorbic acid was added to prevent hydroxytyrosol oxidation; 1-dodecanol 
was used as in situ extractant to overcome product toxicity; NH4Cl was 
removed from the culture to enhance transamination. 
3,4-
Dihydroxyphenyl
acetate 
E. coli 1856 mg/L  
0.17 g/g carbon source 
Sc-ARO10, Ec-feaB, Ec-hpaBC, Ec-tyrA, Ec-ppsA, Ec-tktA, Ec-aroGfbr, 
pykA∆, and pykF∆ 
Shake flask 
(48 h) 
 
Li et al., 2019 
Mixed glucose and glycerol as the carbon sources resulted in best production. 
Salidroside E. coli 288 mg/L Pc-AAS, At-UGT86A1, tyrR∆, pheA∆, and feaB∆ Shake flask 
(48 h) 
Chung et al., 
2017 UGT85A1 was one of the 12 UGTs from A. thaliana that showed a 
glycosylation activity towards tyrosol. 
 E. coli  
co-culture 
6.03 g/L (based on glucose 
and xylose mixed culture) 
0.047 g/L/hr 
Strain 1: Pp-kdc4, Ec-aroGfbr, Ec-tyrAfbr, Ec-aroE, tyrR∆, pykA∆, pykF∆, 
pheA∆, feaB∆, ptsG∆, and manZ∆ 
Strain 2: At-UGT85A1, Ec-galU, Ec-pgm, xylA∆, tyrA∆, and ushA∆ 
Fed batch  
(129 h) 
Liu et al., 2018b 
Salvianic acid E. coli 7.1 g/L (plasmid version) 
 
5.6 g/L (genome integration) 
Ec-aroGfbr, Ec-tyrAfbr, Ec-aroE, Ec-glk, Ec-tktA. Ec-ppsA, Ec-hpaBC, Lp-D-
ldhY52A, ptsG∆, pykF∆, pykA∆, pheA∆, and tyrR∆ 
Fed batch 
(60-70 h) 
Yao et al., 2013 
The genome integration version did not require antibiotics and inducers. Zhou et al., 2017 
L-DOPA E. coli 8.67 g/L Ec-tyrAfbr, Ec-tyrB, Ec-hpaBC, Ec-galP, Ec-glK, tyrR∆, csrA∆, zwf∆, pheLA∆, 
ptsHI∆, and crr∆ 
Fed batch  
(60 h) 
Wei et al., 2016 
TyrAfbr, TyrB, and HpaBC were fused to form a fusion protein chimera 
E. coli 29.8 g/L Ss-tpl Whole-cell 
conversion 
(6 h) 
Lee et al., 1996 
50 mM pyrocatechol and sodium pyruvate, and 0.65 mM ammonia were fed. 
E. coli  
P. aeruginosa 
592 mg/L (E. coli) Cf-tpl, Pp-tdo, and Pp-tcgdh Whole-cell 
conversion 
(14 h) 
Park et al., 1998 
2761 mg/L 
(P. aeruginosa) 
Benzene and pyruvate were added intermittently as the substrates. 
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Table 6. Microbial production of selected benzylisoquinoline alkaloids derived from L-Tyr. 
 
 
Product 
 
Host 
 
Titer 
 
The genetic manipulations in the final producer 
 
Fermentation type 
 
Reference 
 
Bioconversion 
 
(S)-canadine  S. cerevisiae 
(supplemented with 1 mM 
norlaudanosoline) 
621 µg/L  Ps-6OMT, Ps-CNMT, Ps-4’OMT, At-CPR, Ps-BBE, Ps-S9OMT, Tf-
S9OMT, Cj-CAS, and Bw-STOX 
Batch 
(72 h) 
Galanie and 
Smolke, 2015 
Berberine 27 µg/L 1.8 mg/L canadine and 6.5 µg/L berberine in the shake flasks; 
39 µg/L berberine in fed-batch. 
(S)-sanguinarine S. cerevisiae 
(supplemented with 2 mM 
norlaudanosoline) 
80 µg/L  
 
Ps-6OMT, Ps-CNMT, Ps-4’OMT, Ps-BBE, Eca-CFS, Eca-STS, Ps-
TNMT, Ps-MSH, Eca-P6H, and At-CPR (ATR1) 
Tube or  
96-well plate 
(10 day) 
Trenchard and 
Smolke, 2015 
Magnoflorine  E. coli and  
S. cerevisiae co-culture 
(supplemented with 5 mM 
dopamine) 
7.2 mg/L  
 
E. coli: Ml-mao, Cj-PR10A (NCS), Cj-6OMT, Cj-CNMT, and Cj-
4’OMT 
S. cerevisiae: Cj-BBE 
Separately growing two 
strains for 12-20 h, and 
then mixing for 
48-72 h 
Minami et al., 2008 
(S)-scoulerine 8.3 mg/L  
 
E. coli: Ml-mao, Cj-PR10A (NCS), Cj-6OMT, Cj-CNMT, and Cj-
4’OMT 
S. cerevisiae: Cj-CYP80G2 and Cj-CNMT 
 
De novo biosynthesis 
 
 
 
(S)-Reticuline 
E. coli  
(from glycerol) 
46 mg/L  Rs-tyr, Pp-dodc, Ml-mao, Cj-NCS, Cj-6OMT, Cj-CNMT, Cj-4’OMT, 
Ec-aroGfbr, Ec-tyrAfbr, Ec-ppsA, Ec-tktA, and tyrR∆ 
Fed batch  
(80 h) 
Nakagawa et al., 
2011 
S. cerevisiae  
(from glucose) 
19.2 µg/L Rn-TyrHW166Y, R37E, R38E, Pp-dodc, Cj-NCS, Ps-6OMT, Ps-CNMT, Ps-
4’OMT, Eca-CYP80B1, Ps-CPR, Sc-TKL1, Rn-SepR, Rn-PTPS, Rn-
QDHPR, Rn-PCD, Sc-ARO4Q166K, and zwf1∆ 
96-well plates 
(96 h) 
Trenchard et al., 
2015 
S. cerevisiae  
(from glucose) 
80.6 µg/L  Bv-CYP76AD1W13L, F309L, Pp-dodc, Ps-NCS, Ps-6OMT, Ps-CNMT, Ps-
4’OMT, Eca-CYP80B1, and Sc-ARO4K229L 
Shake flask (96 h) DeLoache et al., 
2015 
 
Thebaine 
 
S. cerevisiae  
(from glucose) 
6.4 µg/L  Sc-ARO4Q166K, Sc-TKL, Sc-ARO10, Sc-ARO7T266I, Rn-SepR, Rn-
PTPS, Rn-QDHPR, Rn-PCD, Rn-TyrHR37E, R38E, W166Y, Rn-DHFR, Pp-
dodc, Cj-NCS, Ps-6OMT, Ps-CNMT, Ps-4’OMT, Ps-CPR, Eca-
NMCH, Pb-DRS-DRR, Eca-CFS1-83-PbSalSyn92-504, Pb-SalR, and Ps-
SalAT 
Tube or  
96-well plate 
 (120 h) 
Galanie et al., 
2015 
Hydrocodone 0.3 µg/L  Ps-T6ODM and Pp-MORB in addition to all the above manipulations 
 
Noscapine 
 
S. cerevisiae (from glucose 
and glycerol) 
2.2 mg/L  Sc-ARO4Q166K, Sc-TKL, Sc-ARO10, Sc-ARO7T266I, Sc-ALD6, Sc-
TYR1, Rn-SepR, Rn-PTPS, Rn-QDHPR, Rn-PCD, Rn-TyrHR37E, R38E, 
W166Y, Rn-DHFR, Pp-dodc, Cj-NCS, Ps-6OMT, Ps-CNMT, Ps-4’OMT, 
Ps-CPR, Eca-NMCH, Ps-BBE, Ps-S9OMT, Cj-CAS, Ps-CYP82Y1A, 
Ps-TNMT, Ps-CYP82X1, Ps-CXE1, Ps-MT2, Ps-CYP82X2, Ps-AT1, 
Ps-SDR1, and Ps-MT3 
Shake flask (72 h) Li et al., 2018b 
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Table 7. Microbial production of selected flavonoids and stilbenoids derived from the L-Tyr and L-Phe branches. 
Product Host Titer 
(carbon source with 
additional supplements) 
The genetic manipulations in the final producer Fermentation 
type 
 
Reference 
 
Metabolic engineering strategies  
Naringenin E. coli 29 mg/L  
84 mg/L (with addition of 
cerulenin) 
two copies of (Ec-tyrAfbr and Ec-aroGfbr), Rg-TAL, Pc-4CL, Ph-CHS, Ms-
CHI, pheA∆, and tyrR∆ 
Shake flask 
(48 h) 
Santos et al., 
2011 
Cerulenin is an inhibitor to fatty acid biosynthesis; malonyl-CoA is the rate-
limiting precursor. 
E. coli  
co-culture 
41.5 mg/L Strain 1: two copies of (Ec-tyrAfbr and Ec-aroGfbr), Rg-TAL, pheA∆, and 
tyrR∆; Strain 2: Rg-TAL, Pc-4CL, Ph-CHS, and Ms-CHI 
Shake flask 
(36 h) 
Ganesan et al., 
2017 
L-Tyr and p-coumaric acid are the two connecting molecules. 
S. cerevisiae 109 mg/L  Sc-ARO4G226S, At-PAL1, At-C4H, At-CPR1, At-4CL3, At-CHS3, At-CHI1, 
Rc-tal1, aro3∆, aro10∆, pdc5∆, and pdc6∆ 
Batch fermenter 
(38 h) 
Koopman et al., 
2012 
Two additional copies of At-CHS3 integration increased the titer by 2.5-fold. 
E. coli 421.6 mg/L 
(supplementation of 3 mM  
L-Tyr) 
Anti-fabF/fumC/fabB/sucC/adhE, Rg-TAL, Pc-4CL, Ph-CHS, and Ms-CHI  Shake-flask 
(48 h) 
Wu et al., 2015 
CRISPRi was applied to target central metabolic pathway genes to increase 
malonyl-CoA level. 
(2S)-
Pinocembrin 
E. coli 40.02 mg/L  Ec-aroFwt, Ec-phefbr, Rg-PAL, Pc-4CL, Ph-CHS, Ms-CHI, Rt-matB, and Rt-
matC 
Shake-flask 
(48 h) 
Wu et al., 2013 
MatB and MatC were overexpressed to increase malonyl-CoA level. 
Resveratrol S. cerevisiae 415.65 mg/L (from glucose) 
531.41 mg/L (from ethanol) 
Sc-ARO4K229L, Sc-ARO7G141S, Sc-ACC1S659A, S1157A, Ha-tal, At-4CL1, and Vv-
VST1 (multiple copies of tal, 4CL1, and VST1 were integrated.) 
Two-stage 
fermentation 
(~100 h) 
Li et al., 2015 
Batch fermentation on glucose followed by fed-batch on glucose or ethanol 
Pinosylvin E. coli 281 mg/L  Ec-aroFwt, Ec-pheAfbr, Tc-PAL, Pc-4CL, Vv-STS, and anti-
fabF/fabB/eno/adhE/fumC/sucC sgRNA (CRISPRi) 
Shake-flask 
(48 h) 
Wu et al., 2017 
Ponciretin E. coli 42.5 mg/L Ec-aroGfbr, Ec-ppsA, Ec-tktA, Ec-tyrAfbr, Se-tal, Os-4CL, Pe-CHS, Gm-
SOMT2, tyrR∆, pheA∆, and icdA∆ 
Shake-flask 
(60 h) 
Kim et al., 2013 
Sakuranetin 40.1 mg/L  Ec-aroGfbr, Ec-ppsA, Ec-tktA, Ec-tyrAfbr, Se-tal, Os-4CL, Pe-CHS,  
Os-NOMT, tyrR∆, pheA∆, and icdA∆ 
Shake-flask 
(48 h) 
Kaempferol S. cerevisiae 26.57 mg/L Sc-ARO4K229L, Sc-ARO7G141S, Fj-tal, Pc-4CL, aro10∆, and pdc5∆ (base 
strain) plus Ph-CHS, Ms-CHI, Am-F3H, and At-FLS 
96-well synthetic 
FIT fed-batch 
fermentation 
(72 h) 
Rodriguez et al., 
2017b 
Liquiritigenin 5.31 mg/L plus Ph-CHS, Ms-CHI, and Am-CHR 
Resokaempferol 0.51 mg/L plus Ph-CHS, Ms-CHI, Am-CHR, Am-F3H, and At-FLS  
Quercetin 20.38 mg/L plus Ph-CHS, Ms-CHI, Am-F3H, At-FLS, Ph-FMO, and Cr-CPR 
Fisetin 2.29 mg/L plus 2 copies of Ph-CHS/Am-CHR, Ms-CHI, Am-F3H, At-FLS, Ph-FMO, 
and Cr-CPR 
Curcumin 
 
E. coli 0.6 mg/L (supplemented 
with 3 mM L-Tyr) 
Tp-TAL, At-4CL, Ms-COMT, Se-c3h, and Os-CUS Shake-flask 
(48 h) 
Wang et al., 
2015 Bisdemethoxycurcumin (Tp-TAL, At-4CL, and Os-CUS) and 
dicinnamoylmethane (Tp-PAL, At-4CL, and Os-CUS) can be produced 
when 3 mM L-Tyr and L-Phe were supplied, respectively. 
Phloretin S. cerevisiae 42.7 mg/L At-PAL2, Am-C4H, Sc-CPR1, At-4CL2, Han-CHS, and Sc-TSC13 24-well plate 
batch 
(72 h) 
Eichenberger  
et al., 2017 Phlorizin 65 mg/L At-PAL2, Am-C4H, Sc-CPR1, At-4CL2, Han-CHS, Sc-TSC13,  
plus Pc-UGT88F2 (for phlorizin), Os-CGT (for nothofagin), At-UGT73B2 (for 
trilobatin), or the combination of At-UGT73B2, Cm-1,2RHAT, and At-RHM2 
(for naringin dihydrochalcone) 
Nothofagin 59 mg/L 
Trilobatin 32.8 mg/L 
Naringin 
dihydrochalcone 
11.6 mg/L 
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Figure 1. The backbone reactions of aromatic biosynthesis in S. cerevisiae and E. coli. Some parts of the pathway are organized differently i  the 
two hosts with distinct higher-order enzyme associations. (a) The upstream shikimate pathway; (b) The thr e aromatic amino acid branches in S. 
cerevisiae; (c) The three aromatic amino acid branches in E. coli.  
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Abbreviations of compounds: 4-HPP, 4-hydroxyphenylpyruvate; AA, anthranilate; 3-DHQ, 3-dehydroquinic acid; CA, chorismate; CDRP, 1-(2-
carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate; DHS: dehydroshikimate; DAHP, 3-deoxy-D-arabino-heptulosonic acid 7-phosphate; E4P, 
erythrose 4-phosphate; InGP, indole-3-glycerol-phosate; PEP, phosphoenolpyruvate; SA, shikimic acid; S3P, shikimate 3-phosphate; EPSP, 5-
enolpyruvylshikimate-3-phosphate; L-Phe, L-phenylalanine, PP, Phenylpyruvate; PRA, phosphoribosyl anthranilate; L-Trp, L-tryptophan; L-Tyr, L-
Tyrosine.  
 
Abbreviations of enzymes: Aro1, pentafunctional arom protein; Aro1A/AroA, EPS synthase; Aro1B, SA kinase; Aro1E/AroD, 3DHQ 
dehydratase; Aro1D/AroE, shikimate dehydrogenase; Aro2/ roC, chorismate synthase; Aro3/Aro4/AroF/AroG/AroH, DAHP synthase; Aro7, 
chorismate mutase; Aro8/9, aromatic amino acid transaminase; AroK, SA kinase I; AroL, SA kinase II; PheA/Pha2, prephenate dehydratase; Trp1, 
PRA isomerase; Trp2/3c, anthranilate synthase; Trp3B, InGP synthase; Trp4, anthranilate phosphoribosyl transferase; Trp5, bi-functional Trp 
synthase; TrpA, alpha subunit of Trp synthase; TrpB, beta subunit of Trp synthase; TrpC, bi-functional I GP synthase; TrpDC, C-terminal of TrpD, 
anthranilate phosphoribosyl transferase; TrpE, anthr ilate synthase; TrpG/TrpDN, N-terminal of TrpD, glutamine amidotransferase; Tyr1/TyrA, 
prephenate dehydrogenase; TyrB, aromatic amino acid transaminase. 
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Figure 2. The upstream products derived from the shikimate pahw y and their biosynthetic pathways. 
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Abbreviations of compounds: 2,3-DHBA, 2,3-dihydroxybenzoic acid; 2-ABA, anthranil te; 2-HBA, salicylate; 3-DHQ, 3-dehydroquinic acid; 3-
ABA, 3-aminobenzoic acid; 3-HBA, 3-hydroxybenzoate; 4-ABA, 4-aminobenzoate; 4-HBA, 4-hydroxybenzoate; CA, chorismate; DHS: 
dehydroshikimate; DAHP, 3-deoxy-D-arabino-heptulosonic acid 7-phosphate; E4P, erythrose 4-phosphate; G6P, glucose 6-phosphate; GLC, 
glucose; Gln, glutamine; Glu, glutamate; IsoCA, isoch rismate; MA, muconic acid; PAL, protocatechuic aldehyde; PEP, phosphoenolpyruvate; 
PET, polyethylene terephthalate; PCA, protocatechuate; PCN, phenazine-1-carboxamide; PDC, 2-pyrone-4,6-dicarboxylic acid; PYR, pyruvate;  
SA, shikimic acid; SG, salicylate 2-O-β-D-glucoside; VG, vanillin β-D-glucoside; XYL, xylose.   
 
Abbreviations of enzymes: 3DSD, 3-dehydroshikimate dehydratase; Abz1, aminodeoxychorismate synthase; Abz2, aminodeoxychorismate ly se; 
ACAR, aromatic carboxylic acid reductase; ADH, alcohol dehydrogenase; AntABC, anthranilate 1,2-dioxygenase; Aro1, pentafunctional arom 
protein; Aro3/Aro4/AroF/AroG/AroH, DAHP synthase; AroC, chorismate synthase; AroD, 3DHQ dehydratase; AroE, shikimate dehydrogenase; 
AroK, SA kinase I; AroL, SA kinase II; AroY, protocatechuate decarboxylase; AroZ, DHS dehydratase; AS, glucosyltransferase; AsbF, 
dehydroshikimate dehydratase; BDC, 2,3-DHBA decarboxylase; CAR, carboxylic acid reductase; CatA, catechol 1,2-dioxygenase; DHQ-SD, 
dehydroquinate dehydratase-shikimate dehydrogenase; EntA, 2,3-dihydro-2,3-DHBA dehydrogenase; EntB, isochorismatase; EntC, isochorismate 
synthase; GalP, galactose permease; Glf, glucose transporter; Glk, glucokinase; HexR, glucose catabolism repressor; HQD2, atechol-1,2-
dioxygenase; Hyg5, chorismatase; Irp9, bifunctional salicylate synthase; MenF, IsoCA synthase; MNX1, 4-HBA 1-hydroxylase; NahG, Salicylate 
1-monoxygase;Pad1, flavin mononucleotide prenyltransferase; OMT, O-methyltransferase; PabAB, aminodeoxychorismate synthase; PabC, 4-
amino-4-deoxychorismate lyase; PchB, IsoCA-pyruvate lyase; PctV, 3-ABA synthase; PmdAB, PCA 4,5-dioxygenase; PmdC, CHMS 
dehydrogenase; PobA, 4-HBA hydroxylase; PhzC, DAHP synthase; PhzE, anthranilate synthase; PpsA, phosphoenolpyruvate synthase; PPTase, 
phosphopantetheinyl transferase; PTS, phosphoenolpyruvate: carbohydrate phosphotransferase; PtsH, PtsI, and Crr, PTS glucose transport system; 
PykA/F, pyruvate kinase; Qad, quinic acid dehydrogenas ; RKI1, ketol-isomerase; Sfp, phosphopantetheinyl transferase; ShiA, DHS transporter; 
SthA, pyridine nucleotide transhydrogenase; Tkl1/TktA, transketolase; Trp2, anthranilate synthase; Trp3C, the N-terminal glutamine 
amidotransferase domain of TRP3; TrpE, anthranilate synthase; TrpG, glutamine amidotransferase; UbiC, chorismate lyase; UGT, UDP 
glycosyltransferase; Ugt74F1, salicylate glucosyltransferase; UGT73B6, glycosyltransferase; XanB2, chorismate lyase; XylA, xylose isomerase; 
YdiB, shikimate dehydrogenase; Zwf1, glucose-6-phosphate dehydrogenase.   
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Abbreviations of species: Ac, Acinetobacter calcoaceticus; At, Arabidopsis thaliana; Bs, Bacillus subtilis; Bt, Bacillus thuringiensis; Ca, 
Candida albicans; Cg, Corynebacterium glutamicum; Cp, Candida parapsilosis; Ct, Comamonas testosterone; Ec: E. coli; Ecl, Enterobacter 
cloacae; Hs, Homo sapiens; Kp, Klebsiella pneumonia; Ng, Nocardia genus; Ni, Nocardia iowensis; Pa, Podospora anserine; Pae, Pseudomonas 
aeruginosa; Pc, Pseudomonas chlororaphis; Pp, Pseudomonas putida; Ppa, Podospora pauciseta; Pt, Populus trichocarpa; Rs, Rauvolfia 
serpentine; Rsa, Rhodiola sachalinensis; Sc, S. cerevisiae; Sp, Streptomyces pactum; Xo, Xanthomonas oryzae pv. oryzae; Ye, Yersinia 
enterocolitica; Zm, Zymomonas mobilis. 
 101
       
Figure 3. 
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Figure 3. The products derived from the L-Trp branch and their biosynthetic pathways (a). BH4 biosynthesis and regeneration pathway in human 
and animals (b). MH4 biosynthesis in E. coli and the heterologous regeneration pathway (c). Reconstituting MH4 regeneration in E. coli using 
BH4 regeneration enzymes (d). 
 
Abbreviations of compounds: 5-HAA, 5-hydroxyanthranilate; BH3OH, pterin-4α-carbinolamine; BH4, 5,6,7,8-tetrahydrobiopterin; L-Ser, L-
serine; MH4, tetrahydromonapterin; 
 
Abbreviations of enzymes: AAAHs, pterin-dependent aromatic amino acid hydroxylases; AANAT, N-acetyltransferase; ALD6, acetaldehyde 
dehydrogenase; ASMT, N-acetylserotonin O-methyltransferase; DFR1, dihydrofolate reductase; DHMR, dihydromonapterin reductase; DHPR, 
dihydropteridine reductase; GCHI/FOL2, GTP cyclohydrolase I; FMO, flavin-containing monooxygenase; NDO, naphthalene dioxygenase; P4Hs, 
phenylalanine 4 hydroxylases; PCBD/PCD, pterin-4-alph -carbinolamine dehydratase; PheA, prephenate dehydratase; PTPS, 6-pyruvate-
tetrahydropterin synthase; S5Hs, salicylate 5 hydroxylases; SalABCD, salicylate 5-hydroxylase; SAM, S-adenosyl-L-methionine; SdaA, L-serine 
deaminase; SerA, 3-phosphoglycerate dehydrogenase; SPR, sepiapterin reductase; T5H, tryptophan 5-hydrox lase or tryptamine 5-hydroxylase; 
TDC, tryptophan decarboxylase; TnaA, tryptophanase; TnaB, L-Trp symporter; TPH2, tryptophan hydroxylase 2; TrpB, beta subunit of Trp 
synthase; TrpA, alpha subunit of Trp synthase; TrpC, bi-functional InGP synthase; TrpD, anthranilate phosphoribosyl transferase; TrpE, 
anthranilate synthase; TyrA, prephenate dehydrogenase; VioA, L-Trp oxidase; VioB, iminophenyl-pyruvate dimer synthase; VioE, violacein 
biosynthesis enzyme; VioC, violacein synthase; VioD, tryptophan hydroxylase. 
 
Abbreviations of species: Bs, Bacillus subtilis; Bt, Bos taurus; Cs, Comamonas sp.; Cr, Catharanthus roseus; Cv, Chromobacterium violaceum; 
Ct, Cupriavidus taiwanensis; Ec, Escherichia coli; Hs, Homo sapiens; Jl, Janthinobacterium lividum; Ma, Methylophaga aminisulfidivorans; Os, 
Oryza sativa; Oc, Oryctolagus cuniculu; Pa, Pseudomonas aeruginosa; Pp, Pseudomonas putida; Re, Ralstonia eutropha; Rn, Rattus norvegicus; 
Sc, Saccharomyces cerevisiae; Sm, Schistosoma mansoni; Xc, Xanthomonas campestris.  
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Figure 4. The products derived from the L-Phe branch and their biosynthetic pathways. 
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Abbreviations of enzymes: 4CL, 4-coumarate:CoA ligase; Acar, arylcarboxylic acid reductase; ADH2/Adh4428, alcohol dehydrogenase; Ald3, 
aldehyde dehydrogenases; Aro7, chorismate mutase; Aro8/9, aromatic amino acid transaminase; Aro10, phenylpyruvate decarboxylase; AspC, 
aspartate aminotransferase; CCR, cinnamoyl-CoA reductase; DMD, D-mandelate dehydrogenase; EntD, phosphopantetheinyl transferase; EncH, 
cinnamate-CoA ligase; EncI, cinnamoyl-CoA hydratase; EncJ, 3-keto-3-phenylpropionyl-CoA thiolase; EncM, β-hydroxyacyl-CoA 
dehydrogenase; EncN, benzoate-CoA ligase; EncP, phenylalanine ammonia lyase;FDC1, ferulic acid decarboxylase; FldA: cinnamoyl-
CoA:phenyllactate CoA-transferase; HmaS, 4-hydroxymandelate synthase; Hmo, 4-hydroxymandelate oxidase; HpgT, L-phenylglycine 
aminotransferase; HpgAT, D-phenylglycine aminotransferase; Kdc4427, 2-keto acid decarboxylase; PADC, trans-cinnamate decarboxylase; PAL, 
phenylalanine ammonia lyase; PAL2, phenylalanine ammonia lyase 2; PheA/PheA2, prephenate dehydratase; Pdc5, pyruvate decarboxylase; 
PPR/PprA, phenylpyruvate reductase; Trp2/3, anthranilate synthase; TrpE, anthranilate synthase; Tyr1/TyrA, prephenate dehydrogenase; TyrB, 
aromatic amino acid aminotransferase.  
 
Abbreviations of species: Ao, Amycolatopsis orientalis; At, Arabidopsis thaliana; Av, Anabaena variabilis; Bs, Bacillus subtilis; Cs, Clostridium 
sp.; Ec, Escherichia coli; Es, Enterobacter sp.; Lp, Lactobacillus plantarum; Np, Nostoc punctiforme; Ns, Nocardia sp.; Pp, Pseudomonas putida; 
Rg, Rhodotorula graminis; Sc, S. cerevisiae; Sco, Streptomyces coelicolor; Sm, Streptomyces maritimus; Wf, Wickerhamia fluorescens. 
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Figure 5. The products derived from the L-Tyr branch and their biosynthetic pathways.  
 106
Abbreviations of compounds: Glc, glucose; UDP, uridine diphosphate. 
 
Abbreviations of enzymes: 4CL, 4-coumarate:CoA ligase; AAS, aromatic aldehyde synthase; ADH, alcohol dehydrogenase; Aro7, chorismate 
mutase; Aro8/9, aromatic amino acid transaminase; Aro10, phenylpyruvate decarboxylase; C4H, cinnamate 4-hydroxylase; C3H/Sam5, P450 4-
coumarate 3-hydroxylase; Com, O-methyltransferase; CYP199A2, P450 hydroxylase; D-LDH, D-lactate dehydrogenase; ER, enoate reductases; 
FCS, feruloyl-coenzyme A synthetase; FeaB, phenylacetaldehyde dehydrogenase; GalU, UDP-glucose pyrophosphorylase; HpaBC, nonP450 
hydroxylase; KDC, 2-keto acid decarboxylase; PAL, phenylalanine ammonia-lyase; PDC, p-coumaric acid decarboxylase; Pdc5, pyruvate 
decarboxylase; PdR, putidaredoxin reductase; Pgm, phosphoglucomutase; PheLA, prephenate dehydratase and its leader peptide genes; Pux, 
palustrisredoxin; TAL, tyrosine ammonia-lyase; TCGDH, cis-toluene dihydrodiol dehydrogenase; TDO, toluene dioxygenase; TE, CoA 
thioesterases; TPL, tyrosine phenol-lyase; TyrA, prephenate dehydrogenase; TyrB, aromatic amino acid aminotransferase; UGT85A1, uridine 
diphosphate-dependent glycosyltransferase; UshA, UDP-sugar hydrolase.   
 
Abbreviations of species: At, Arabidopsis Thaliana; Ca, Clostridium acetobutylicum; Cf, Citrobacter freundii; Ec, Escherichia coli; Fj, 
Flavobacterium johnsoniaeu; Lp, Lactobacillus plantarum; Lpe, Lactobacillus pentosus; Pa, Pseudomonas aeruginosa; Pc, Petroselinum crispus; 
Rc, Rhodobacter capsulatus; Rg, Rhodotorula glutinis; Rp, Rhodopseudomonas palustris; Rt, Rhodosporidium toruloides; Pc, Petroselinum 
crispum; Pp, Pseudomonas putida; Ppa, Pichia pastoris; Sc, Saccharomyces cerevisiae; Se, Saccharothrix espanaensis; Ss, Symbiobacterium 
species.  
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Figure 6. The microbial production of benzylisoquinoline alkaloids derived from L-Tyr.   
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Abbreviations of enzymes: Aro8, aromatic aminotransferase I; Aro9, aromatic aminotransferase II; Aro10, phenylpyruvate decarboxylase; BBE, 
berberine bridge enzyme; CAS, canadine synthase; CFS, cheilanthifoline synthase; CNMT, coclaurine-N-methyltransferase; CPR, cytochrome 
P450 reductase; CYP76AD1*(TyrH*), tyrosine hydroxylase mutant; CYP80B1 (NMCH), N-methylcoclaurine hydroxylase; CYP80G2, diphenyl 
ring bridging enzyme; DBOX, dihydrobenzophenanthridine oxidase; DODC, L-DOPA decarboxylase; DRS-DRR, 1,2-dehydroreticuline synthase-
1,2-dehydroreticuline reductase; MAO, monoamine oxidase; MSH, cis-N-methylstylopine 14-hydroxylase; NCS, norcoclaurine synthase; 4′OMT, 
3′-hydroxy-N-methylcoclaurine 4′-O-methyltransferase; 6OMT, 6-O methyltransferase;  P6H, protopine 6-hydroxylase; Pdc5 and Pdc6, pyruvate 
decarboxylase; PR10A, pathogenesis-related 10 protein; S9OMT, scoulerine 9-O-methyltransferase; STOX, (S)-tetrahydroprotoberberine oxidase; 
STS, stylopine synthase; TNMT, tetrahydroprotoberberine N-methyltransferase; TYR, tyrosinase.  
 
Abbreviations of species: Am, Argemone mexicana; At, Arabidopsis thaliana; Bv, Beta vulgaris; Bw, Berberis wilsonae; Cj, Coptis japonica; 
Eca, Eschscholzia californica; Ml, Micrococcus luteus; Pb, Papaver bracteatum; Pp, Pseudomonas putida; Ps, Papaver somniferum; Rn, R. 
norvegicus; Rs, Ralstonia solanacearum; Sca, Streptomyces castaneoglobisporus; Sc, Saccharomyces cerevisiae; Tf, Thalictrum flavum. 
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Figure 7. Microbial production of flavonoids and stilbenoids erived from L-Tyr and L-Phe.   
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Abbreviations of enzymes: ACC1, acetyl-CoA carboxylase; Aro10, phenylpyruvate decarboxylase; 4CL, 4-coumarate-CoA ligase; C3H, 4-
coumarate 3-hydroxylase; C4H, cinnamic acid hydroxylase; CHI, chalcone isomerase; CHR, chalcone reductase; CHS, chalcone synthase; COMT, 
caffeic acid 3-O-methyltransferase; CPR, cytochrome P450 reductase; CUS, curcumin synthase; DBR, double bond reductase; F3H, flavanone 3-
hydroxylase; FLS, flavonol synthase; FMO, flavonoid 3’-monooxygenase; IcdA, isocitrate dehydrogenase; matB, malonyl-CoA synthetase; matC, 
malonate carrier protein; NOMT, naringenin 7-O-methyltransferase; PAL, phenylalanine ammonia lyase; Pdc5 and Pdc6, pyruvate decarboxylase; 
1,2RHAT, 1,2 rhamnosyltransferase; RHM2, UDP-glucose 4,6-dehydratase; SOMT2, soybean O-methyltransferase; TAL, tyrosine ammonia lyase; 
TSC13, very long chain enoyl-CoA reductase; UGT88F2, UGT73B2, CGT, UDP-dependent-glycosyltransferase; VST1 (STS), resveratrol 
synthase or stilbene synthase.  
 
Abbreviations of species: Ama, Ammi majus; Am, Astragalus mongholicus; Ah, Arachis hypogaea; At, Arabidopsis thaliana; Cm, Citrus maxima; 
Cr, Catharanthus roseus; Ec, Escherichia coli; Fj, Flavobacterium johnsoniae; Gm, Glycine max; Ha, Herpetosiphon aurantiacus; Han, 
Hypericum androsaemum; Ms, Medicago sativa; Os, Oryza sativa; Pc, Petroselinum crispum; Pco, Pyrus communis; Pe, Populus euramericana; 
Ph, Pericallis hybrida; Pl, Pueraria lobata; Rc, Rhodobacter capsulatus; Rg, Rhodotorula glutinis; Rsp, Rhodobacter sphaeroides; Rt, Rhizobium 
trifolii; Sc, Saccharomyces cerevisiae; Sco, Streptomyces coelicolor; Se, Saccharothrix espanaensis; Tc, Trichosporon cutaneum; Tp, Trifolium 
pretense; Vv, Vitis vinifera.  
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Figure 8. Proposed strategies that could potentially enhance the de novo production of aromatic amino acid pathway derivatives in S. cerevisiae. 
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Abbreviations of enzymes and proteins: MAE1, pyruvic-malic enzyme; MDH, malate dehydrogenase; MPC1-2, mitochondrial pyruvate inner 
membrane carriers; Mqo, malate:quinone oxidoreductase; OAC1, mitochondrial oxaloacetate transport protein; ODC1-2, mitochondrial carriers; 
PDK, orthophosphate dikinase; POR1-2, outer membrane tr sporters; PPCK, phosphoenolpyruvate carboxykinase; PpsA, Phosphoenolpyruvate 
synthase; PYC, pyruvate carboxylase; PYK, pyruvate kinase. 
 
Abbreviations of species: At, Arabidopsis thaliana; Ec, Escherichia coli; Zm, Zea mays. 
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• The aromatic amino acid biosynthesis pathway yields commercially valuable products. 
• The broad scope of products from aromatic amino acid biosynthesis is described. 
• Biosynthetic pathways and interconnections among the sub-branches are presented. 
• High-level organization of enzymes of the upstream module is illustrated. 
• The sophisticated endogenous regulations in the upstream pathway at various levels 
are discussed. 
 
